Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY1,Aminoacylase-1,29478,0.197341616435068,0.00427174499005656,0.188968996254557,0.205714236615579,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.29314785390101,0.00575063804831224,0.281876603326317,0.304419104475702,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADIPOQ,Adiponectin,24966,-0.251719305741547,0.00458498136824322,-0.260705869223304,-0.242732742259791,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFM,Afamin,24966,0.0592121405403229,0.00134926105212039,0.056567588878167,0.0618566922024789,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR3,Anterior gradient protein 3,28764,0.171889346461791,0.00415247484204579,0.163750495771381,0.180028197152201,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRP,Agouti-related protein,29786,0.292200506904607,0.00339529812752396,0.28554572257466,0.298855291234554,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APCS,Serum amyloid P-component,24726,0.110227018710347,0.00239492148816692,0.10553297259354,0.114921064827154,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.0937799922581531,0.002064191311851,0.0897341772869251,0.0978258072293811,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCHE,Cholinesterase,24528,0.0887409016601067,0.00193725403202097,0.0849438837573456,0.0925379195628678,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9,Complement component C9,24951,-0.176369642921807,0.00365600666343539,-0.18353541598214,-0.169203869861473,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.208504809361518,0.00514019646971865,0.19843002428087,0.218579594442167,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL16,C-C motif chemokine 16,29820,0.150213512099881,0.00364978934569973,0.14305992498231,0.157367099217452,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL23,C-C motif chemokine 23,29581,0.137829403012053,0.00287348050115119,0.132197381229797,0.143461424794309,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL27,C-C motif chemokine 27,29478,0.239358031979672,0.00417087693392752,0.231183113189174,0.24753295077017,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN1,CCN family member 1,29301,0.380854702292134,0.00493508064939707,0.371181944219315,0.390527460364952,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.107438585794777,0.00261984893778395,-0.112573489712834,-0.102303681876721,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.104557597851416,0.00205941548192553,0.100521143506842,0.10859405219599,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.341880486835346,0.00731548084616191,0.327542144376869,0.356218829293824,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES1,Liver carboxylesterase 1,29489,0.343659778411213,0.00544149708946444,0.332994444115862,0.354325112706563,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFH,Complement factor H,23693,0.0686454602792518,0.00162084300524423,0.0654686079889731,0.0718223125695305,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFI,Complement factor I,24966,0.0594085177891932,0.00138179635620484,0.0567001969310317,0.0621168386473547,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFP,Properdin,24966,0.064778292008388,0.00160489689291006,0.0616326940982843,0.0679238899184917,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.16463299881228,0.00392807920907966,0.156933963562484,0.172332034062076,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKB,Creatine kinase B-type,24938,-0.164051975854627,0.00413058372239958,-0.17214791995053,-0.155956031758723,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN3,Contactin-3,29443,0.101476853217688,0.00223766045248508,0.0970910387308171,0.105862667704559,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPM,Carboxypeptidase M,29584,0.119679149757073,0.00235751169597201,0.115058426832968,0.124299872681178,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIP2,Cysteine-rich protein 2,29218,0.112020702293646,0.0025197075528059,0.107082075490146,0.116959329097145,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.238507904672339,0.00533825417139526,0.228044926496404,0.248970882848274,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.492306926746706,0.0101634393978652,0.472386585526891,0.512227267966522,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.300667938045117,0.00597674748175597,0.288953512980875,0.312382363109359,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG2,Desmoglein-2,29443,-0.0919222256889333,0.00186158300956574,-0.0955709283876821,-0.0882735229901845,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO3,Beta-enolase,24240,0.168146091044167,0.00419892595466892,0.159916196173016,0.176375985915318,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0575386622697611,0.00135852323731281,0.054875956724628,0.0602013678148942,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0721670764012532,0.0018050270683632,0.0686292233472613,0.0757049294552451,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F7,Coagulation factor VII,29544,0.118722303773711,0.00208617009447312,0.114633410388544,0.122811197158878,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F9,Coagulation factor IX,29545,0.0538540769488921,0.00126570987691743,0.051373285590134,0.0563348683076503,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF21,Fibroblast growth factor 21,29674,0.346163618589355,0.00826041124868121,0.32997321254194,0.36235402463677,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0606757987681433,0.00154406964453233,0.0576494222648599,0.0637021752714267,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.309949588525017,0.00769756746166076,0.294862356300162,0.325036820749872,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.240744660744785,0.00593525054398752,0.229111569678569,0.252377751811,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FURIN,Furin,29566,0.13589143933104,0.00227020755420258,0.131441832524803,0.140341046137277,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCG,Pro-glucagon,28797,0.530509059531785,0.00837548827099068,0.514093102520643,0.546925016542927,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHR,Growth hormone receptor,24381,0.114279155430691,0.00193151105792791,0.110493393757152,0.11806491710423,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR37,Prosaposin receptor GPR37,28916,0.225296523341971,0.00456388971724941,0.216351299496162,0.23424174718778,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA1,Glutathione S-transferase A1,29426,0.263238306524418,0.00584155896811593,0.251788850946911,0.274687762101925,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTA3,Glutathione S-transferase A3,28797,0.235576695866284,0.00532261955945995,0.225144361529743,0.246009030202826,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUSB,Beta-glucuronidase,29604,0.188053432858735,0.00414512438221132,0.179928989069601,0.196177876647869,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.300994332361512,0.0051422261187894,0.290915569168685,0.311073095554339,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.111808308334688,0.00236760049351316,0.107167811367402,0.116448805301973,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.407943692153374,0.00842139731153808,-0.424449630883989,-0.39143775342276,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.201568765686161,0.0043114278353699,-0.210019164243486,-0.193118367128836,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0840889412222407,0.00213054111887655,0.0799130806292427,0.0882648018152387,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF9,Protein turtle homolog A,24922,0.342873248866683,0.00555171084623085,0.33199189560807,0.353754602125295,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBC,Inhibin beta C chain,29443,0.152136307150662,0.00282682983595921,0.146595720672182,0.157676893629142,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYNU,Kynureninase,29786,0.130834952004467,0.00316649518129503,0.124628621449129,0.137041282559805,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0575424854290954,0.00136500276765134,0.0548670800044987,0.060217890853692,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0849596667544223,0.00150415423650432,0.0820115244508738,0.0879078090579707,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLR,Low-density lipoprotein receptor,29500,0.421387743416215,0.00287864034379885,0.415745608342369,0.42702987849006,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPL,Lipoprotein lipase,29478,-0.198174883659688,0.00316959007140365,-0.20438728019964,-0.191962487119737,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFGE8,Lactadherin,29443,0.255392424576036,0.00277111154092607,0.249961045955821,0.260823803196251,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0936717493163528,0.00211800435974855,-0.0978230378614599,-0.0895204607712456,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCS1,Neuronal calcium sensor 1,29725,0.0787873154815979,0.00200097538857706,0.0748654037199868,0.0827092272432089,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.149141513569402,0.00368996423585096,0.141909183667134,0.156373843471669,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0968229889933101,0.00238305945826482,-0.101493785531509,-0.0921521924551111,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPY,Pro-neuropeptide Y,29725,0.372839924460698,0.004197938538737,0.364611964924773,0.381067883996622,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP1,Neuropilin-1,29628,-0.0945058483354698,0.0019173047914311,-0.0982637657266748,-0.0907479309442649,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.154765023829161,0.00384008087842252,0.147238465307453,0.162291582350869,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0799413695997811,0.00192330136069147,0.0761716989328258,0.0837110402667364,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.0993446698372314,0.00220960671740751,0.0950138406711127,0.10367549900335,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAT,Tissue-type plasminogen activator,29736,0.153473094377807,0.00349446509479074,0.146623942792017,0.160322245963597,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLTP,Phospholipid transfer protein,29702,-0.116272855952375,0.00248748348945931,-0.121148323591715,-0.111397388313035,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.0873083417127067,0.00197055178316461,-0.0911706232077094,-0.0834460602177041,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.163151720770794,0.00275080003315223,0.157760152705816,0.168543288835773,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0928938986517579,0.00218916707863751,0.0886031311776284,0.0971846661258874,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROC,Vitamin K-dependent protein C,29545,0.0861689626273723,0.00178627535787637,0.0826678629259346,0.0896700623288099,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.180237095972947,0.00411676159841424,0.172168243240055,0.188305948705838,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH,Parathyroid hormone,24195,0.30395103267835,0.00549148357598682,0.293187724869415,0.314714340487284,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.184612707123958,0.00321146013431834,0.178318245260694,0.190907168987222,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP5,Retinol-binding protein 5,29349,0.16635533714213,0.00390596128114078,0.158699653031094,0.174011021253166,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA4,Kallistatin,24557,0.0724814200600358,0.00165441627197882,0.0692387641669573,0.0757240759531143,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.0986713381515982,0.00220253931466733,0.0943543610948502,0.102988315208346,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPIND1,Heparin cofactor 2,24914,0.0795989001192253,0.00196362795588119,0.0757501893256982,0.0834476109127524,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.0786079186196957,0.00181189577646158,0.075056602897831,0.0821592343415604,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHBG,Sex hormone-binding globulin,24951,-0.158205135940453,0.00357196217745264,-0.16520618180826,-0.151204090072646,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.202591094809031,0.00508482312774201,0.192624841478657,0.212557348139406,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.188534189355261,0.00367144810333238,0.181338151072729,0.195730227637792,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.286792370775875,0.00565441795470938,0.275709711584645,0.297875029967106,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.129813460924574,0.0022317743832007,0.125439183133501,0.134187738715648,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCA,Alpha-synuclein,24381,0.323567340774652,0.00806596993387406,0.307758039704259,0.339376641845045,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.343016889338222,0.00794775046920115,0.327439298418588,0.358594480257857,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.153379141473436,0.00291685570953016,0.147662104282757,0.159096178664115,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.154643807575497,0.00363644350985328,0.147516378296185,0.161771236854809,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS15,Enteropeptidase,29349,0.316844339524074,0.00620946653498466,0.304673785115504,0.329014893932644,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTR,Transthyretin,24707,0.0815573535640545,0.00174859568037236,0.0781301060305247,0.0849846010975844,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPB1,Beta-ureidopropionase,24922,0.27602267069606,0.00634374754104467,0.263588925515612,0.288456415876507,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.213849031146437,0.00471688890142278,0.204603928899648,0.223094133393226,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.267192663499396,0.00548541743433297,0.256441245328103,0.277944081670688,0
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLA,Alpha-galactosidase A,24329,0.102365774381541,0.00262246019671642,0.0972257523959769,0.107505796367105,1.1125369292536e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.128986051410687,0.00331706036243932,0.122484613100306,0.135487489721068,1.11253692925361e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0765497956521392,0.00198145159151694,0.072666150532766,0.0804334407715124,1.11253693110666e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRP,Gastrin-releasing peptide,24240,0.145611858583331,0.00377328057191317,0.138216228662381,0.153007488504281,1.1125369450863e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH1,Somatotropin,29433,-0.47718406118338,0.0124279532571753,-0.501542849567444,-0.452825272799317,1.11253738578483e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0666817295034785,0.00173700955190921,0.0632771907817365,0.0700862682252206,1.11253747922385e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.0893535143278421,0.00233145658103868,0.0847838594290063,0.0939231692266779,1.11254265897394e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.10228083989307,0.00267028821372334,-0.107514604791968,-0.0970470749941724,1.112549255681e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.185737192704767,0.0048482907547681,0.176234542825422,0.195239842584113,1.11279773911301e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR2,Cadherin-related family member 2,29349,0.193436865362492,0.00507681307405836,0.183486311737338,0.203387418987647,1.13421307787015e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.330248688970223,0.00868822761652124,0.313219762841841,0.347277615098605,1.70110576390465e-308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.180415721363328,0.00475341961618936,0.171099018915597,0.189732423811059,1.23619273084239e-307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUMB,Protein numb homolog,24229,0.222102332100012,0.0058417730046314,0.210652457010934,0.233552207189089,2.8869124498912e-307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0841006677237814,0.00222638054769699,0.0797369618502953,0.0884643735972675,6.06505446502051e-305
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS1,Protein MTSS 1,24805,0.293791760842742,0.00776392883117403,0.278574460333641,0.309009061351843,1.11821854303324e-304
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOMO1,Nodal modulator 1,29443,0.0621880834221624,0.00164795972873903,0.0589580823538339,0.0654180844904909,2.28106165708955e-304
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEG1,Protein HEG homolog 1,24381,0.0720511154199065,0.0019046022203108,0.0683180950680974,0.0757841357717157,2.28130485117156e-304
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.22557743552067,0.00596640865261353,0.213883274561548,0.237271596479793,5.67897942820586e-304
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.0834929274176931,0.00221914353834791,0.0791434060825312,0.087842448752855,1.3092203225452e-302
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCLY,Selenocysteine lyase,29632,0.127328860119897,0.00339640480588059,0.120671906700371,0.133985813539423,1.47364679067135e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F10,Coagulation factor X,24951,0.0723293701148795,0.00192572018394069,0.0685549585543557,0.0761037816754032,2.26353932556921e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.152108409433745,0.00405077127068139,0.144168897743209,0.16004792112428,3.338889552555e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0538638464168624,0.00143774063256492,0.0510458747770351,0.0566818180566896,3.42401296566424e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS8,Prostasin,29347,0.107780303094503,0.00287830071810445,0.102138833687019,0.113421772501988,8.13796898897231e-300
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTYMK,Thymidylate kinase,24922,0.179569863012205,0.0047905909552187,0.170180304739976,0.188959421284433,3.41857510504338e-299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,P4HB,Protein disulfide-isomerase,29313,0.100551554027103,0.00271691680736331,0.0952263970846709,0.105876710969535,4.56956220561951e-293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.164066394893414,0.00444850381235707,0.155347327421194,0.172785462365634,5.52390675514812e-291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.14839004942759,0.00401566266619384,0.14051935060185,0.15626074825333,7.66195614812359e-291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.101795998861827,0.00277768018969066,0.0963517456900331,0.10724025203362,1.52654688664082e-287
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11R,Junctional adhesion molecule A,29443,0.144280280175691,0.00393965004623512,0.13655856608507,0.152001994266312,3.53058747837675e-287
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL16,Pro-interleukin-16,29786,0.106162711567405,0.00290166408295326,0.100475449964816,0.111849973169993,1.04791139091778e-286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAB2,Stabilin-2,24938,0.072362195281735,0.00197442868745535,0.0684923150543225,0.0762320755091475,1.83987695555412e-286
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPY30,Protein dpy-30 homolog,29604,0.152442669912861,0.00419571034907072,0.144219077628682,0.160666262197039,8.09038985740394e-283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORD,Sorbitol dehydrogenase,29595,0.173571200474834,0.00477883878626506,0.164204676453755,0.182937724495914,1.24189122913352e-282
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MVK,Mevalonate kinase,28931,0.203091032124671,0.00559307905918684,0.192128597168665,0.214053467080677,2.38982155172253e-282
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.232367728491655,0.00641192898837095,0.219800347674448,0.244935109308862,2.09395836675968e-281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.141392296746361,0.00389414910144205,0.133759764507535,0.149024828985188,2.72461935139966e-281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.35596224002744,0.00980425390975459,0.336745902364321,0.375178577690559,2.89510395630592e-281
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH9,Myosin-9,24938,0.286759998722006,0.00791319695060824,0.271250132698813,0.302269864745198,2.83624863951561e-280
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.17238926768437,0.00477409167032163,0.16303204801054,0.181746487358201,4.1231526071075e-278
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.136469448913106,0.00379160247253577,0.129037908066936,0.143900989759276,1.19332111159038e-277
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORT1,Sortilin,29433,0.0939420129204393,0.00261485322816041,0.0888169005932449,0.0990671252476337,1.14230288998027e-276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.0640197856265871,0.00178285043814984,0.0605253987678134,0.0675141724853607,1.97424789015787e-276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0643069536355275,0.00178865619347831,0.0608011874963101,0.067812719774745,5.03564621072708e-276
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.190333299519991,0.00529664016415371,0.17995188479825,0.200714714241732,1.35356859558543e-275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHK,Ketohexokinase,24240,0.161553076947841,0.00449747766664858,0.15273802072121,0.170368133174472,2.38807944833333e-275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EEF1D,Elongation factor 1-delta,24922,0.229168207942517,0.00640488546290257,0.216614632435228,0.241721783449806,1.86308035604466e-273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBP,Protein AMBP,29683,0.0503307005591878,0.0014135501942443,0.047560142178469,0.0531012589399067,6.08001367000798e-272
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.157555373527593,0.00443048779188114,-0.16623912959968,-0.148871617455505,3.20941926178418e-271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLUL1,Clusterin-like protein 1,29435,-0.112596437982498,0.00317000842148934,-0.118809654488617,-0.106383221476379,1.30067105616712e-270
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYY,Peptide YY,24111,0.241972789883389,0.00681383456563695,0.22861767413474,0.255327905632037,2.77221804390478e-269
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MME,Neprilysin,29349,0.199426681311635,0.00563723195516786,0.188377706679506,0.210475655943764,1.72598921991566e-268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.2823801357653,0.0079878870255369,0.266723877195248,0.298036394335352,4.12407068405731e-268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0690642426050294,0.00195423595774409,0.0652339401278509,0.0728945450822078,5.63117123912459e-268
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRN,"Attractin, Isoform 2",24966,0.0411569886613978,0.00116613522916225,0.0388713636122398,0.0434426137105558,2.59434725639597e-266
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FYB1,FYN-binding protein 1,29400,0.227441734178157,0.00645803637932173,0.214783982874686,0.240099485481628,3.60846736766301e-266
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.124316116552298,0.00353381834033432,0.117389832605242,0.131242400499353,1.37380926652723e-265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.098446168564319,0.00279908841212425,0.0929599552765555,0.103932381852083,1.73612618139937e-265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.107840864351578,0.00306789295182801,0.101827794165995,0.113853934537161,3.54203577583211e-265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.298783375796809,0.00848562551583317,0.282151549785776,0.315415201807842,6.68215357444879e-265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.05397821765579,0.00153350967798309,0.0509725386869431,0.0569838966246368,8.73862525970114e-265
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.162846220206526,0.00462885451632938,0.153773665354521,0.171918775058532,1.17789785067538e-264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPC,C-type natriuretic peptide,29434,0.118108800641085,0.00336841022158648,0.111506716606776,0.124710884675395,6.59757001301412e-264
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.16659295628057,0.00475638310998295,0.157270445385004,0.175915467176137,2.50034157279787e-263
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELN,Elastin,24922,0.0864798699028001,0.00246706779306748,0.0816444170283878,0.0913153227772123,8.27285283775244e-263
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.121573510484849,0.00347010230144412,0.114772109974019,0.12837491099568,2.14996409276883e-262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.0806228001997204,0.00230771291016004,0.0760996828958067,0.085145917503634,4.15649756797431e-262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSD,Cathepsin D,27442,0.099684451025852,0.00285596367316321,0.0940867622264521,0.105282139825252,3.36872579115175e-261
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPY,Pancreatic prohormone,29400,0.247921611141934,0.00715854871618139,0.233890855658218,0.261952366625649,1.23207547313651e-257
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0725180948833771,0.00209590603494203,0.0684101190548907,0.0766260707118634,3.43283909910056e-257
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR5,Cadherin-related family member 5,29478,0.0946299577347402,0.00273709844657055,0.0892652447794619,0.0999946706900185,8.75591535569105e-257
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.217018790664693,0.00628506624079761,0.204700060832729,0.229337520496656,4.24063091236299e-256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.133993037460057,0.00388630973692211,0.126375870375689,0.141610204544424,2.53655142942093e-255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.193093713350219,0.00559125616536896,0.182134851266096,0.204052575434342,2.69056259190678e-255
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLN,Promotilin,29434,0.21581011143665,0.00626986564399704,0.203521174774416,0.228099048098885,1.42225685108933e-254
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.114112734912509,0.0033176249115666,0.107610190085838,0.120615279739179,3.30180300100742e-253
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYAP1,Synapse-associated protein 1,24381,0.138511376108104,0.00403866318615648,0.130595596263237,0.14642715595297,8.56500811328377e-252
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4R,Reticulon-4 receptor,29725,0.0814305845237444,0.00238008585154248,0.0767656162547211,0.0860955527927676,1.18436113533022e-251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.126285397214594,0.00368580899155196,0.119061211591152,0.133509582838036,2.07146550806765e-251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.262663479230077,0.0076744998742668,0.247621459476514,0.27770549898364,6.88002849164959e-251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HJV,Hemojuvelin,24867,0.1064799535128,0.00311153293120893,0.100381348967631,0.11257855805797,7.7581845077266e-251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLKB1,Plasma kallikrein,24454,0.0603953298819163,0.00176607137668539,0.056933829983613,0.0638568297802197,2.08236478900001e-250
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.145856732781458,0.0042810952839686,0.13746578602488,0.154247679538037,1.33435122560134e-249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3F,Semaphorin-3F,29478,0.0631804993441568,0.0018550809098591,0.059544540760833,0.0668164579274806,2.13210008287107e-249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.141453362480701,0.00415370964518715,-0.149594633385268,-0.133312091576135,2.62341605273398e-249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.203902461011274,0.00599813238137897,0.192146121543772,0.215658800478777,2.11193819400022e-248
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.131335605724929,0.00387361593530323,0.123743318491735,0.138927892958123,4.33873695158154e-247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.201542938541938,0.00594826008860597,0.189884348768271,0.213201528315606,6.53899535155401e-246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2AP,CD2-associated protein,29478,0.151216274755247,0.00447311368532147,0.142448971932017,0.159983577578477,8.17956017791382e-246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN2,Ficolin-2,29381,0.0974536231178276,0.00288807612959488,0.0917929939038216,0.103114252331834,6.40112485080306e-245
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES3,Carboxylesterase 3,29349,0.164435806791014,0.00491077436424579,0.154810689037092,0.174060924544936,2.82840894471722e-241
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0695931945926284,0.0020784792651469,0.0655193752329405,0.0736670139523163,1.83364854806333e-240
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.0987787050935517,0.00295879602024234,0.0929794648938767,0.104577945293227,6.11375067698542e-240
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.075433304699913,0.00225497441591878,0.0710135548447122,0.0798530545551138,8.4962842699331e-240
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJAP1,Tight junction-associated protein 1,29566,0.194044010477227,0.0058324230080763,0.182612461381398,0.205475559573057,2.64540370622938e-238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXLNA,Alpha-taxilin,29218,0.207449074162888,0.00623838052005548,0.195221848343579,0.219676299982197,5.00481548654431e-238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.188598062227585,0.00572346712468113,0.17738006666321,0.19981605779196,7.38881173724151e-234
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.225731687292733,0.00687660936962337,0.212253532928271,0.239209841657195,3.88954922065551e-232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EZR,Ezrin,29694,0.0555624505859419,0.00169381020187796,0.0522425825902611,0.0588823185816227,7.37315607101512e-232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.119323880992141,0.00364337929763106,0.112182857568784,0.126464904415498,4.96249150155321e-231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0828289023852963,0.00252989749858703,0.0778703032880657,0.0877875014825269,5.67642067300011e-231
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BECN1,Beclin-1,24240,0.139166453671645,0.00424766562303958,0.130841029050488,0.147491878292803,2.10037629816734e-230
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.224212552407021,0.00685756283762528,0.210771729245275,0.237653375568766,2.46955872403422e-230
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGF,Hepatocyte growth factor,29786,0.0790213230967838,0.0024260718166376,0.0742662223361741,0.0837764238573935,1.07362411921405e-228
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCXR,L-xylulose reductase,29566,0.123067740314275,0.00378162318165891,0.115655758878224,0.130479721750327,2.77858402376268e-228
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.187558408816659,0.00577101100518114,0.176247227246504,0.198869590386814,1.04661282011716e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOST,Sclerostin,29433,0.0885175984841755,0.00272898869204791,0.0831687806477616,0.0938664163205894,8.48131538060191e-227
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.142633153386605,0.00439242022721589,0.134024009741262,0.151242297031948,1.96320249844204e-226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.092976208151931,0.00286690077729116,0.0873570826284403,0.0985953336754217,5.2049117758254e-226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL22,C-C motif chemokine 22,29169,0.117947603631919,0.00364368835845035,0.110805974449356,0.125089232814482,7.18638345260608e-226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.185246364625939,0.00573230523577318,0.174011046363823,0.196481682888054,1.87320850063004e-224
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0459738088774573,0.00142694320092041,0.0431770002036533,0.0487706175512613,7.76996330294101e-224
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.121466533966129,0.00377046210164588,0.114076428246903,0.128856639685355,8.95639230941681e-224
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THOP1,Thimet oligopeptidase,29343,0.0700523178928361,0.0021762754002543,0.0657868181083377,0.0743178176773346,1.95033071610712e-223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN1,Dynactin subunit 1,29725,0.147102568620412,0.00457705540348905,0.138131540029574,0.156073597211251,8.24605953773092e-223
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0911271674893268,0.00284018702425489,-0.0966939340568664,-0.0855604009217872,4.82093938502553e-222
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTD,Biotinidase,24966,0.0468023932901192,0.00145828736374338,0.0439441500571822,0.0496606365230563,1.69437838113949e-221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.0968012494130267,0.0030320782165578,0.0908583761085734,0.10274412271748,6.68114207569646e-220
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.106600650518677,0.0033347249212644,0.100064589672999,0.113136711364355,8.94675636104325e-220
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK1,Dickkopf-related protein 1,29694,0.133424338403147,0.00418501695926155,0.125221705162994,0.1416269716433,2.43448385369529e-219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREG1,Protein CREG1,29079,0.0855171222039364,0.00268613793206781,0.0802522918570835,0.0907819525507892,1.16099064458312e-218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXT,Oxytocin-neurophysin 1,29694,0.311793727838941,0.00981400844160834,0.292558271293389,0.331029184384493,7.47479407405705e-218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.252600174688893,0.00794260124964175,0.237032676239595,0.268167673138191,1.58593887171173e-217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.237896296596548,0.00749552904666075,0.223205059665093,0.252587533528003,2.13899590975036e-217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.185878189963666,0.00584690513371632,0.174418255901582,0.19733812402575,2.37331628468476e-217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A4,Protein S100-A4,29566,0.127439456099084,0.00402087763282363,0.11955853593875,0.135320376259418,7.95665017641805e-217
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAXX,Protein PAXX,24381,0.102249947479694,0.00322650679540125,0.0959259941607072,0.10857390079868,5.05736472521005e-216
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP20,Centrosomal protein 20,28797,0.166027946519549,0.00524866162685435,0.155740569730914,0.176315323308183,6.61201463078622e-216
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARF6,ADP-ribosylation factor 6,24805,0.238628844772739,0.00753660182218063,0.223857105201265,0.253400584344213,1.00179291933227e-215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0669309080421868,0.00211400921419358,0.0627874499823674,0.0710743661020062,1.06494277175763e-215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.159500456839437,0.00504575387253998,0.149610779249259,0.169390134429616,1.28052509940003e-215
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0303019694558699,0.000960923233052058,0.0284185599190879,0.032185378992652,5.56471398735224e-214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.114612320546967,0.00364648678368241,0.10746520645095,0.121759434642985,3.11639688506789e-213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD63,CD63 antigen,29169,0.113810016986707,0.00362141519088066,0.106712043212581,0.120907990760833,3.14731584621187e-213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXIN1,Axin-1,29434,0.211080130375466,0.00672053565718355,0.197907880487386,0.224252380263545,5.17478122940081e-213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.21638935704462,0.00688271345961902,0.202899238663767,0.229879475425474,8.56620799164122e-213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHBP1,EH domain-binding protein 1,24922,0.165669183390571,0.00527009218757417,0.155339802702925,0.175998564078216,9.41800921172372e-213
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTSS2,Protein MTSS 2,24793,0.220090077282561,0.00700185351975494,0.206366444383841,0.233813710181281,1.06992813045831e-212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.147766418688348,0.00471163014454935,0.138531623605031,0.157001213771664,2.5072675570917e-212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.160254496667653,0.00511656531820309,0.150226028643975,0.170282964691331,3.04214283297024e-211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.160337167312588,0.00512718453726812,0.150287885619542,0.170386449005633,3.07439114147663e-211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.174328508400344,0.00557542870445676,0.163400668139609,0.18525634866108,4.46360783575674e-211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.14104143753168,0.00451684803732009,0.132188415378533,0.149894459684828,1.56366450594336e-210
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC1,Stanniocalcin-1,29694,0.0957715555833652,0.00306879304345472,0.089756721218194,0.101786389948536,2.08471022821781e-210
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FN1,Fibronectin,24966,0.0589522164986647,0.00188754212556953,0.0552526339325485,0.062651799064781,4.29988808940844e-210
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.088555258944327,0.00284021255803556,0.0829884423305773,0.0941220755580767,5.37939518642815e-210
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.210732474694974,0.00677172919623206,0.197459885470359,0.224005063919589,3.04496642342994e-209
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSO,Cathepsin O,29786,0.066583588665699,0.00214353155471796,0.0623822668184518,0.0707849105129462,1.65229319466919e-208
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0512355422886339,0.00165419919519718,0.0479933118660474,0.0544777727112204,2.58567428575451e-207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGRN,Agrin,29581,0.0751297984274969,0.00243215063530467,0.0703627831822998,0.0798968136726941,3.07601526031455e-206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0600762843460607,0.00194329932863024,0.0562674176619454,0.0638851510301759,6.16244176819542e-206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPL,N-acetylneuraminate lyase,24922,0.0977525142001442,0.00316751027951085,0.091544194052303,0.103960834347985,2.91673386980085e-205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEP,Leptin,29478,0.14619165590347,0.00474650629480398,0.136888503565654,0.155494808241285,4.71981486746894e-205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.227597287777643,0.00739670761679469,0.213099740848726,0.242094834706561,1.19782164293024e-204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTBS,Di-N-acetylchitobiase,24653,0.0591381349713727,0.0019237954430558,0.0553674959029833,0.062908774039762,1.15264691757961e-203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.15747481264555,0.00512424913647408,0.147431284338061,0.167518340953039,1.7457627185726e-203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUOM,Fucose mutarotase,24381,0.137951241371788,0.00449392772832585,0.12914314302427,0.146759339719307,4.54537012129594e-203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.0509790645632766,0.00166826001282229,0.0477092749381449,0.0542488541884083,6.76434654541349e-202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNA4,Plexin-A4,29434,0.176257204036298,0.00577092287254968,0.1649461952061,0.187568212866495,1.01531943819684e-201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM1,Isthmin-1,29434,0.0848285653184409,0.00278049292397652,0.0793787991874469,0.0902783314494349,2.76538435876233e-201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.231741179423579,0.00762756733972022,0.216791147437727,0.24669121140943,4.17451475087432e-199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.106076519325404,0.00349815627842849,0.0992201330196838,0.112932905631123,7.56541212627759e-199
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.232964308923583,0.00770160166038222,0.217869169669234,0.248059448177932,2.1327075996767e-197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.136344885040976,0.00451437923384817,0.127496701742633,0.145193068339318,2.2851277545146e-197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0846569142582429,0.00280302661046226,-0.090150846414749,-0.0791629821017369,2.28799739490162e-197
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELE,E-selectin,29820,0.107196416248682,0.00356057818727911,0.100217683001615,0.114175149495749,3.47207254107762e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBIN,Erbin,29349,0.217708980442143,0.00723270515820259,0.203532878332066,0.23188508255222,4.58041084544662e-196
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUCB2,Nucleobindin-2,29652,0.0789891203541476,0.00263413131003122,0.0738262229864864,0.0841520177218088,1.18622258366753e-194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZN,Kazrin,24805,0.220775279452968,0.00736267976465488,0.206344427114245,0.235206131791692,4.39609292304653e-194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELP,P-selectin,29594,0.120173355721818,0.00401467280933956,0.112304597015512,0.128042114428123,5.66110480893887e-194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFC,Platelet-derived growth factor C,28797,0.061248326970576,0.00204684666632891,0.0572365075045713,0.0652601464365807,9.14367155730503e-194
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN1,Perilipin-1,28774,0.0737215221741618,0.00246514759733582,0.0688898328833836,0.07855321146494,1.5389305237978e-193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0810008374146793,0.00270980988183023,0.0756896100462921,0.0863120647830666,1.84166771284031e-193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.156731892073167,0.00525297300626042,0.146436064980897,0.167027719165437,4.05387210884337e-192
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0789471231295086,0.00264938564763761,0.0737543272601389,0.0841399189988784,1.12694840244562e-191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD6,T-cell differentiation antigen CD6,29760,0.110396365314449,0.0037241580193647,0.103097015596494,0.117695715032404,2.4381637981924e-190
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCR,Breakpoint cluster region protein,29434,0.192024872003314,0.00648247330875181,0.179319224318161,0.204730519688468,4.80535484989833e-190
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0582066290672632,0.00196820034297418,0.0543489563950338,0.0620643017394926,1.9392329605806e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FETUB,Fetuin-B,29545,0.0690165956800395,0.00233463654768941,0.0644407080465683,0.0735924833135107,2.64742100505924e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R9B,Neurabin-2,29786,0.196913562122679,0.00666753832117247,0.183845187013181,0.209981937232177,5.76863941811902e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.216876380230013,0.00734713780184931,0.202475990138388,0.231276770321638,9.46681340557269e-189
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.139461750013653,0.00472649148215544,0.130197826708628,0.148725673318677,1.29840075845881e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.181282262042278,0.00614695042867568,0.169234239202073,0.193330284882482,2.03932217259794e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.178038347499699,0.00603167723834317,0.166216260112546,0.189860434886851,3.12202678483593e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.19119143723827,0.00648687769577427,0.178477156954552,0.203905717521987,3.43317759049003e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.0772604052081983,0.00262235724675454,0.0721205850045594,0.0824002254118372,5.00560968264978e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.120401596598696,0.00408991333409532,0.11238536646387,0.128417826733523,9.76465724322551e-188
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.140944807136808,0.00478175763586232,0.131572562170517,0.150317052103098,1.26517081545909e-187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.18385890210094,0.00625246079017314,0.1716040789522,0.196113725249679,7.37551129959674e-187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BACH1,Transcription regulator protein BACH1,29434,0.152632021515751,0.00521575102298739,0.142409149510696,0.162854893520806,1.37918893106595e-185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH2,Cadherin-2,29478,0.0732671744996999,0.00250548374720237,0.0683564263551832,0.0781779226442165,2.48091383262429e-185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.18981712069092,0.00649492790535469,0.177087061996425,0.202547179385415,4.55582711808561e-185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAB2,Disabled homolog 2,29725,0.228325856453747,0.00781516458383411,0.213008133869433,0.243643579038062,5.08519223296562e-185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.258444266788426,0.00885353035952791,0.241091347283751,0.275797186293101,1.05442847516664e-184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD5,Programmed cell death protein 5,29694,0.119261831096825,0.00409457746477487,0.111236459265866,0.127287202927783,6.39780319028819e-184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCTN3,Tectonic-3,24922,0.0613822866271739,0.00210786845886176,0.0572508644478049,0.0655137088065429,2.33069319386924e-183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.125975475075829,0.00433142983747575,0.117485872594376,0.134465077557281,2.58599892954188e-183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.137188124832281,0.00472068014877186,0.127935591740688,0.146440657923874,4.1102395332378e-183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.144121560231514,0.00497240412180486,0.134375648152776,0.153867472310251,4.18970186812866e-182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.152762020488899,0.00527264172257601,0.14242764271265,0.163096398265148,1.81116709064522e-181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPK2,SRSF protein kinase 2,29434,0.171465612109403,0.00593712981296284,0.159828837675996,0.18310238654281,7.1014908091901e-181
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.136813830495695,0.00474286927957972,0.127517806707719,0.146109854283671,1.71546761072689e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.162352877178183,0.00563001511940713,0.151318047544145,0.173387706812221,8.05712658172021e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC13,Mucin-13,28774,0.104945131148028,0.00364417312177376,0.0978025518293516,0.112087710466705,8.11840655870211e-180
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.109521676225876,0.00380446853040444,-0.116978434545469,-0.102064917906284,1.03247248779012e-179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.141389286563018,0.00491711343221649,0.131751744235874,0.151026828890163,2.66327108968665e-179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.113116125225471,0.00393793096236563,0.105397780539234,0.120834469911707,5.42057403645744e-179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.278965610866309,0.00971594270502251,0.259922363164465,0.298008858568153,8.03680324762005e-179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.171431191090666,0.00597884095507234,0.159712662818724,0.183149719362608,2.4012248005886e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.200431056314481,0.00700314536631743,0.186704891396499,0.214157221232463,9.66912452969204e-178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLA2,Src-like-adapter 2,24867,0.212176195207605,0.00740893491646835,0.197654682771327,0.226697707643883,1.73077276319492e-177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.153011940941073,0.0053560644912107,0.1425140545383,0.163509827343846,4.13694625619463e-177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.0725364769456697,0.00254013620093375,0.0675578099918395,0.0775151438994998,6.23390685601324e-177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0402640130047572,0.00141002568065538,0.0375003626706726,0.0430276633388417,6.2775695118409e-177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.166748308033481,0.00584888955431898,0.155284484507016,0.178212131559946,2.53696588362911e-176
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0848472915466176,0.00298386857448816,0.0789989091406208,0.0906956739526144,1.68141088385942e-175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.257598049365587,0.00906334810511584,0.239833887079559,0.275362211651614,2.41382195224152e-175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.128950037746009,0.00453745593165062,0.120056624119973,0.137843451372044,3.10679952334069e-175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.191068556880381,0.0067337347065701,0.177870436855504,0.204266676905258,9.15347382270496e-175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.215688424119498,0.00759552359801139,0.200801197867395,0.2305756503716,1.34011701097252e-174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB2,Carboxypeptidase B2,24914,0.0453556748226668,0.00159923789431602,0.0422211685498074,0.0484901810955262,3.61454596409738e-174
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.138654342897759,0.00490578078423031,0.129039012560668,0.148269673234851,5.32756469700269e-173
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL17,C-C motif chemokine 17,29414,0.181413208266009,0.00644138185867574,0.168788099823004,0.194038316709013,3.16212847046339e-172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.117431632048057,0.00416589347602693,0.109266480835044,0.12559678326107,4.15463772377873e-172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0467551491647322,0.00166088788022099,0.043499808919499,0.0500104894099653,4.49703605130299e-172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.210126053797865,0.00747556671584024,0.195473943034818,0.224778164560912,1.40151335614454e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.125809497097437,0.00447444647225039,0.117039582011826,0.134579412183047,2.88364355976455e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0785290112531098,0.00279770688343694,0.0730455057615734,0.0840125167446461,3.95019643828332e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.10571620272053,0.0037685121504559,0.0983299189056363,0.113102486535423,6.62900939710666e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.226055139504251,0.00805841871921805,0.210260638814583,0.241849640193918,6.78146127589312e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.226841801420095,0.0080775314372862,0.211009839803014,0.242673763037176,7.4751955026238e-171
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.152984453508434,0.00545404247773209,0.14229453025208,0.163674376764789,1.79590567560363e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGLN1,Egl nine homolog 1,29434,0.107833234797072,0.00385255638439311,0.100282224283662,0.115384245310483,3.65912212842944e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.075078921853794,0.0026826669190689,0.069820894692419,0.0803369490151691,4.01215071325181e-170
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMIP,C-Maf-inducing protein,24793,0.164244001829378,0.00587313982024445,0.152732647781698,0.175755355877057,1.83999786556872e-169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDUA,Alpha-L-iduronidase,29725,0.0910936022318637,0.00326570907912394,0.0846928124367808,0.0974943920269466,4.77921382796391e-169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.086963980640969,0.003119713034036,0.0808493430942584,0.0930786181876796,8.38389231166146e-169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINH1,Serpin H1,24445,0.254159643918853,0.00910833367278596,0.236307309920193,0.272011977917514,1.05189506190193e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0790425138999454,0.00283824491392972,0.0734795538686431,0.0846054739312476,4.2731297954229e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO1,Forkhead box protein O1,29434,0.16852628473662,0.00606127992508128,0.156646176083461,0.180406393389779,5.82313756812027e-168
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.202331315397289,0.00728187099592592,0.188058848245274,0.216603782549303,2.71463230004807e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN2,CCN family member 2,29478,0.11201979297815,0.00404337015438755,0.104094787475551,0.11994479848075,8.48284515603381e-167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1A,Meprin A subunit alpha,24805,0.141522554210345,0.00510351996568185,0.131519655077608,0.151525453343081,1.05159009224438e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXN,Paxillin,28774,0.101052229124484,0.00364871872230264,0.0939007404287711,0.108203717820197,1.22763861975411e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.165198906277079,0.00596154696688165,0.153514274221991,0.176883538332167,1.75888085009318e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP5,Fatty acid-binding protein 5,29624,0.133351977924414,0.00481977477195157,0.123905219371389,0.142798736477439,2.24393905460895e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP43,Centrosomal protein 43,28705,0.136342911213565,0.00493132495525244,0.12667751430127,0.146008308125859,4.40868232001134e-166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AAMDC,Mth938 domain-containing protein,24240,0.104661762556603,0.00378601218661238,0.0972411786708425,0.112082346442363,1.2141337453115e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.18740664874078,0.00679137275595337,0.174095558139111,0.200717739342448,1.79894639863185e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.124639674350435,0.0045133086944479,0.115793589309317,0.133485759391553,2.21397673533803e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.176817543524546,0.00640299919727282,0.164267665097891,0.1893674219512,2.32856464307763e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK2,Docking protein 2,29478,0.237476588689863,0.00862127968863468,0.220578880500139,0.254374296879587,6.19847399757587e-165
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.043714861483,0.00158806042318779,0.0406022630535519,0.046827459912448,1.08931414861112e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEXIM1,Protein HEXIM1,29434,0.158520504714381,0.00575983850195474,0.14723122125055,0.169809788178212,1.18052478942379e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.184526941581117,0.00670608504230411,0.171383014898201,0.197670868264033,1.411376690854e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.10119448518193,0.00368601761362965,0.0939698906592163,0.108419079704645,7.21964530471672e-164
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL5,C-C motif chemokine 5,29594,0.195028701163591,0.00711243914195035,0.181088320445368,0.208969081881813,1.72347132599836e-163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.130158780063337,0.00475183333266593,0.120845186731312,0.139472373395362,4.33054335129638e-163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGFR,Opioid growth factor receptor,29349,0.0633542549783598,0.00231526531336678,0.0588163349641609,0.0678921749925587,8.24445728783213e-163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.141413698713158,0.00516925933341643,0.131281950419662,0.151545447006655,1.06666393911786e-162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.115176073943474,0.00421555405502744,0.10691358799562,0.123438559891328,2.53154297296736e-162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.071481610930015,0.00261864078237484,0.0663490749965604,0.0766141468634697,4.58790226329982e-162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.122044846513295,0.00447342911100354,0.113276925455728,0.130812767570862,1.66196279932414e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0965035804862478,0.00354230684352802,0.0895606590729329,0.103446501899563,1.90984379271114e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.209686830449025,0.00769045568643124,0.19461353730362,0.224760123594431,2.58387660594461e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0541860026959952,0.00199105703165057,0.0502835309139601,0.0580884744780304,4.28800217797542e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.14785009918233,0.00543450906710554,0.137198461410803,0.158501736953857,5.54171263764305e-161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL13,C-C motif chemokine 13,29732,0.132903567649449,0.00489348194134469,0.123312343044413,0.142494792254484,1.79656450555323e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.133805856155291,0.00492014938549065,0.12416236335973,0.143449348950853,1.88448012643866e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE4,Ribonuclease 4,24194,0.0529564894447073,0.00195091111900161,0.0491327036514642,0.0567802752379505,7.31780167358422e-160
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLK1,Protein delta homolog 1,29820,0.106931574897854,0.00395134319975645,0.0991869422263314,0.114676207569377,2.33031652393677e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINK1,Misshapen-like kinase 1,24845,0.178252333875462,0.00657983515336709,0.165355856974863,0.191148810776062,2.62362515339345e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.215380983532601,0.00796703978209008,0.199765585559704,0.230996381505497,5.18278770025551e-159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.038908442106426,0.00144067908029816,0.0360847111090416,0.0417321731038104,1.07038947307043e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA5,Integrin alpha-5,29443,0.0478702470680371,0.00177439558500555,0.0443924317214262,0.051348062414648,2.248655737943e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.149188773172906,0.00552922569755665,0.138351490805695,0.160026055540117,5.06537889199733e-158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.138079688477047,0.00512853007432888,0.128027769531363,0.148131607422732,2.09350720854077e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5E,5'-nucleotidase,29566,0.106949423819299,0.00398087238364087,0.0991469139473625,0.114751933691235,4.26410775777123e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0514062780234499,0.00191469465473088,0.0476534765001773,0.0551590795467224,6.96160386929123e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPD52L2,Tumor protein D54,24381,0.206301761285853,0.00767481631205851,0.191259121314219,0.221344401257488,7.22907274038577e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.113558363617348,0.00422567729575712,0.105276036117664,0.121840691117032,7.93461706676839e-157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.105790007360216,0.00394276877798075,0.0980621805553742,0.113517834165059,1.01989159908539e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.115816781394047,0.00431632027402266,0.107356793656962,0.124276769131131,1.15188992090702e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT2,Omega-amidase NIT2,24813,0.141679617213375,0.00528167783111042,0.131327528664399,0.152031705762352,2.82559460343127e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QDPR,Dihydropteridine reductase,29345,0.0819339702055702,0.00305804548334785,0.0759402010582084,0.087927739352932,2.97926338520257e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0531280130490922,0.00198319059896895,0.049240959475113,0.0570150666230713,3.57770675394483e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.108533792673391,0.00405576417627883,0.100584494887885,0.116483090458898,6.89326540610375e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP2,Methionine aminopeptidase 2,29674,0.108939512169796,0.00407296720788367,0.100956496442344,0.116922527897248,9.46155379602803e-156
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.109665322570243,0.0041082260186476,0.101613199573694,0.117717445566792,3.80479894387376e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.211275578067401,0.00791452240397796,0.195763114155605,0.226788041979198,3.99048489095108e-155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USO1,General vesicular transport factor p115,29349,0.169606671877,0.00636590494162857,0.157129498191408,0.182083845562592,1.49533540319654e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.122475967184272,0.00460940864012176,0.113441526249633,0.13151040811891,9.30517770296778e-154
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.144461879724403,0.00543470888593853,0.133809850307963,0.155113909140842,1.58244620866104e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.136074568559701,0.00512001080563227,0.126039347380662,0.146109789738741,1.77464230737431e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR,GMP reductase 1,29786,0.0934297303059637,0.00352083670375649,0.0865288903666009,0.100330570245326,2.25923422124237e-153
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.094022932482843,0.00356003953288846,0.0870452549983816,0.101000609967304,1.47622755596526e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.144719756759829,0.00549403741785889,0.133951443420825,0.155488070098832,7.61334363287622e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0995339252136359,0.00377820153828484,0.0921286501985977,0.106939200228674,7.63893737254834e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.065385995617471,0.00248495438702855,-0.0702565062160469,-0.060515485018895,7.65074627893919e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.160384534939128,0.006096530323668,0.148435335504739,0.172333734373518,8.75659907623676e-151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.136174168786273,0.00517383715075168,0.1260334479708,0.146314889601746,1.3072739817157e-150
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.191425825917125,0.00727466612081162,0.177167480320334,0.205684171513915,1.54768218921397e-150
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNMBP,Dynamin-binding protein,29218,0.113692261202365,0.00433386511274446,0.105197885581385,0.122186636823344,6.04818299657358e-150
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNST,Consortin,29478,0.201516821603206,0.00768380658088561,0.18645656070467,0.216577082501742,7.04265788516337e-150
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGF,Placenta growth factor,29786,0.048827286905069,0.00186213567004968,0.0451775009917716,0.0524770728183663,7.69967838851153e-150
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BID,BH3-interacting domain death agonist,29434,0.12406905845042,0.00473331222116777,0.114791766496931,0.133346350403909,1.02188209623605e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAMBP,STAM-binding protein,29163,0.118782872769896,0.00453205213483919,0.109900050585612,0.127665694954181,1.12625569775691e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOF,Apolipoprotein F,24951,-0.0465211491917263,0.00177427362515357,-0.0499987254970273,-0.0430435728864253,1.67903293254953e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAG1,Dystroglycan,29581,0.0880081261436031,0.00336510354245405,0.0814125232003932,0.0946037290868131,4.51326815178131e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F13B,Coagulation factor XIII B chain,24833,0.0479890227650278,0.00183322243431161,0.044395906793777,0.0515821387362786,5.06754799028692e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.211791330049817,0.00809158121346342,0.195931830871429,0.227650829228206,5.45479589676815e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.190966956205815,0.00730784823784604,0.176643573659637,0.205290338751993,7.77819138758322e-149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.158408900332444,0.00607653078838796,0.146498899987204,0.170318900677685,3.88288864528711e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.106743815332974,0.00409713952686709,0.0987134218603141,0.114774208805633,5.72320584370185e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH2B3,SH2B adapter protein 3,28797,0.181322376463113,0.00695934210610643,0.167682065935145,0.194962686991082,6.22314636364727e-148
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.155583367310565,0.00598159436886765,0.143859442347585,0.167307292273546,1.7827938416705e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EREG,Proepiregulin,29163,0.147925035527056,0.00568989314047502,0.136772844971725,0.159077226082387,2.51017494320808e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLM2,Protein GOLM2,29694,0.0416864942823922,0.00160383372996367,0.0385429801716634,0.0448300083931209,2.73696169258203e-147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA2,Apolipoprotein A-II,24951,-0.0890431569232407,0.00343146577770622,-0.0957688298475449,-0.0823174839989366,1.64364106651867e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH2,Neutral ceramidase,29218,0.0973425958753179,0.00375526274488172,0.0899822808953497,0.104702910855286,1.72848947715382e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMN,Protein amnionless,28931,0.0873507043492261,0.00337047973016665,0.0807445640780994,0.0939568446203527,2.04961355755151e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEC31A,Protein transport protein Sec31A,24240,0.141658903390086,0.00546221999485546,0.13095295220017,0.152364854580003,2.71204201462176e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTDH,Protein LYRIC,24229,0.171133553275724,0.00660534615464918,0.158187074812612,0.184080031738837,5.23681753000721e-146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.104550572121291,0.0040410101862403,0.0966301921562599,0.112470952086322,1.3021024685959e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.155591968929292,0.00601388009457699,0.143804763943921,0.167379173914663,1.31956521373368e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0803701837193507,0.00311759788072993,0.07425969187312,0.0864806755655814,6.5428049787659e-145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.190429115049529,0.00739357801871506,0.175937702132848,0.204920527966211,1.09128252829134e-144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBPL,FK506-binding protein-like,24805,0.10822246099152,0.00420037382148059,0.0999897283014182,0.116455193681622,1.74841012381906e-144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.0933856445023259,0.00363120667697771,0.0862684794154496,0.100502809589202,2.92900029315886e-144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS9,Galectin-9,29453,0.0581419834314074,0.00226462990513892,0.0537033088173351,0.0625806580454797,8.76104761029764e-144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLB1,Beta-galactosidase,29218,0.0762242690615184,0.00296986894244978,0.0704033259343169,0.08204521218872,1.10480115690686e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.165298733764781,0.00643770184514824,0.152680838148291,0.177916629381272,1.60215999759409e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.11498646994395,0.0044825013730633,0.106200767252746,0.123772172635154,2.92902860340668e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0604887607288869,0.00236157430305368,-0.0651174463628721,-0.0558600750949017,3.90824323304632e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSB,Arylsulfatase B,29349,0.100182950199276,0.00391226842041215,0.0925149040952687,0.107850996303284,4.7223953944687e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.177075799807092,0.00690745553108215,0.163537186966171,0.190614412648013,4.96848005612499e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0596083832097871,0.00232848123163017,0.0550445599957919,0.0641722064237822,5.5548328209091e-143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOA,Elongin-A,29349,0.0948275678188269,0.00370835766874144,0.0875591867880937,0.10209594884956,1.1664558458758e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0811082578234635,0.00317414874161358,0.0748869262899008,0.0873295893570261,1.85628192645969e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.111080196404478,0.00434757119039724,0.102558956871299,0.119601435937656,1.97349474024273e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.156315174624845,0.00612182375481488,0.144316400065408,0.168313949184282,2.89656765731733e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST3,Cystatin-C,29530,0.0513265075904207,0.00201248566136342,0.0473820356941484,0.0552709794866929,6.14521027544605e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX15,Sorting nexin-15,24381,0.097963813705903,0.0038375704888647,0.0904421755477282,0.105485451864078,7.14015959658711e-142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.100018174738312,0.0039243207193312,0.0923265061284232,0.107709843348202,1.81597475476948e-141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.167896911663776,0.0066352771065705,0.154891768534897,0.180902054792654,9.68972178775028e-140
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIAE,Sialate O-acetylesterase,29495,0.0837200375472989,0.00330924316924289,0.0772339209355829,0.090206154159015,1.02061983322433e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.187321607406346,0.00742053643485701,-0.201865858818666,-0.172777355994026,4.01162350809469e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CES2,Cocaine esterase,29349,0.0978978016431958,0.00387967041980619,0.0902936476203756,0.105501955666016,5.2321146807377e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.162458011249941,0.00643301606938974,0.149849299753938,0.175066722745945,5.7703014234408e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL11,Eotaxin,29786,0.0674545664626923,0.0026753161129618,0.0622109468812872,0.0726981860440974,8.13736685340669e-139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0615648730732487,0.00244267801504946,0.0567772241637518,0.0663525219827457,1.0497492537167e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANG,Angiogenin,29435,0.0602309225130871,0.00239416163549748,0.0555383657075121,0.0649234793186622,3.39624682268493e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.100807378072331,0.00400729250819058,0.0929530847562779,0.108661671388385,3.5190064751843e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.113053357404019,0.00449698547687336,0.104239265869347,0.121867448938691,5.64168843523639e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP10,Stromelysin-2,29439,-0.105443097115827,0.00419594216865825,-0.113667143766398,-0.0972190504652572,6.71005375926434e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN1,Pantetheinase,24951,0.129919513780421,0.00516556015583073,0.119795015874993,0.140044011685849,7.19354275270699e-138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.127870238374187,0.00508746113537658,0.117898814548849,0.137841662199525,1.18732936225118e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIP,Gastric inhibitory polypeptide,24240,0.0914053192149138,0.00363765222959665,0.0842755208449043,0.0985351175849232,1.43680558053618e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0912318941606662,0.0036319140420589,0.0841133426382307,0.0983504456831017,1.5984727046779e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.142750557479658,0.0056830558449217,0.131611768023611,0.153889346935704,1.61762756859086e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRAP,BRCA1-associated protein,24565,0.195683360493424,0.00779234297134588,0.180410368269586,0.210956352717262,1.98342399668582e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0908310213888718,0.00362396374272785,0.0837280524531252,0.0979339903246184,3.64288433217978e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GLB2,Endophilin-B2,24845,0.118460274492726,0.00472353532288841,0.109202145259864,0.127718403725587,4.31667312844531e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.0766552976656184,0.00305870973930385,0.0706602265765829,0.082650368754654,7.43549244207459e-137
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.136554760350247,0.00546370556097215,0.125845897450742,0.147263623249753,1.93263552232128e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.13436298675793,0.00537104541118794,0.123835737752002,0.144890235763858,1.98839032061487e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBKS,Ribokinase,28795,0.0882372211374388,0.00353300299297898,0.0813125352712,0.0951619070036776,3.22174204374463e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB3,Plexin-B3,29383,0.0839731085188754,0.00336289817782078,0.0773818280903466,0.0905643889474041,3.3819216920132e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.13401605626354,0.00536915514235126,0.123492512184532,0.144539600342549,4.36963985952517e-136
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.178756107264222,0.00718297571581541,0.164677474861224,0.19283473966722,2.64709729770462e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUS,RNA-binding protein FUS,28765,0.0698767724063255,0.00281033814252376,0.064368509646979,0.0753850351656721,4.86184977224075e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.150087415991494,0.00603688763606602,0.138255116224805,0.161919715758184,5.15784009388324e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MITD1,MIT domain-containing protein 1,29218,0.170320473411236,0.0068552709326642,0.156884142383214,0.183756804439258,7.34769082447917e-135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0811686874179422,0.00327087100856149,0.0747577802411617,0.0875795945947227,1.4735969554821e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NIT1,Deaminated glutathione amidase,24240,0.0835838255710132,0.00336534728329216,0.0769877448957606,0.0901799062462659,1.73650904202017e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS8,Galectin-8,29694,0.106743668917786,0.00430716897996109,0.0983016177170627,0.11518572011851,3.18986216774116e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TALDO1,Transaldolase,24888,0.0784518027348513,0.00316258899851677,0.0722531282977584,0.0846504771719442,3.28875129046977e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYDGF,Myeloid-derived growth factor,24922,0.175983177713597,0.00709856869584447,0.162069983069742,0.189896372357452,4.68833126066699e-134
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COCH,Cochlin,24922,0.081280667881783,0.00328831036876836,0.074835579558997,0.0877257562045689,2.76276664041203e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.133344358064078,0.00540152225727727,0.122757374439815,0.143931341688342,5.97745666128025e-133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRKL,Crk-like protein,29491,0.185503654530314,0.00753229757033089,0.170740351292465,0.200266957768162,1.39732747480732e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0606850618683688,0.00246613037418105,0.055851446334974,0.0655186774017637,2.42771393750631e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.115192427880403,0.00467741560890386,0.106024693286952,0.124360162473855,2.48319571878743e-132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0870592713175019,0.00354784223666389,0.0801055005336406,0.0940130421013631,1.20445799212748e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM13A,Protein FAM13A,24805,0.117863780584461,0.00480164322369356,0.108452559866022,0.1272750013029,1.7486658891761e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0578093523621127,0.0023548501224954,0.0531938461220217,0.0624248586022037,1.89870198143898e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOD,Apolipoprotein D,23787,-0.0759111092559306,0.0030926473263987,-0.081972698015672,-0.0698495204961891,2.07953928137624e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0824171607078051,0.00335889912408557,0.0758337184245974,0.0890006029910128,2.20146497826642e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD1,COMM domain-containing protein 1,24240,0.106902886364657,0.00435928321143748,0.0983586912702392,0.115447081459074,3.33849814404658e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.135748035569221,0.00554203357011408,0.124885649771797,0.146610421366645,6.07304084853673e-131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPHN1,Oligophrenin-1,24845,0.186876371169914,0.0076404640140132,0.171901061702448,0.20185168063738,1.42483416443969e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0975259080956574,0.00399352153747291,0.0896986058822104,0.105353210309104,2.08307603907201e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.112295264043872,0.00459954928457936,0.103280147446096,0.121310380641647,2.40035439920804e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0568963722567892,0.00233158709270907,0.0523264615550794,0.061466282958499,3.20270999648963e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.156484301573278,0.00640794023592647,0.143924738710862,0.169043864435694,3.89805025566875e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0883055275837085,0.00362078329872134,0.0812087923182146,0.0954022628492023,4.75150541590071e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD36,Platelet glycoprotein 4,24229,0.078521895114236,0.00322014267704659,0.0722104154672247,0.0848333747612473,9.15144274081154e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCC,Tubulin-specific chaperone C,29218,0.139827804855667,0.00574034570007029,0.128576727283529,0.151078882427805,9.24746054630452e-130
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0296069099391567,0.00121457440390039,0.0272263441075119,0.0319874757708014,1.00298880440292e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDHD2,Phospholipase DDHD2,24867,0.114756861448256,0.00471093294760995,0.105523432870941,0.123990290025572,1.51323485633219e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.134689587374342,0.00553531379821487,0.123840372329841,0.145538802418843,1.7967146219698e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASHC3,WASH complex subunit 3,24845,0.13050316296698,0.00535902962484826,0.119999464902278,0.141006861031683,1.82245310110685e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.142157411285754,0.00583938384094578,0.1307122189575,0.153602603614008,2.15193340457389e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.0488199546283059,0.00201106898932687,0.0448782594092252,0.0527616498473866,6.43900637893385e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST13,Hsc70-interacting protein,24381,0.0963387044093181,0.00396729892827989,0.0885627985098895,0.104114610308747,9.9967578161335e-129
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.130426019286442,0.00537968209670249,0.119881842376905,0.140970196195979,1.46741331066359e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSZ,Cathepsin Z,29487,0.0542560008635884,0.00224464362455939,0.049856499359452,0.0586555023677248,7.84139227382308e-128
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0851034583715329,0.00351978717477113,0.0782046755089814,0.0920022412340843,1.21897060850253e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.152824059765185,0.00632773235692528,0.140421704345611,0.165226415184758,2.13690811165063e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0461541593273765,0.00191127967664504,0.0424080511611522,0.0499002674936008,2.25867409849839e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0827761431508434,0.00342812756187506,0.0760570131295682,0.0894952731721185,2.42630563651255e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0499816610958246,0.00207200515172355,0.0459205309984464,0.0540427911932027,2.42703619392371e-127
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBNL,Drebrin-like protein,29581,0.157939681248425,0.00657204730850572,0.145058468523754,0.170820893973096,2.10263972996376e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C19orf12,Protein C19orf12,28774,0.110096017505061,0.00458430922736299,0.101110771419429,0.119081263590692,3.3293053068807e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGA,Protein O-GlcNAcase,24805,0.12074955830584,0.00502751519923177,0.110895628515346,0.130603488096335,4.99996725020465e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.103614281470141,0.00431527233350827,0.095156347696465,0.112072215243817,5.80232095099843e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.180621869652921,0.00752242393592332,0.165877918738511,0.195365820567331,6.12880352002346e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.097323828162918,0.0040547381222498,0.0893765414433084,0.105271114882528,7.16628792076586e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNCG,Gamma-synuclein,29218,0.113836731280407,0.00474838437640867,0.104529897902646,0.123143564658168,8.59406263241711e-126
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.0954651438679817,0.00398583388334568,0.0876529094566242,0.103277378279339,1.43619136594069e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.115114904061011,0.00480206323327023,0.105702860123801,0.12452694799822,1.4535632787941e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0933023788893214,0.00389193598394779,0.0856741843607837,0.100930573417859,1.53563204216996e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0989160264078618,0.00412797132288154,0.090825202615014,0.10700685020071,1.94122641783525e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.221070293701914,0.0092354611679051,0.20296878981282,0.239171797591008,1.96931695589837e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.10596956511208,0.00442606632783114,0.0972944751095308,0.114644655114629,3.2356536140156e-125
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.181796734404489,0.00761426886634719,0.166872767426449,0.19672070138253,1.38311575501878e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0473390433712332,0.00198553212184031,0.0434474004124262,0.0512306863300402,1.8766920384672e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.119261900694153,0.00500815276772033,0.109445921269421,0.129077880118885,3.62473523156125e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMA,Granzyme A,29786,0.0586158143964848,0.00246557658228693,0.0537832842952024,0.0634483444977672,8.92549001274813e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.122437025128255,0.00515051288218822,0.112342019879166,0.132532030377344,9.61979193180644e-124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.149210781018534,0.00627600486762059,0.136909811477998,0.16151175055907,1.58531264578413e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.195677351000584,0.00826421216310397,0.1794794951609,0.211875206840268,8.70663155861857e-123
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.0624517693646856,0.00263832545252867,0.0572806514777294,0.0676228872516418,1.00966650591284e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.161424408561269,0.00681656516440822,0.148063940839028,0.174784876283509,1.29595571894524e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTBDN,Retbindin,29349,0.0498201922229559,0.00210726949678099,0.0456899440092652,0.0539504404366467,1.99350647948572e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS2,Trypsin-2,29594,0.0899234254425069,0.00380569301285771,0.0824642671373058,0.097382583747708,2.66370477252557e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.130426358685032,0.00551486422197453,0.119617224809962,0.141235492560102,2.87572498100965e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.184358527511967,0.00781964311552355,0.169032027005541,0.199685028018393,8.98154041084226e-122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D23,TBC1 domain family member 23,29349,0.150104237336939,0.00637901587127275,0.137601366229244,0.162607108444633,2.62237738713397e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMPR2,GMP reductase 2,24381,0.112392383511188,0.00477782951659784,0.103027837658657,0.12175692936372,5.20873086274108e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.245468703920665,0.0104359996799312,0.225014144548,0.26592326329333,5.2232500883501e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IST1,IST1 homolog,24636,0.16625195000019,0.00707105772734283,0.152392676854598,0.180111223145782,6.67238373359619e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.138950099384715,0.00591194134801845,0.127362694342599,0.150537504426831,7.92775008105216e-121
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMNL1,Formin-like protein 1,28774,0.102513040216029,0.00436810677298035,0.0939515509409875,0.111074529491071,1.16674668725527e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.137707820250749,0.00587327386026325,0.126196203484633,0.149219437016865,3.07779288820458e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0742894750653839,0.00317132488253014,0.0680736782956249,0.080505271835143,3.1481592827737e-120
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.074777303788681,0.00319684667035038,-0.0810431232625677,-0.0685114843147942,1.03864714716179e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0569821615499805,0.00243823317018657,-0.0617610985635462,-0.0522032245364148,1.05680909134992e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADD1,Alpha-adducin,24381,0.116435959342891,0.00497858212268568,0.106677938382427,0.126193980303355,1.19552771772042e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0332830337996166,0.00142338765591445,0.0304931939940242,0.0360728736052089,1.25039438941093e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.117757179999634,0.00504196326593737,0.107874931998396,0.127639428000871,1.47627494333915e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RWDD1,RWD domain-containing protein 1,29694,0.105396920719552,0.00451316173831366,0.0965511237124577,0.114242717726647,1.53213217029767e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASC3,Protein CASC3,24195,0.0697929945644892,0.00298769503062882,0.0639371123044567,0.0756488768245217,2.28200309634861e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0812626715471174,0.00348244800471102,0.0744370734578838,0.088088269636351,2.49154512164982e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.150055716964014,0.00642614468785517,0.137460473375818,0.16265096055221,2.80952911847808e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0992495022232615,0.00426018438486264,0.0908995408289308,0.107599463617592,5.93733422742175e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.196337591294954,0.00842420981236688,0.179826140062715,0.212849042527193,7.20294681921181e-119
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.141909090559593,0.00609596938160682,0.129960990571643,0.153857190547542,1.42821781779762e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPB1,Carboxypeptidase B,29820,0.0976542808780636,0.00420042672308666,0.0894214445008137,0.105887117255313,1.6673410770638e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0368371063610974,0.00158491689693368,0.0337306692431074,0.0399435434790874,1.92851874014581e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0937486672636813,0.00403618867505439,0.0858377374605747,0.101659597066788,2.81897612630077e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0523800646431265,0.00225478164855336,0.0479606926119619,0.0567994366742911,4.36092030536833e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN3,Ataxin-3,24845,0.102075320937174,0.00439598252706401,0.0934591951841288,0.11069144669022,5.15980848976715e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.201146708043645,0.0086784291209638,0.184136986966556,0.218156429120734,9.36420346225682e-118
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTPBP2,GTP-binding protein 2,24195,0.133221802273546,0.00575725037014243,0.121937591548067,0.144506012999025,3.453691523522e-117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.131266245253801,0.00568547075707667,0.120122722569931,0.142409767937671,1.11530761769789e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.118596877822139,0.00514635805085455,0.108510016042464,0.128683739601814,1.76744790610925e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PENK,Proenkephalin-A,24381,0.0506535110850162,0.00219886969873981,0.0463437264754862,0.0549632956945462,3.53081757484719e-116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG2,Secretogranin-2,29559,0.0531417331093748,0.00232108706759686,0.0485924024568849,0.0576910637618646,5.20942340157713e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0633817534242421,0.00276577273531456,0.0579608388630256,0.0688026679854587,5.23656395830307e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.110329654546176,0.0048232937015549,0.100875998891128,0.119783310201223,8.24763132542814e-115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.112406091502496,0.00491451297825609,0.102773646065114,0.122038536939878,1.44281267477016e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TWF2,Twinfilin-2,24938,0.136425391467616,0.00596896829134064,0.124726213616588,0.148124569318643,1.92417308596936e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.129708582937524,0.00568241733452042,0.118571044961864,0.140846120913184,2.47066291672506e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOT,Angiomotin,24381,0.0654851132822426,0.00286772529181203,0.059864371710291,0.0711058548541942,3.24257074713494e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0433824777061181,0.00190203998167978,0.0396544793420257,0.0471104760702105,3.68898604188849e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.0413512277683526,0.00181333778829616,-0.0449053698334131,-0.0377970857032922,4.03421966287205e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEFTY2,Left-right determination factor 2,29674,0.0841768036280872,0.00369281378851002,0.0769388886026075,0.0914147186535668,4.94330475238764e-114
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0421468993563448,0.00185165832703007,0.0385176490353659,0.0457761496773238,1.02893306354857e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0423515591771877,0.00186012666623529,0.0387057109113665,0.0459974074430088,1.47769709900132e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPACT,Protein IMPACT,24845,0.0901699983909632,0.00396682907329502,0.082395013407305,0.0979449833746215,3.16756886885665e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.142528191002204,0.00627992940273619,0.130219529372841,0.154836852631567,4.64454823906792e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0740091100435444,0.00326244145406191,-0.0804034952935057,-0.067614724793583,5.74064479049491e-113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBXN1,UBX domain-containing protein 1,24381,0.11127225202637,0.00490861013719201,0.101651376157474,0.120893127895266,1.33107341215592e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPART,Spartin,24381,0.124840941941753,0.00550745075688147,0.114046338458266,0.135635545425241,1.36538841020466e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0787271582015478,0.00347463397466465,0.0719168756112051,0.0855374407918905,1.73893339945229e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.151341553113455,0.00669637379538489,0.138216660474501,0.16446644575241,3.86081628415739e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0774051305733678,0.00342296420126374,0.0706961207388909,0.0841141404078447,4.32154922387042e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.139121926435594,0.00615758247774035,0.127053064779223,0.151190788091965,4.80772338563456e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.147496498478884,0.00653240046907707,0.134692993559493,0.160300003398276,6.51575152639275e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18,Interleukin-18,29335,0.0739101832814912,0.00327372779624662,0.0674936768008478,0.0803266897621346,6.60711756849475e-112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0631857231528339,0.00280161347888531,0.0576945607342187,0.0686768855714491,1.14628083199042e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL7,C-C motif chemokine 7,29434,0.094305194193235,0.00418177670153825,0.08610891185822,0.10250147652825,1.15083855141916e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICA1,Islet cell autoantigen 1,28931,0.127684342165636,0.00566665158736907,0.116577705054393,0.138790979276879,1.81656403893861e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0932658804681308,0.00415096821585693,0.0851299827650513,0.10140177817121,7.63176587325165e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.107620460064576,0.00478668555986901,0.0982385563672332,0.11700236376192,8.11223568685394e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0536804482861396,0.00239065736824536,0.0489947598443787,0.0583661367279005,9.83146821684158e-111
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.138260687899874,0.0061554909162335,0.126195925704056,0.150325450095692,1.26143994132513e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL3,C-C motif chemokine 3,29434,0.0967113715273864,0.00431133533381858,0.088261154273102,0.105161588781671,1.62783927913017e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YJU2,Splicing factor YJU2,24793,0.0519243656838368,0.00231323118050916,0.0473904325700389,0.0564582987976348,1.74343310135676e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.166682844779987,0.00743560536765757,0.152109058259378,0.181256631300596,2.26908230993377e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.115434489525966,0.00515249926150105,0.105335590973424,0.125533388078508,4.78865351977448e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA1,Carboxypeptidase A1,29820,0.0968780681570987,0.00432914871029215,0.0883929366849261,0.105363199629271,5.19443517833381e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.124771543926724,0.00557552519943635,0.113843514535829,0.13569957331762,5.378607205495e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THPO,Thrombopoietin,28916,0.0614458864789523,0.0027470883278187,0.0560615933564276,0.0668301796014769,6.97515756215016e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.124990057198249,0.00558985084138824,0.114033949549128,0.135946164847369,8.30016197890199e-110
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.135031601559013,0.00604207895663944,0.123189126804,0.146874076314026,1.07178029768392e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1S,Complement C1s subcomponent,24966,0.0332988458128989,0.00148903883971489,0.0303803296870578,0.0362173619387401,1.08903424740881e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.130376239485365,0.00583466168406638,-0.141812176386135,-0.118940302584595,1.09543154933334e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY4,Protein canopy homolog 4,29349,0.118868609626559,0.00533056192685439,0.108420708249924,0.129316511003193,3.03084991437097e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.103322876847618,0.004632325212765,0.0942435194305991,0.112402234264638,4.10436723579126e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0847302736846915,0.00380118858833995,0.0772799440515452,0.0921806033178378,5.90374609093161e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0698305545315134,0.00313612228611598,0.0636837548507261,0.0759773542123008,6.30252604414511e-109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSNL1,Visinin-like protein 1,24845,0.0605629015425453,0.00272076162076566,0.0552302087658446,0.065895594319246,1.05582207783608e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOK1,Docking protein 1,24845,0.216592144588243,0.0097306698733025,0.197520031636571,0.235664257539916,1.07518958276605e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.0383125070995795,0.00172331743694386,0.0349348049231695,0.0416902092759894,1.32742368468087e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0601649073165327,0.00270455648069783,0.0548639766143649,0.0654658380187004,1.43430859245871e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0990460760031343,0.0044551677332953,0.0903139472458755,0.107778204760393,1.93482873970358e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OCLN,Occludin,24867,0.0695586572202151,0.00312890189348267,0.0634260095089891,0.0756913049314412,1.96528989517572e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.146908589309111,0.00661358122167432,0.133945970114629,0.159871208503593,2.0731182701482e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAX,Protein max,28774,0.165966329399872,0.0074899702254638,0.151285987757963,0.180646671041781,6.92146950972767e-108
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RFC4,Replication factor C subunit 4,24793,0.0335770264512705,0.00151564791661504,0.0306063565347051,0.036547696367836,1.07097340334317e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX2,Heme oxygenase 2,28774,0.073550976126147,0.00332441666126626,0.0670351194700652,0.0800668327822289,1.45317993867022e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0480952407174959,0.00217547820385509,0.0438313034379399,0.0523591779970519,1.98393584899175e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0848947505487797,0.0038494747093552,0.0773497801184435,0.0924397209791159,6.53331612947419e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0556513598417653,0.00252376745402369,0.0507047756318789,0.0605979440516518,6.89883420537324e-107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.105641410667661,0.00479623717177907,0.0962407858109736,0.115042035524348,1.15856579284539e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.108568135770958,0.00492725761615173,0.0989107108433007,0.118225560698615,1.48793480415811e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.124213921324155,0.00564515529227706,0.113149416951292,0.135278425697018,1.95037559521486e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0896737945835688,0.004078334010798,0.0816802599224047,0.0976673292447329,2.82629879522848e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.130323478923563,0.00592811495868184,0.118704373604547,0.14194258424258,2.93599645408834e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0690554842057124,0.00313986919037161,0.0629013405925841,0.0752096278188408,3.60144192860623e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.150305732752751,0.00684499687903462,0.136889538869844,0.163721926635659,5.11409876665983e-106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0751853242994289,0.00343001039822045,0.0684625039189169,0.081908144679941,1.67954757301254e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESYT2,Extended synaptotagmin-2,24845,0.128492277089981,0.00586391935731957,0.116998995149635,0.139985559030328,1.97803780605311e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53,Cellular tumor antigen p53,28797,0.0680652752279085,0.0031125782337849,0.0619646218896901,0.0741659285661269,3.78354481441997e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLG4,Disks large homolog 4,24845,0.110568204066211,0.00505614600295824,0.100658157900413,0.12047825023201,5.12897772565892e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINC1,Antithrombin-III,24914,0.0230130190508434,0.00105302447448411,0.0209490910808546,0.0250769470208323,6.86720652148816e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0601782219664099,0.0027567048483149,0.0547750804637127,0.0655813634691071,8.15525094305041e-105
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0488897032624505,0.00223967719965813,0.0444999359511205,0.0532794705737804,1.18983569447721e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDC,Nuclear migration protein nudC,29786,0.0983667046949005,0.00451048156443711,0.0895261608286038,0.107207248561197,1.27299264858048e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL4,C-C motif chemokine 4,29498,0.101318112773946,0.00464802547362282,0.0922079828456454,0.110428242702247,1.6203714324318e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRY2,Protein sprouty homolog 2,28931,0.143418728131259,0.00658394827500431,0.130514189512251,0.156323266750267,2.32099222980836e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPP,Lipoma-preferred partner,24111,0.103353086886246,0.00474157146130401,0.0940596068220898,0.112646566950401,2.51210554862981e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXJ3,Forkhead box protein J3,24229,0.0688689263138606,0.00316022425561069,0.0626748867728636,0.0750629658548575,2.75350291346537e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA11,Annexin A11,29373,0.10360211257347,0.00475980038148895,0.094272903825752,0.112931321321189,3.25047712225124e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0948215950431083,0.00435664431925486,0.0862825721773687,0.103360617908848,3.29737438790927e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFASC,Neurofascin,29786,0.0439290876819914,0.00201957378662094,0.0399707230602143,0.0478874523037684,4.31373299123014e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0446710419231571,0.0020525029823309,0.0406481360777885,0.0486939477685256,4.96877811782812e-104
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.129456779735827,0.00596851247741701,0.11775849528009,0.141155064191565,1.6540968913633e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN3,Centrin-3,24805,0.119897465519831,0.00552839131238408,0.109061818547558,0.130733112492104,2.45574852976491e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP10,Caspase-10,28774,0.110362236895073,0.00509355175161167,0.100378875461914,0.120345598328232,2.8160642448061e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD207,C-type lectin domain family 4 member K,28835,0.0594723951429284,0.00275218113048348,0.0540781201271808,0.064866670158676,9.64079682912179e-103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.118619514010031,0.0054916620347838,0.107855856421855,0.129383171598207,1.13007410829003e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.121880786507528,0.00564304041638495,0.110820427291414,0.132941145723643,1.62977880948601e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0889341779717801,0.00412111552346586,0.0808567915457871,0.0970115643977732,2.54323687738786e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC5,Glypican-5,29218,0.0862983408284993,0.00400404855401066,0.0784504056626384,0.0941462759943602,3.12672590791336e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POSTN,Periostin,24938,-0.0582136523537332,0.00270314462066238,-0.0635118158102315,-0.0529154888972349,6.15209402560491e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD69,Early activation antigen CD69,29344,0.134403880202046,0.00624885786317683,0.122156118790219,0.146651641613872,7.93637208012987e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRAS,Ras-related protein R-Ras,24195,0.200749640187709,0.00932577591192366,0.182471119400339,0.21902816097508,7.97818338794642e-102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0877113672328355,0.00408121742141849,0.0797121810868553,0.0957105533788157,1.13332440793897e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C3,Complement C3,23779,0.0712468103738662,0.00331763742803747,0.0647442410149128,0.0777493797328196,2.44339968830001e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDT,D-dopachrome decarboxylase,24938,0.0624842249187269,0.00291075681622829,0.0567791415589194,0.0681893082785343,2.64103208113139e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.195193962427933,0.00910682110243817,0.177344593067154,0.213043331788712,3.83426633979357e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARC,SPARC,29566,0.107342945984755,0.00500887118016074,0.09752555847164,0.11716033349787,4.08590102286598e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0997715790863943,0.00465949406235593,0.0906389707241767,0.108904187448612,5.93683385912646e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.109430389341221,0.00511464754951797,0.0994056801441662,0.119455098538277,8.44775911631307e-101
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD226,CD226 antigen,24229,0.0642562733139566,0.00300367270526413,0.0583690748116389,0.0701434718162743,1.33811011027358e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0549352328171244,0.00257200479307056,0.0498941034227061,0.0599763622115427,1.86448653330018e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF19,Fibroblast growth factor 19,29581,0.117242147182087,0.00548990608209927,0.106481931261172,0.128002363103001,1.97286740594027e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRADD,Death domain-containing protein CRADD,29163,0.115155816806572,0.00539382977033428,0.104583910456717,0.125727723156427,2.31448421719139e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.116762342720838,0.00546481414113885,0.106051307004206,0.12747337843747,2.32723442584559e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0815460998668525,0.0038174118677556,0.0740639726060515,0.0890282271276535,2.5316558047711e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEXN,Nexilin,24951,0.104753172530153,0.00490809192651583,0.0951333123541824,0.114373032706124,3.57260691467333e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL32,Interleukin-32,29434,-0.0662687984048418,0.0031076723501857,-0.0723598362112058,-0.0601777605984778,3.87909807861342e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MENT,Protein MENT,24381,-0.0344846829739494,0.0016161491382879,-0.0376523352849937,-0.0313170306629051,4.196097047856e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.129521867753123,0.00607872245820611,0.117607571735039,0.141436163771207,7.89760067633475e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM17,Splicing factor 45,24867,0.1161351840476,0.0054525601513875,0.105448166150881,0.12682220194432,9.00905760834919e-100
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CETN2,Centrin-2,28774,0.102406944037893,0.00481220694417122,0.0929750184273173,0.111838869648468,1.00897600516939e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.0763576836348128,0.0035945529408729,0.0693123598707019,0.0834030073989237,2.15574229859912e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGF,Pro-epidermal growth factor,29379,0.156271837261754,0.00735732744950812,0.141851475460718,0.17069219906279,2.26994515937892e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0720575678261514,0.00339139946859591,0.0654104248677034,0.0787047107845994,2.66753825346498e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGLL,Monoglyceride lipase,29536,0.13102768467421,0.00617884333848937,0.11891715173077,0.143138217617649,4.62838657552688e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YWHAQ,14-3-3 protein theta,24381,0.111660342241428,0.00526646059131333,0.101338079482454,0.121982605000402,7.13687670295488e-99
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.148205477696289,0.00700433342270237,0.134476984187792,0.161933971204785,1.28413036670433e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.114955833624897,0.00544025816366132,0.104292927624121,0.125618739625673,2.32890627243201e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.084740546226787,0.00401741537249718,0.0768664120966925,0.0926146803568815,4.90585562238161e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINE2,Glia-derived nexin,24922,0.0968743413599997,0.0045925968671171,0.0878728515004502,0.105875831219549,6.54796135057691e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PF4,Platelet factor 4,24822,0.146048241753988,0.00692877950266557,0.132467833928763,0.159628649579212,9.02812592017776e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH9,Protocadherin-9,24805,0.0508976440644504,0.00241506189773697,0.0461641227448859,0.0556311653840148,9.70228143840505e-98
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0999696798211423,0.00474481089775222,0.090669850461548,0.109269509180737,1.12673296192578e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT1,Angiopoietin-1,29322,0.126210938184381,0.00599772687367923,0.114455393511969,0.137966482856792,1.39508227392579e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS1,Galectin-1,29478,0.0513368287427803,0.00244223108658274,0.0465500558130781,0.0561236016724825,2.21429472860378e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TADA3,Transcriptional adapter 3,24793,0.0593002725333288,0.00282336603288121,0.0537664751088817,0.064834069957776,4.28860409676042e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0888803449031062,0.00423605754053499,0.0805776721236576,0.0971830176825548,4.8899182351752e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.127010791680367,0.00605348886099799,0.115145953512811,0.138875629847923,5.17023680504296e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.092535896391453,0.00441159123674303,0.0838891775674367,0.101182615215469,5.83684212767253e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.139688038865847,0.00666208536528738,0.126630351549884,0.15274572618181,8.93245284923072e-97
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.060915208004861,0.00291087193959945,0.0552098990032461,0.066620517006476,1.51298786731857e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RILPL2,RILP-like protein 2,24922,0.146138718582278,0.00698132225888851,0.132455326954857,0.1598221102097,1.82390428120891e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.073882236597272,0.00353125010286377,0.066960986395659,0.080803486798885,2.34533601297539e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD22,B-cell receptor CD22,29786,0.0623240481478376,0.00298250785422544,0.0564783327535558,0.0681697635421195,2.83225716673273e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPBP,Platelet basic protein,24816,0.126062677459068,0.00602896707505228,0.114245901991966,0.137879452926171,2.9727214275487e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6AP2,Renin receptor,28797,0.0604762509268674,0.00289472048764749,0.0548025987710783,0.0661499030826564,3.28830868301558e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.0832652938678912,0.00398601362608186,0.0754527071607708,0.0910778805750117,3.46579551361706e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.069607828779998,0.00333313732784434,0.0630748796174231,0.0761407779425729,3.71780049891863e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATG4A,Cysteine protease ATG4A,28797,0.0876877439877072,0.00419953707426736,0.0794566513221431,0.0959188366532712,4.17505685591006e-96
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM2,Paralemmin-2,24845,0.0563005122378548,0.002701945168755,0.051004699707095,0.0615963247686146,1.3160713417945e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM3,Junctional adhesion molecule C,24381,0.0752551839782486,0.00361179899703257,0.0681760579440648,0.0823343100124324,1.39477116331455e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0339010731662027,0.0016284744131911,0.0307092633163481,0.0370928830160572,2.02751929521068e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM3,Dynamin-3,24867,0.0814933191819343,0.00391503921762883,0.0738198423153818,0.0891667960484868,2.04551625692813e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMT,Catechol O-methyltransferase,28591,0.124955316550945,0.00600739694576158,0.113180818537252,0.136729814564638,2.19502905362522e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0852435459562466,0.00410038121772105,0.0772067987695134,0.0932802931429799,2.66145333436131e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.14481640087975,0.00696231455471252,0.131170264352514,0.158462537406987,2.81036325177659e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.069964427608387,0.00336895504146058,0.0633612757271242,0.0765675794896497,5.44017840941306e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.080943260552193,0.00390209896760988,0.0732951465756777,0.0885913745287084,6.89552663505731e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0661385940104386,0.00318676003329982,0.059892544345171,0.0723846436757063,7.52774980298604e-95
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.118579082664517,0.00572358379753912,0.10736085842134,0.129797306907694,1.59214475412946e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.054478332090185,0.00263016631068934,0.0493232061212339,0.0596334580591361,1.67022056935637e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATOX1,Copper transport protein ATOX1,29566,0.105264361183239,0.00508747118062323,0.0952929176692172,0.11523580469726,1.95691679610395e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2,Microtubule-associated protein 2,24845,0.0682744665126037,0.00329784567043507,0.061810688998551,0.0747382440266565,2.05400747330222e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0996064366864683,0.0048173648837516,0.0901644015143152,0.109048471858621,2.63636720269324e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED8,Protein TMED8,24805,0.151732205814447,0.00733700594345404,0.137351674165277,0.166112737463617,3.2490724981602e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0772216303171071,0.00373874848754701,0.069893683281515,0.0845495773526992,5.75777977946698e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.184837176919054,0.00895270096816028,0.16728988302146,0.202384470816649,6.75784153421534e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0518852382141584,0.00251383119492015,0.0469581290721149,0.0568123473562019,7.41560975173999e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.0860008894990087,0.0041670408680064,0.0778334893977162,0.0941682896003013,7.64573957518169e-94
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4D,Semaphorin-4D,29694,0.0440090293915741,0.00213532864780631,0.0398237852418737,0.0481942735412744,1.01400531254689e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIFBP,KIF-binding protein,29349,0.120785234446965,0.00586862346351478,0.109282732458476,0.132287736435454,1.84051149957542e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0650894400631352,0.00316283564721518,0.0588902821945934,0.0712885979316769,2.54289577048641e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX4,Syntaxin-4,29349,0.0868632107080511,0.004226826075534,0.0785786316000045,0.0951477898160978,3.46052801557278e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC4,Syndecan-4,29478,0.0678505760644338,0.00330310302925728,0.0613764941270895,0.0743246580017781,4.12654438527084e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL2,C-C motif chemokine 2,29169,0.0767377621090431,0.00374014168060247,0.0694070844150622,0.0840684398030239,6.83855385950379e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0776069079667023,0.00378013418165379,0.0701978449706609,0.0850159709627437,6.85996677376142e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0975534711061155,0.00475523427029496,0.0882332119363374,0.106873730275894,9.29472453160195e-93
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPSE,Heparanase,24688,0.137331448431979,0.00670208205359423,0.124195367606934,0.150467529257024,1.53205805745878e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCB,Tubulin-folding cofactor B,29218,0.146512344729036,0.00716170661774473,0.132475399758256,0.160549289699816,2.27976351806416e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.121271390985161,0.00593772376420717,0.109633452407315,0.132909329563007,5.86485965643981e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.0659390302283406,0.00323242581670083,0.059603475627607,0.0722745848290742,7.58765305650041e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNMT,Histamine N-methyltransferase,29082,0.0684497307865853,0.00335668988130089,0.0618706186192356,0.0750288429539351,8.64732603652329e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIF,Macrophage migration inhibitory factor,29386,0.0988132579127052,0.00484598697017824,0.0893151234511559,0.108311392374255,8.74202985174759e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0872199436159895,0.0042774066863063,0.0788362265108292,0.0956036607211499,8.98604091254406e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.124117490538734,0.00608439330780944,0.112192079655428,0.136042901422041,9.57347718200372e-92
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.111895978190651,0.00549512965936934,0.101125524058287,0.122666432323014,1.53097915135743e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0421460761506003,0.00207144727174172,0.0380860394979865,0.0462061128032141,2.12298418252496e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WDR46,WD repeat-containing protein 46,24793,0.0523528242256782,0.00257175814089173,0.0473121782695304,0.0573934701818259,2.25990031200142e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0516186130802267,0.00253862258574125,0.0466429128121738,0.0565943133482795,2.75910118449325e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARK7,Parkinson disease protein 7,29443,0.0756469273490232,0.00372044507827143,0.0683548549956112,0.0829389997024352,2.80007870357074e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F12,Coagulation factor XII,24966,0.0602658433348538,0.00296375746102472,0.0544568787112453,0.0660748079584622,3.51121692795409e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.162524905319065,0.0079937581858282,0.146857139274842,0.178192671363288,3.86655162035677e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.150684567778266,0.00742648973428288,0.136128647899072,0.165240487657461,8.84465456730815e-91
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0579291815259464,0.00285679360299101,0.052329866064084,0.0635284969878087,1.09848493687722e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0480872768398349,0.00237354238085926,0.0434351337733507,0.0527394199063191,1.21322896490057e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0434413628575261,0.00214433975076445,0.0392384569460278,0.0476442687690244,1.2582763691897e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.106739212769758,0.00526925426664012,0.0964114744071434,0.117066951132373,1.32337786638376e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP7,Caspase-7,24845,0.1213317247013,0.00599530554013897,0.109580925842627,0.133082523559972,2.43891218789281e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACYBP,Calcyclin-binding protein,24329,0.14845162962886,0.00734052810379692,0.134064194545418,0.162839064712302,3.35517331711047e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.049960341583497,0.00247315048770561,0.045112966627594,0.0548077165394,3.87077472876281e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0889624343131152,0.00440175667715606,0.0803349912258894,0.0975898774003411,4.16783672777909e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0740244788310715,0.00366273831380885,0.0668455117360062,0.0812034459261369,4.24745609812324e-90
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLG,Plasminogen,24421,0.0318759718580803,0.00158106243561397,0.0287770894842769,0.0349748542318837,1.15597028859436e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX8,Syntaxin-8,29434,0.069291226595389,0.00345082326144512,0.0625276130029566,0.0760548401878214,4.40265097568932e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.13944140513881,0.00694392661283111,0.125831308977661,0.153051501299959,5.7285477827989e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.0471112108004699,0.00234723197691921,0.0425106361257082,0.0517117854752315,6.68040468031405e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EHD3,EH domain-containing protein 3,24240,0.168334467414087,0.00838903974891141,0.151891949506221,0.184776985321954,7.71805561246599e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0906315965616525,0.00452114118955722,0.0817701598301204,0.0994930332931847,8.5315157416261e-89
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.170060272374917,0.0084813654884024,0.153436796017648,0.186683748732186,1.02758214193363e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTF1,Cardiotrophin-1,28916,0.120627011806209,0.00602325940344422,0.108821423375458,0.132432600236959,1.2840700825111e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0537764970320159,0.00268784549528578,0.0485083198612558,0.0590446742027761,1.89184687965478e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.127107816951621,0.00635615878248446,0.114649745737952,0.139565888165291,2.24587634330999e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.108768596603475,0.00544298993022583,0.0981003363402324,0.119436856866718,2.95746435390504e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BIN2,Bridging integrator 2,29443,0.128147168177432,0.00641488302965993,0.115573997439299,0.140720338915566,3.39066880869098e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTNB,Dystrobrevin beta,24752,0.062013883828792,0.00310332376872349,0.0559313692420939,0.06809639841549,3.83991877868267e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.047310572717977,0.00237168063106617,0.0426620786810873,0.0519590667548667,5.96797698121668e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.044507772443506,0.00223192215819912,-0.0488823398735762,-0.0401332050134357,6.74224384035202e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0609769728659871,0.00305564912396756,0.0549879005830107,0.0669660451489635,6.77003899853691e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.106797086709261,0.00535733520930112,0.096296709699031,0.117297463719491,9.8364104238479e-88
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.146764661511178,0.00737915605994824,0.132301515633679,0.161227807388676,2.4299968844176e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0934370741420858,0.00470414607269787,0.0842169478395979,0.102657200444574,3.18946080764595e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THTPA,Thiamine-triphosphatase,24755,0.125047543895428,0.00629446803061298,0.112710386555426,0.137384701235429,3.81412016961414e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2,Prothrombin,24966,0.0209836360777829,0.00105666300488628,0.0189125765882058,0.02305469556736,4.391687479928e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0909987918988272,0.00458442376968104,0.0820133213102524,0.0999842624874021,5.27444337450513e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIAPIN1,Anamorsin,29566,0.088597370633876,0.0044675392845949,0.07984099363607,0.097353747631682,5.87976644110575e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0864149770065028,0.00436040476436005,0.0778685836683571,0.0949613703446485,7.6688299194243e-87
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APP,Amyloid-beta precursor protein,29395,0.0939631913349636,0.00474564842660726,0.0846617204188134,0.103264662251114,1.09840845485501e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.0468133001787867,0.00236468103820611,0.0421785253439027,0.0514480750136707,1.53293306250507e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0939569814840284,0.0047459724519252,0.084654875478255,0.103259087489802,1.53488284172847e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG6,Large proline-rich protein BAG6,28916,0.0513294083320166,0.00259657783999168,0.0462401157656329,0.0564187008984003,2.08937797841422e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL8,C-C motif chemokine 8,29683,0.0852478643117806,0.00431398205363897,0.0767924594866482,0.0937032691369129,2.32871938759249e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0940949956378377,0.00475967038262972,0.0847660416878835,0.103423949587792,2.64981382261426e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD244,Natural killer cell receptor 2B4,29786,0.0381162102980144,0.00193048676740118,0.0343324562339081,0.0418999643621207,3.19955527851205e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.0876646228679746,0.00443773590355134,0.0789666604970139,0.0963625852389352,3.37720908694523e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK13,Kallikrein-13,28845,0.0620393198419769,0.00314577285316766,0.0558736050497683,0.0682050346341855,5.20935296753618e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.0675141732562625,0.00342264053869283,0.0608057978004246,0.0742225487121005,5.88330676950485e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD2,Polycystin-2,24111,0.0831120905878322,0.00421464431021653,0.0748513877398077,0.0913727934358566,6.93511700637713e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0909758224996973,0.00461492284070978,0.0819305737319061,0.100021071267488,7.52777367698867e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.12756138582525,0.00647345320859515,0.114873417536403,0.140249354114096,9.13076926990692e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOXO3,Forkhead box protein O3,28797,0.135546590733974,0.00688340674311329,0.122055113517472,0.149038067950476,9.3144492687364e-86
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0446298466953,0.00227166174528184,-0.0490823037160524,-0.0401773896745476,2.15845035412569e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK10,Kallikrein-10,29466,0.0560165221075729,0.00285178883069356,0.0504270159994136,0.0616060282157323,2.35649167160033e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0794569560357394,0.00404699294492678,0.0715248498636829,0.0873890622077959,2.78081574798865e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.102893989668205,0.00524742366773385,0.0926090392794469,0.113178940056964,5.9696285400902e-85
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0859944057170726,0.00439214613870346,0.0773857992852138,0.0946030121489313,1.05295824919487e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.138674130528431,0.00709122034690681,0.124775338648494,0.152572922408368,1.66819966321854e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB6,Serpin B6,29623,0.0824424762213482,0.00422074955186285,0.074169807099697,0.0907151453429994,1.97225728392881e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.0769221825995676,0.00393719803348899,0.0692052744539292,0.084639090745206,2.28476070413609e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.128532724962476,0.00657868264754343,0.115638506973291,0.141426942951661,2.34022613960231e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREH,Trehalase,24938,0.104418332677583,0.00535013258568842,0.0939320728096335,0.114904592545532,3.35295970668244e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEPR,Leptin receptor,29478,-0.0432185724346843,0.00221707548549928,-0.0475640403862629,-0.0388731044831057,4.22685098796263e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.123082218109729,0.00632057557609519,0.110693889980582,0.135470546238876,7.78427375434904e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRL,Appetite-regulating hormone,29478,0.112100943102162,0.00576256763018277,0.100806310547004,0.12339557565732,9.17528785470387e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.124514230293636,0.00639788352294001,0.111974378588673,0.137054081998598,9.7061014591357e-84
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.155049445555392,0.00797742086503508,0.139413700659923,0.170685190450861,1.2742175955706e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP2,Caspase-2,29434,0.0941961183566206,0.00484688928583512,0.0846962153563838,0.103696021356857,1.32381604371093e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB1,Heat shock protein beta-1,29039,0.0953625602193578,0.00490685402430883,0.0857451263317125,0.104979994107003,1.33996126489414e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.106817464171897,0.00550152088596208,0.0960344832354114,0.117600445108383,1.88086753185876e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0905631646373144,0.00466576144663439,0.081418272201911,0.0997080570727178,2.16397874568676e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCA,Calcitonin,29163,0.0859514389810233,0.00443132990908763,0.0772660323592115,0.094636845602835,2.7805677589117e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRB1,Chymotrypsinogen B,29443,0.0769872474036895,0.00396983228060985,0.0692063761336942,0.0847681186736848,2.92516026851627e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LARP1,La-related protein 1,24793,0.0869823136977413,0.00448766667808186,0.0781864870087009,0.0957781403867818,4.4720673299212e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.084512276910892,0.00436517312974478,0.0759565375765922,0.0930680162451917,5.45791640503884e-83
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.129778928309827,0.00671521529245101,0.116617106336623,0.142940750283031,1.06549108334573e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.086774294006451,0.00449100614092879,0.0779719219702306,0.0955766660426715,1.13581430215629e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBN,Nibrin,28931,0.0723655214432351,0.00374798627985438,0.0650194683347205,0.0797115745517497,1.52855042551464e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0281785471819635,0.00146190439631493,-0.0310438797987408,-0.0253132145651862,2.77627038493798e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.15383322241449,0.00798485145245695,0.138182913567674,0.169483531261305,3.44385304155899e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0613548074222658,0.0031912769620367,0.0550999045766739,0.0676097102678578,9.16837144424608e-82
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0870874974307001,0.00453121335633909,0.0782063192522755,0.0959686756091248,1.02481352856592e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0631094507749078,0.00328357457343116,0.0566736446109827,0.0695452569388328,1.02769287450556e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0937975092285599,0.00488212278669177,0.084228548566644,0.103366469890476,1.18911906741168e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.129992060235043,0.00677226241614494,0.116718425899399,0.143265694570688,1.29108207657067e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0648263937142786,0.0033769522393725,0.0582075673251085,0.0714452201034487,1.53612361023103e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0639842944499801,0.00333344792972227,0.0574507365077245,0.0705178523922358,1.6000766575454e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSS,Cathepsin S,23389,0.0334815125109753,0.00174436153957308,0.0300625638934121,0.0369004611285386,1.75638747205823e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMVK,Phosphomevalonate kinase,28757,0.150173208115301,0.00783104169282019,0.134824366397374,0.165522049833229,1.87341178791886e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0376758211077239,0.00196486582422423,0.0338246840922444,0.0415269581232034,2.32242640233623e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D5,TBC1 domain family member 5,29434,0.106769139111345,0.00557860906593459,0.0958350653421134,0.117703212880577,3.72478432563285e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0557177310170957,0.00291209544333418,0.0500100239481607,0.0614254380860307,4.13561340176788e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0445294991562424,0.00232872751083607,0.0399651932350037,0.0490938050774811,5.10206742866043e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.100547862612254,0.00525729288724757,0.090243568553249,0.11085215667126,6.06364401060561e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0656104078720961,0.00343279285481612,0.0588821338766565,0.0723386818675357,7.77668336651845e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA2,Carboxypeptidase A2,29577,0.0889270532482434,0.0046561978594942,0.0798009054436348,0.0980532010528521,7.95888508653979e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.136341067166982,0.00713913569717093,0.122348361200527,0.150333773133437,8.14592758813822e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CERT,Ceramide transfer protein,28774,0.0836909013788029,0.00438335934304334,0.075099517066438,0.0922822856911679,9.15701657816954e-81
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.100335992226107,0.00525524412392425,0.0900357137432158,0.110636270708999,1.0990081749962e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0725352944563203,0.00380476255479141,0.0650779598489291,0.0799926290637114,1.87809567991509e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.116187539396564,0.00609859595957738,0.104234291315793,0.128140787477336,1.95533487953878e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.0987574824259435,0.00518159931223475,0.0886015477739634,0.108913417077924,2.05505189270308e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0821533682699681,0.00431037284060287,0.0737050375023865,0.0906016990375498,2.11112014401599e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0664253611955913,0.00349153834797927,0.0595819460335519,0.0732687763576307,4.0962028049091e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0756273387817546,0.00398088015848743,0.0678248136711192,0.08342986389239,5.51214342612738e-80
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0847550239246318,0.00446991966569418,0.0759939813798712,0.0935160664693924,1.05627072874775e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.148166985826823,0.00781404625527335,0.132851455166487,0.163482516487158,1.0606139067506e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.134986336010622,0.00711768515931606,0.121035673098362,0.148936998922881,1.21667528248903e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MESD,LRP chaperone MESD,29443,0.163978830193015,0.00865347336363251,0.147018022400296,0.180939637985735,1.32982810649165e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM106A,Transmembrane protein 106A,24793,0.0957831918244616,0.00505341677716198,0.0858784949412242,0.105687888707699,1.49297246230879e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0822065622949708,0.00434043035692038,0.0736993187954068,0.0907138057945347,1.94127781804133e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBI,Acyl-CoA-binding protein,29329,0.105821636055597,0.00559204843131275,0.0948612211302238,0.11678205098097,2.17049750171927e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0413313578456361,0.00218428951123894,0.0370501504036078,0.0456125652876644,2.20535973157672e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0892865048676285,0.00471899259053239,0.080037279390185,0.098535730345072,2.32699425737081e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FEN1,Flap endonuclease 1,28797,0.0848879126222789,0.00449875089442941,0.0760703608691973,0.0937054643753606,6.12656437516119e-79
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0385102018486819,0.00204440214055278,0.0345031736531985,0.0425172300441654,1.08071216724148e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICALL2,MICAL-like protein 2,24195,0.0920529283408193,0.00488765985065692,0.0824731150335317,0.101632741648107,1.45929975635931e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7,Interleukin-7,29434,0.0865681228958624,0.00460296218376452,0.0775463170156839,0.0955899287760408,1.90970272672316e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.040779363459323,0.00216851352370199,0.0365290769528671,0.0450296499657789,2.41674382043904e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA3,Annexin A3,29640,0.0934549718501584,0.00497280700334628,0.0837082701235997,0.103201673576717,2.45356062749179e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.126778705929056,0.00674555739281602,0.113557413439137,0.139999998418976,2.94115861472998e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.144768367962658,0.00770370575150446,0.12966910468971,0.159867631235607,3.07286286948428e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0508843358051585,0.00271176576172839,0.0455692749121708,0.0561993966981461,4.18162068611462e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB9,Serpin B9,29218,0.0444163728719153,0.00236818309344552,0.039774734008762,0.0490580117350685,5.02610729623031e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.038010952306403,0.00202787194980546,0.0340363232847843,0.0419855813280217,6.19959906961525e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.117415357746383,0.00626338907858688,0.105139115152353,0.129691600340413,7.17757026848446e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL18,C-C motif chemokine 18,29166,0.093926955249446,0.00501693148018195,0.0840937695482893,0.103760140950603,9.37469311824583e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACYP1,Acylphosphatase-1,24297,0.0878063645633288,0.00468730150515373,0.0786192536132275,0.0969934755134301,9.45353388153151e-78
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12A_IL12B,Interleukin-12,29349,0.103687362129731,0.00553981635285567,0.0928293220781335,0.114545402181328,1.02651262991638e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0701625564783047,0.00374904822919269,0.062814421949087,0.0775106910075224,1.08637154717449e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0434783950151269,0.00232424686989197,0.0389228711501386,0.0480339188801152,1.24269405346007e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0562928765941473,0.00300928594063512,0.0503946761505024,0.0621910770377921,1.53507047944103e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.038248246534881,0.00204826949571505,0.0342336383232795,0.0422628547464825,2.28245451296542e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0534772016577552,0.00286250406581726,0.0478666936887534,0.0590877096267571,2.34716519219804e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON2,Spondin-2,29311,-0.0464682715624306,0.00248915328601936,-0.0513470120030285,-0.0415895311218327,2.52178434317014e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0729312902230835,0.00390592801081278,0.0652756713218905,0.0805869091242766,2.92155540689225e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSNAX,Translin-associated protein X,24111,0.0524177450876669,0.00281369973548607,0.0469028936061142,0.0579325965692196,6.43598003267891e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.101532508934067,0.00545282781134719,0.0908449664238262,0.112220051444307,7.3816406685879e-77
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2,Complement C2,29545,0.0309836890679356,0.00166663615947015,0.0277170821953741,0.0342502959404971,1.05125023005455e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0896463129225663,0.00482197294164282,0.0801952459569464,0.0990973798881863,1.06598881315076e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0399118184117559,0.0021480714665752,0.0357015983372685,0.0441220384862433,1.26341691098375e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0605266690583001,0.00325638760047183,0.0541441493613753,0.0669091887552249,1.35458959047264e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.105799830842856,0.00569297479820974,0.0946416002383651,0.116958061447347,1.4256267670631e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GET3,ATPase GET3,24922,0.0731804357322443,0.00393932268004297,0.0654593632793601,0.0809015081851285,1.62647091807689e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.0845941243114654,0.00455612233972691,-0.0935241240973301,-0.0756641245256006,1.94379989041181e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRD2,Protein ZNRD2,24805,0.0910479492260386,0.00491145830921321,0.0814214909399807,0.100674407512097,3.34901392205954e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUGT1,Protein SGT1 homolog,28797,0.106671695392496,0.00576126930369913,0.0953796075572462,0.117963783227747,4.30359768824164e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0766015892280888,0.00413994720147478,0.0684872927131982,0.0847158857429793,5.39057052746757e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTF2,Transcription termination factor 2,24195,0.0649519969100794,0.00351089273641819,0.0580706471466997,0.071833346673459,6.88420821568319e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0637224903370155,0.00344643575787304,0.0569674762515843,0.0704775044224466,6.91581083417206e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP3,Caspase-3,29820,0.116012879994112,0.00627965790212398,0.103704750505949,0.128321009482275,8.80295917457361e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GMFG,Glia maturation factor gamma,24922,0.0947803694854129,0.00512805737932606,0.0847293770219339,0.104831361948892,9.14527788395879e-76
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.12944721830028,0.00700589967976989,0.115715654927931,0.143178781672629,1.017155860431e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARSA,Arylsulfatase A,29443,0.0589970104566601,0.0031965298272565,0.0527318119952373,0.0652622089180828,1.23495180013181e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164,Sialomucin core protein 24,29443,0.0352221976662358,0.0019115644238022,0.0314755313955835,0.0389688639368881,2.16608536529419e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.134800168367625,0.00731224576215818,0.120468166673795,0.149132170061455,2.26325631300632e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.123731777321757,0.00671609174948852,0.110568237492759,0.136895317150754,2.28133186522193e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F2R,Proteinase-activated receptor 1,29536,0.0753996822467955,0.00409309862074411,0.067377208950137,0.0834221555434539,2.35200157691888e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSTN,Growth/differentiation factor 8,28916,0.0691949999979181,0.00375676546753839,0.0618317396815429,0.0765582603142933,2.50898954387901e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0485272884916118,0.00263709991173742,0.0433585726646064,0.0536960043186171,4.10754291357033e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0852830042117546,0.00463791657763672,0.0761926877195867,0.0943733207039226,5.14176026682818e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XCL1,Lymphotactin,29725,0.0727466924949124,0.00396068042040644,0.0649837588709157,0.080509626118909,6.25420409983514e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.0308865193604827,0.0016822245124806,0.0275893593160207,0.0341836794049447,7.052049172126e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0793066524409989,0.00432012298822399,0.0708392113840798,0.0877740934979179,7.5566639091324e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KITLG,Kit ligand,29478,-0.0489101104902065,0.00266439652979725,-0.0541323276886091,-0.0436878932918038,7.60488275189347e-75
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0551651756553415,0.00300728226023387,0.0492709024252831,0.0610594488853998,1.1542994285223e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.049733821000073,0.00271758772212677,0.0444073490647046,0.0550602929354415,2.12070716343526e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBCA,Tubulin-specific chaperone A,24381,0.112062173415961,0.00612014877368171,0.100066681819545,0.124057665012377,2.15956545319418e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.0534336088935968,0.00292164917090243,0.0477071765186281,0.0591600412685656,2.64153670701704e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAP3,Cytosol aminopeptidase,28931,0.0635047074759307,0.00347494301684326,0.0566938191629179,0.0703155957889435,3.42541420691652e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UMOD,Uromodulin,29750,-0.0702772578263958,0.00385519193306847,-0.07783343401521,-0.0627210816375816,7.64304387225712e-74
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA1,Apolipoprotein A-I,24966,-0.0357344210407771,0.00196337760785937,-0.0395826411521814,-0.0318862009293727,1.53121164117075e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.0394557598931828,0.00216885002779443,0.0352048138387057,0.0437067059476599,1.78340184818955e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0549914561671432,0.00302610429544056,0.0490602917480797,0.0609226205862067,2.13014210082226e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0990693800828553,0.00545922398877555,0.0883693010648552,0.109769459100855,4.02466282105093e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDCP1,CUB domain-containing protein 1,29218,0.067288403386198,0.00371597355225485,0.0600050952237784,0.0745717115486175,6.92411862986314e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0858746295977534,0.00474148750956215,0.0765813140790116,0.0951679451164952,7.64215237447927e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.111804238106654,0.00617736052606411,0.0996966114755687,0.12391186473774,9.52639489504399e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0640986692319419,0.00354122725633542,0.0571578638095245,0.0710394746543594,9.72706591977278e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.107966607655164,0.0059688861378828,0.0962675908249142,0.119665624485415,9.74735619864728e-73
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0528373647313103,0.00292182252291581,0.0471105925863953,0.0585641368762253,1.07155163235191e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.112784316012467,0.0062349219943092,0.100563868903621,0.125004763121313,1.16081176997601e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.118516788173387,0.00655594903411672,0.105667128066518,0.131366448280255,1.18122975232719e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRGN,Neurogranin,24951,0.117858914819247,0.00652166768310839,0.105076446160355,0.13064138347814,1.54151139843515e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3C,Protein FAM3C,29433,0.0387034979884534,0.00214327889982535,0.0345026713447958,0.0429043246321111,1.6805668828869e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0387749536738049,0.00214825985142281,0.0345643643650162,0.0429855429825936,1.9600843832997e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.105436113387051,0.0058431821755627,0.0939834763229484,0.116888750451154,2.15092278213141e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0409774208957998,0.00227238854042054,0.0365235393565755,0.045431302435024,2.70014805056359e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F11,Coagulation factor XI,24606,0.0399615041370089,0.0022152299410245,0.0356196534526009,0.044303354821417,2.79483982731979e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.103044308714038,0.00572304804359909,0.0918271345485837,0.114261482879492,5.23873016985289e-72
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0571610607396298,0.00318163768498454,0.0509250508770601,0.0633970706021995,1.02791604495003e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFB,Complement factor B,24538,0.0421355972674668,0.00234780816277633,0.0375338932684251,0.0467373012665084,1.46035166791095e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0725398990504194,0.00404237660347901,0.0646168409076005,0.0804629571932382,1.53047738266606e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMSB10,Thymosin beta-10,29443,0.0970863518105649,0.00541566217479209,0.0864716539479724,0.107701049673157,1.74526588245067e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0624230283866485,0.00348459958600836,0.0555932131980721,0.0692528435752249,2.57882544494087e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTD,Deoxycytidylate deaminase,24381,0.121461023095305,0.00678450799264691,0.108163387429717,0.134758658760893,3.21440082594734e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.040946203184417,0.00228920342342898,0.0364593644744962,0.0454330418943378,3.56775971487619e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0763995255414016,0.00427184804819509,0.0680267033669392,0.084772347715864,3.7888308446194e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.053726520694205,0.0030069451514176,0.0478329081974265,0.0596201331909835,4.99730839311947e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP1,Guanylate-binding protein 1,24816,0.0824420801368203,0.00461995974539839,0.0733869590358394,0.0914972012378011,8.80198138291929e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0849690991844024,0.00476234693719927,0.0756348991874919,0.094303299181313,9.5440316809472e-71
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF6,SLAM family member 6,28797,0.0486704920239469,0.00273512782511131,0.0433096414867287,0.054031342561165,1.85769027331286e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0557557446267337,0.00313399484534653,0.0496131147298545,0.0618983745236129,1.9822966524798e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ING1,Inhibitor of growth protein 1,28719,0.058440332072628,0.00328641770969968,0.0519989533616166,0.0648817107836394,2.31001657431655e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0777961143007934,0.00437330518634856,0.0692244361355502,0.0863677924660366,2.42180224286449e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB1,Beta-crystallin B1,24922,0.083030365437889,0.00467026617481949,0.0738766437352428,0.0921840871405352,2.82067852130543e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RP2,Protein XRP2,29349,0.0530614818156092,0.002988979900992,0.0472030812096648,0.0589198824215535,3.84924834943252e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADM,Pro-adrenomedullin,29725,0.0336846374619334,0.00189798978853401,0.0299645774764067,0.03740469744746,4.14744019641919e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3B,Protein FAM3B,29349,0.0451425245244754,0.00254558658349536,0.0401531748208245,0.0501318742281263,5.3531371063567e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.12606800677781,0.00710703880808017,0.112138210713973,0.139997802841647,5.71711463244392e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0548900666637598,0.00309867814856316,0.048816657492576,0.0609634758349435,9.02469486747717e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0863038926001906,0.00487224329989415,0.076754295732398,0.0958534894679831,9.12776294043844e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPH,Hephaestin,24922,0.0334686295732197,0.00188995397404571,0.0297643197840901,0.0371729393623493,9.62160110342894e-70
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0527724171758824,0.00298299756094753,0.0469257419564253,0.0586190923953396,1.31471145776e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.159903047715734,0.00904325938108536,0.142178259328806,0.177627836102661,1.53942411464869e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0707830621777203,0.00400485129932082,0.0629335536310515,0.0786325707243891,1.80688137016813e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.0979903817919188,0.00554557117943864,0.0871210622802191,0.108859701303619,1.89909282744727e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.0717005248354217,0.00405952499928235,0.0637438558368283,0.0796571938340151,1.90581069829474e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.140082889589365,0.00793159918231921,0.124536955192019,0.155628823986711,1.92904425005283e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0550683665179995,0.00311893298264972,0.048955257872006,0.0611814751639929,2.48214463952052e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCN1,Ficolin-1,24919,0.0704277932142423,0.00400398319120197,0.0625799861594864,0.0782756002689981,7.74573982964833e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF23,Fibroblast growth factor 23,29693,0.0712773723999254,0.00405752054828792,0.063324632125281,0.0792301126745697,9.87624470968648e-69
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0399758032472077,0.00227484723152595,0.0355171026734168,0.0444345038209986,1.03492956140775e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLF4,Krueppel-like factor 4,24101,0.0499642345133924,0.00284510151920171,0.0443878355357571,0.0555406334910278,1.30112122246029e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.113427987445163,0.00647099500995461,0.100744837225652,0.126111137664674,2.28973984220014e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0867919010268395,0.0049518549246568,0.0770862653745122,0.0964975366791668,2.36245716230583e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NADK,NAD kinase,29478,0.0676016579358246,0.00386302075850072,0.0600301372491632,0.075173178622486,3.19140288619794e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.149243846942483,0.0085298321050266,0.132525376016631,0.165962317868335,3.35268058700565e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0356036597860043,0.00203787441471248,0.0316094259331679,0.0395978936388408,6.06356379824908e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPPK1,Epiplakin,24240,0.0922285423237594,0.00527854496992492,0.0818825941827066,0.102574490464812,6.07851102189574e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.0426646454256934,0.00244603474986616,0.0378704173159558,0.0474588735354311,8.68631200146784e-68
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLO1,Lactoylglutathione lyase,28916,0.0721033204881672,0.00413830562306664,0.0639922414669565,0.0802143995093778,1.21636855654794e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB10,Ras-related protein Rab-10,24922,0.0666954596150814,0.00382782160500055,0.0591929292692803,0.0741979899608824,1.3694197885675e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0596914273912718,0.00342754203872715,0.0529734449953666,0.066409409787177,1.59660903252435e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.108855189877778,0.00625730417110382,0.0965908737024147,0.121119506053142,2.20851923437517e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.0491093389315089,0.00283277685579637,0.043557096294148,0.0546615815688697,5.50256537719402e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL1,Growth-regulated alpha protein,29420,0.117883255698089,0.00680365938628232,0.104548083300975,0.131218428095202,6.39204455065282e-67
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0394254817670781,0.00228181579234842,0.0349531228140752,0.043897840720081,1.69900363223521e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0954371527273322,0.00552370400646736,0.0846106928746562,0.106263612580008,1.73339261698838e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0971467912707076,0.00562670905562317,0.0861184415216862,0.108175141019729,1.81498204400417e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0790628839976403,0.00458018296422064,0.0700857253877678,0.0880400426075127,1.96839488499603e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVR,Poliovirus receptor,29694,0.0456307164180358,0.00264609662191144,0.0404443670390893,0.0508170657969822,2.59047979059956e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0506834287244347,0.00294852169213588,0.0449043262078484,0.056462531241021,6.78552368959287e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGR1,Prostaglandin reductase 1,24922,0.100397133068613,0.00583900348489515,0.0889526862382187,0.111841579899008,7.04632043143857e-66
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMTN,Smoothelin,24776,0.116111315523514,0.0067610299536669,0.102859696814327,0.129362934232701,1.00623565315605e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPLAH,5-oxoprolinase,24240,0.0843747536284955,0.00491310638986309,0.0747450651043639,0.0940044421526272,1.02948780064418e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLMH,Bleomycin hydrolase,29820,0.0389950604290451,0.00227269330303102,0.0345405815551043,0.0434495393029859,1.13157558674708e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSE,Cathepsin E,24381,0.064104875445251,0.00373588219451657,0.0567825463439986,0.0714272045465035,1.30349173455354e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0869778317617755,0.00506954692392738,0.0770415197908779,0.0969141437326732,1.33002600090461e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGLAP,Osteocalcin,24938,0.108702640995701,0.00633906903219953,0.0962780656925895,0.121127216298812,1.54600639848628e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0346012754730366,0.00201818717130691,0.0306456286172751,0.0385569223287982,1.67563595175054e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.132185306902933,0.00772210332853631,0.117049984379001,0.147320629426864,2.71106163660345e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0318285747726451,0.00186201407157678,-0.0354781223529356,-0.0281790271923547,3.89108250544598e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0703421797037572,0.00412050068825874,0.06226599835477,0.0784183610527443,5.09637632280371e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0308991215217521,0.00180982122056333,0.027351871929448,0.0344463711140562,5.52489502807225e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.106613760941789,0.00625315126140149,0.0943575844694423,0.118869937414136,7.19147186340695e-65
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0577047989943538,0.00338840765807501,0.0510635199845268,0.0643460780041808,1.01001781047655e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0564337390508724,0.00331541848412139,0.0499355188219945,0.0629319592797504,1.1496524264345e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0436311299469538,0.00256629436058594,0.0386011930002053,0.0486610668937022,1.89400750302065e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX,Glutaredoxin-1,29291,0.0680859873804635,0.00401018809576928,0.0602260187127557,0.0759459560481713,2.41951823549542e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0820302532036628,0.00482945211513682,0.0725645270579946,0.091495979349331,2.49510970796847e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCOF1,Treacle protein,24922,0.0380266762784284,0.00223910118705929,0.0336380379517922,0.0424153146050646,2.52693341270841e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100P,Protein S100-P,28916,0.0649545987412528,0.00382917202398237,0.0574494215742474,0.0724597759082583,3.15295711775884e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSTB,Cystatin-B,29030,0.0515738573906133,0.00304040344776616,0.0456146666329916,0.057533048148235,3.15790212988202e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0862118196259841,0.00508323205800114,0.0762486847923018,0.0961749544596663,3.29505651799347e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.105770036946067,0.00623458145904782,0.0935502572863337,0.117989816605801,3.49897273328555e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0659240334932277,0.00389218180057582,0.0582953571640991,0.0735527098223564,4.7483282465545e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA4,Ephrin-A4,29169,0.0371309993318855,0.00219753721488218,0.0328238263907164,0.0414381722730546,9.58376117879799e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLNK,B-cell linker protein,24229,0.048237076255451,0.00285378034013456,0.0426436667887873,0.0538304857221147,9.94665327274679e-64
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.100417841894353,0.00594679457907327,0.0887621245193694,0.112073559269337,1.28772130155295e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLB,Beta-klotho,28774,-0.0892793278470124,0.00529820196278337,-0.0996638036940678,-0.0788948519999569,2.08426648310464e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.0551775553312865,0.00328033786748413,0.0487480931110176,0.0616070175515554,3.41175743951708e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA2,Annexin A2,23907,0.0854094941949985,0.00508465116603021,0.0754435779095793,0.0953754104804177,5.8501711980956e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0593925325557601,0.0035381804873675,-0.0663273663110004,-0.0524576988005198,6.05120145759509e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSL,Cathepsin L1,29478,0.0292105685009002,0.00174032947063261,0.0257995227384602,0.0326216142633401,6.21642404187754e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0496747361145594,0.00295916431791993,0.0438747740514364,0.0554746981776825,6.88803497029606e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0614901455713185,0.00366868635604945,0.0542995203134616,0.0686807708291755,9.38011824708259e-63
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0610942009541389,0.00364837564346689,0.0539433846929438,0.068245017215334,1.18749047539101e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA9,Serpin A9,29227,0.086496704072298,0.00516715815049741,0.0763690740973231,0.0966243340472729,1.31886992950661e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA14,Carbonic anhydrase 14,29725,-0.0425621183681386,0.00254376606480743,-0.0475478998551612,-0.0375763368811161,1.48426888591231e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0343482121977163,0.002060575060515,0.0303094850791069,0.0383869393163257,4.23450516218811e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP7,Matrilysin,28870,0.0595155387935253,0.00357070425246006,0.0525169584587036,0.0665141191283471,4.39293746739311e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0901109205672412,0.0054076054931279,0.0795120138007105,0.100709827333772,4.71122604990429e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0434839959995256,0.00261187840003654,0.038364714335454,0.0486032776635972,6.87657325932424e-62
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.070566422139649,0.00424695240387103,0.0622423954280618,0.0788904488512363,1.17610684805505e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP6,Platelet glycoprotein VI,29400,0.104332351248174,0.00628436821868862,0.0920149895395445,0.116649712956804,1.28975533921873e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.0544807446341154,0.00328217612381733,0.0480476794314334,0.0609138098367973,1.34470437440107e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0629451293754707,0.00379261106064882,0.055511611696599,0.0703786470543424,1.60848316031936e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABHD14B,Protein ABHD14B,29121,0.0678925567011675,0.00409512030897282,0.0598661208955808,0.0759189925067542,1.8961981816164e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.116532787463563,0.00702824287727559,0.102757431424102,0.130308143503023,2.06118169943806e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID1,Nidogen-1,29518,0.0449173687955529,0.00271095516385696,0.0396038966743932,0.0502308409167125,2.21866373753115e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0633463906125614,0.00382451669925985,0.0558503378820121,0.0708424433431107,2.44174753898195e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0423658897318852,0.00256177317263848,0.0373448143135138,0.0473869651502566,3.76162082572984e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.0810785984560482,0.00490671777271143,0.0714614316215338,0.0906957652905626,4.63486619257387e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0367934464589827,0.00222931963885853,-0.0411629129511454,-0.0324239799668199,6.9781041989949e-61
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0458701659095501,0.00278664815505504,0.0404083355256422,0.051331996293458,1.49977816268609e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0232097723190764,0.00141207422583851,-0.0259774378017198,-0.0204421068364329,1.9487319793909e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBN1,Drebrin,24229,0.0603329471940276,0.00367321833438492,0.0531334392586332,0.0675324551294221,2.68166440656851e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP5,Platelet glycoprotein V,24381,0.042437223941402,0.00258789824838273,0.0373649433745719,0.0475095045082322,4.12759364939363e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.101353571424143,0.00618206084570012,0.0892367321665704,0.113470410681715,4.3932720237987e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.141043144919263,0.00860723061770061,0.12417297290857,0.157913316929957,4.40420197194485e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0286352507476369,0.00174831471381953,0.0252085539085506,0.0320619475867231,5.00603565624916e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN4,CCN family member 4,29725,0.0468801760002789,0.00286570263802307,0.0412633988297537,0.0524969531708041,6.85563164671379e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0608090439160197,0.00371931890409976,0.0535191788639842,0.0680989089680553,8.05094901790094e-60
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0521719781591748,0.00319453826624623,0.0459106831573322,0.0584332731610174,1.22583953093448e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SWAP70,Switch-associated protein 70,24805,0.0418544471908404,0.00256474079115012,0.0368275552401862,0.0468813391414947,1.47468371842938e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0710809160656077,0.00436076197144381,-0.0796280095296376,-0.0625338226015779,2.04136885111526e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.0819565806738606,0.00503000061543808,0.072097779467602,0.0918153818801193,2.27879015864391e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN9,Septin-9,29349,0.0330342526503766,0.00202980547229437,0.0290558339246796,0.0370126713760736,2.72100527535592e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0308282371117,0.00189720659226418,0.0271097121908622,0.0345467620325378,4.08018183060618e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0455142129947464,0.00280150440118076,-0.0510051616210607,-0.0400232643684322,4.28940683846015e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0353999207224276,0.00217961905547454,0.0311278673736975,0.0396719740711577,4.66477065940722e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.081637958182801,0.00502782215692466,0.0717834267552286,0.0914924896103733,5.55188713647858e-59
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FADD,FAS-associated death domain protein,29478,0.088123940655736,0.00545503381316829,0.0774320743819262,0.0988158069295459,1.88010277493441e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0776076967719324,0.00480801598789905,0.0681839854356503,0.0870314081082146,2.36075895516836e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN2,Dynactin subunit 2,29349,0.1087538239213,0.0067389614230463,0.0955454595321294,0.121962188310471,2.45857221948415e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASS1,Argininosuccinate synthase,24111,0.0916392396395079,0.00567865891512792,0.0805090681658572,0.102769411113159,2.81230938385824e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX9,Sorting nexin-9,29478,0.078739504457826,0.00488332845003321,0.0691681806957609,0.0883108282198911,3.06645980417461e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.06206112215852,0.00384892218755686,0.0545172346709086,0.0696050096461315,3.1012416870451e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.139924724220269,0.00868205053078629,0.122907905179927,0.15694154326061,3.46665201600259e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.137594435186893,0.00853804789810293,0.120859861306611,0.154329009067175,3.52261045117815e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF2,Fibroblast growth factor 2,29434,0.0777577019444634,0.00482886659274794,0.0682931234226775,0.0872222804662494,4.32986693131079e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0543345838529602,0.00337438067954659,0.0477207977210489,0.0609483699848716,4.86043895970783e-58
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0459315953493866,0.00286612556763722,0.0403139892368176,0.0515492014619555,1.643858617166e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0752545785339827,0.00469776553983797,0.0660469580759002,0.0844621989920651,1.65939208491605e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0596202141124572,0.00372383990385231,0.0523214879009067,0.0669189403240077,1.8990786107194e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB2,Calretinin,28774,0.03494396124133,0.00218514079890694,0.0306610852754724,0.0392268372071876,2.58332873304051e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.0389735978223835,0.00243789026438454,0.0341953329041898,0.0437518627405772,2.78668375290309e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.0413693766804569,0.00258943386290539,0.0362940863091624,0.0464446670517515,3.28093158948817e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD83,CD83 antigen,29434,0.0388928888263724,0.00243457366776573,0.0341211244375516,0.0436646532151932,3.31065804196902e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0439130372918674,0.00274891914007112,0.038525155777328,0.0493009188064068,3.69933762900466e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.121329025135866,0.00759553986210013,0.10644176700615,0.136216283265582,3.75471736479326e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.0307734067435472,0.00192761728522453,-0.0345515366225873,-0.0269952768645072,3.92726564313704e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0862108639973028,0.00540420968134492,0.0756186130218668,0.0968031149727389,5.31009996166461e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC79,Protein unc-79 homolog,24016,0.0640528699918806,0.0040197555528861,0.0561741491082239,0.0719315908755374,7.14765611489625e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0362672040338889,0.00227772650562029,0.0318028600828732,0.0407315479849047,7.58747196373239e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0534849018091552,0.00336052884404805,0.046898265274821,0.0600715383434894,8.63044663892461e-57
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0677610902371573,0.00425954305349214,0.0594123858523127,0.0761097946220019,1.06021857246748e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNF,Tumor necrosis factor,28868,0.0434924993819047,0.00273524257189442,0.0381314239409916,0.0488535748228178,1.09007196320751e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPT,Dermatopontin,29820,0.0299534946824398,0.00188472986651055,0.0262594241440791,0.0336475652208004,1.21668305357031e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0635070205407504,0.00399646226537168,0.055673954500622,0.0713400865808789,1.40706617483592e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAL,Integrin alpha-L,24229,0.0495555468341969,0.00312220504930103,0.0434360249375669,0.0556750687308269,1.90908836650115e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0515937713018947,0.00325478561797811,0.0452143914906576,0.0579731511131318,2.62836102085246e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTN6,Dynactin subunit 6,28774,0.0808034211751005,0.00510318423482116,0.070801180074851,0.09080566227535,3.13897444424748e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0840553774948934,0.00530769872778479,0.0736522879884352,0.0944584670013515,3.31904447448896e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0494657110281172,0.00312418898980594,0.0433423006080976,0.0555891214481369,3.4682199117986e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA,Adenosine deaminase,29786,0.0393889295475671,0.00248939792009697,0.034509709624177,0.0442681494709571,3.67903719189021e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0766867924839585,0.00485338811637073,0.0671741517758719,0.0861994331920451,5.20178349015159e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0317046072751973,0.00200604955075137,0.0277727501557247,0.03563646439467,5.53796118522354e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDHB,Succinate dehydrogenase,24805,0.0777801413888822,0.00492593179726132,0.06812531506625,0.0874349677115144,6.83658539099297e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APLP1,Amyloid-like protein 1,29478,-0.058030132698948,0.00368061521485054,-0.065244138520055,-0.0508161268778409,8.95883459237068e-56
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0578605460918878,0.003672017478606,0.0506633918338201,0.0650577003499556,1.03693274847269e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD40LG,CD40 ligand,29786,0.0875543289758317,0.00555713097504797,0.0766623522647377,0.0984463056869257,1.06078085443244e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0369089646589632,0.00234759502321884,0.0323076784134543,0.0415102509044721,1.80485707237948e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK3,NT-3 growth factor receptor,29694,-0.0243450583298438,0.00154964277337682,-0.0273823581656624,-0.0213077584940252,2.15694039601723e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASAH1,Acid ceramidase,24732,0.0523657337733016,0.00333606260415537,0.0458270510691571,0.0589044164774461,2.93877718774065e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRN1,Secernin-1,29434,0.062705553909081,0.00399767801660642,0.0548701049965324,0.0705410028216295,3.1834418503666e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0782822071156628,0.00498897462611997,0.0685038168484676,0.0880605973828579,3.25947280646327e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0394038307907019,0.0025196471744057,0.0344653223288667,0.0443423392525371,6.60653429957165e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0717606807373004,0.004588125437436,0.0627679548799258,0.080753406594675,7.15580815142491e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.0990533905026523,0.00633403310542484,0.0866386856160196,0.111468095389285,7.29567594477089e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.0513419042384087,0.00328536197750364,0.0449025947625016,0.0577812137143158,7.84422402132067e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL15,C-C motif chemokine 15,29820,0.0491712550400158,0.00314912038244551,0.0429989790904226,0.055343530989609,9.59426448769995e-55
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.044671751923776,0.00286611778522279,0.0390541610647393,0.0502893427828127,1.50176195639769e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0842203884473162,0.00540686333729296,0.073622936306222,0.0948178405884104,1.75388234164519e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0919181464141192,0.00590452738846621,0.0803452727327254,0.103491020095513,1.99968750848176e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0427737961747479,0.0027469393297096,0.0373897950885171,0.0481577972609787,2.05825199132841e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0579169849828295,0.00372137427566792,0.0506230914025204,0.0652108785631386,2.14893405168683e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1R,Complement C1r subcomponent,24966,0.0216178951187499,0.00138870645810173,0.0188960304608705,0.0243397597766293,2.20192729928875e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0745908926720449,0.00480367355608678,0.0651756925021148,0.084006092841975,4.03624434870199e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0391463102578374,0.00252261486978792,-0.0440906354026218,-0.0342019851130531,4.76198102715537e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0686468473968193,0.00442519341067918,0.0599734683118881,0.0773202264817505,5.10850137124674e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0583252518408048,0.00376377676865871,0.0509482493742337,0.0657022543073759,6.05597397352464e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0810565720660404,0.00523208340242298,0.0708016885972913,0.0913114555347894,6.42625801197108e-54
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0766267509075346,0.00495757003926386,0.0669099136305774,0.0863435881844917,1.1106682244068e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0422946476258602,0.00274072870939586,0.0369228193554444,0.0476664758962761,1.63765857252346e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA13,Carbonic anhydrase 13,29114,0.115067663067703,0.00746090626282952,0.100444286792557,0.129691039342848,1.87415777951146e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0795024788190756,0.00515716380099057,0.0693944377691341,0.0896105198690171,2.0873544087958e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0483166567147097,0.0031363481078717,0.0421694144232812,0.0544638990061383,2.45957583810859e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.108022263761987,0.00701252195676394,0.0942777207267299,0.121766806797245,2.48836055995532e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP1,Interstitial collagenase,28424,0.100935027422912,0.00655270603524202,0.0880917235938372,0.113778331251986,2.54558709307107e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.0303664385625527,0.00197256041690223,0.0265002201454244,0.0342326569796811,3.13842272991433e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.105663280637082,0.00686935018665917,0.0921993542712299,0.119127207002934,3.5072772007467e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0485572600167367,0.00315896806789126,0.0423656826036699,0.0547488374298036,4.11478224288416e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC3B,Tetranectin,24381,0.0235765573864907,0.00153323658830697,0.020571413673409,0.0265817010995724,4.14982536771446e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0964142770123041,0.00627943145002485,0.0841065913702554,0.108721962654353,5.84099540246329e-53
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.125580214549411,0.00820933733502571,-0.141670515726062,-0.109489913372761,1.27658486008495e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0622629227816209,0.00407466422290296,0.0542765809047311,0.0702492646585108,1.65854539559801e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.0247610407945421,0.00162221738718858,0.0215814947156525,0.0279405868734317,2.30690136573291e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGRN,Neugrin,24845,0.0242331624715167,0.00158800044619944,0.0211206815969658,0.0273456433460676,2.43499706425378e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK4,Dickkopf-related protein 4,29169,0.0499955888093468,0.00328124606584192,0.0435643465202966,0.0564268310983969,3.20521148250164e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0961438308773095,0.00631220996425824,0.0837718993473633,0.108515762407256,3.49110386560211e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS3,Galectin-3,29544,0.0324245340851775,0.00213187398924158,0.028246061066264,0.036603007104091,4.82599869137755e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX16,Syntaxin-16,28797,0.0632390972729622,0.0041586795825148,0.0550880852912332,0.0713901092546912,5.10012560183952e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0422152295348931,0.00277760593127696,0.0367711219095903,0.047659337160196,5.67875084753776e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN2,Matrilin-2,29497,0.0323364480645432,0.00212878235840429,0.0281640346420708,0.0365088614870156,6.46828053805777e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0415461806537104,0.00273678970587684,0.0361820728301918,0.046910288477229,7.47318950344836e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0632301351987438,0.00416545919344164,0.0550658351795982,0.0713944352178894,7.61282312293528e-52
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN4,Cerebellin-4,29725,0.0344210041535739,0.00227198645784162,0.0299679106962043,0.0388740976109434,1.17893576302118e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0261966559188712,0.00172914084359517,0.0228075398654247,0.0295857719723178,1.18708610738727e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL24,C-C motif chemokine 24,29536,0.0897584155873519,0.00592487768990479,0.0781456553151385,0.101371175859565,1.19606491462177e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0367568020802943,0.00243078300237882,0.0319924673956318,0.0415211367649568,2.00138326461512e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1F,Protein phosphatase 1F,24922,0.0569621130918252,0.00377658820286295,0.0495600002142139,0.0643642259694366,3.52967195029989e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL26,C-C motif chemokine 26,29434,0.0961113773499582,0.0063841745730925,0.0835983951866969,0.10862435951322,4.98867251901463e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRBP,Acrosin-binding protein,24793,0.0418282443926098,0.00277800244438793,0.0363833596016094,0.0472731291836101,5.22753618175281e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0552981044679301,0.00367473001275923,0.048095633642922,0.0625005752929382,5.46688986621422e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.0945579963737414,0.00628552036892956,0.0822383764506395,0.106877616296843,5.87539015325879e-51
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO1A,Coronin-1A,28847,0.0958567325454199,0.00638942464779252,0.0833334602357465,0.108380004855093,1.10034930264378e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA6,Integrin alpha-6,29434,0.05597933332965,0.0037317728928509,0.0486650584596622,0.0632936081996378,1.11834648596177e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN2,Nectin-2,29433,0.031983148843632,0.00213296351512955,0.0278025403539781,0.036163757333286,1.22393206741231e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.104145933844791,0.00696631743057054,0.0904919516808729,0.117799916008709,2.38788930912552e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0293531905816111,0.00196671653244825,0.0254984261780125,0.0332079549852096,3.44327791685018e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDA,Cytidine deaminase,24890,0.0499580023411813,0.00334632410101206,0.0433992071031976,0.0565167975791649,3.51013755904227e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NID2,Nidogen-2,29443,0.0781304736945962,0.0052431817113632,0.0678538375403244,0.0884071098488681,4.91842976176368e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTC,Probetacellulin,28797,0.0793618847986186,0.00532690281244909,0.0689211552862184,0.0898026143110188,5.19343705496751e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0636560630997215,0.00427667378328343,0.0552737824844859,0.072038343714957,6.36501096855875e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAP,Prosaposin,24761,0.0303167667728013,0.00203805166547475,0.0263221855084708,0.0343113480371318,7.82375567074236e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML2,Trem-like transcript 2 protein,29443,0.0360683143351823,0.00242663492209957,0.0313121098878671,0.0408245187824974,8.62262025305826e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0344301424970313,0.00231595818608184,0.0298908644523109,0.0389694205417517,8.89583535234123e-50
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMB1,Laminin subunit beta-1,24240,0.0323903594276123,0.00218185021752031,0.0281139330012725,0.0366667858539521,1.23245345799532e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFP,Alpha-fetoprotein,29132,0.0722035657390336,0.00486593945584342,0.0626663244055805,0.0817408070724867,1.25300547643899e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPL14,60S ribosomal protein L14,24240,0.0428486057291699,0.00288804462251288,0.0371880382690447,0.0485091731892952,1.40393130484618e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGMN,Legumain,29581,0.0380272867522285,0.00256473349142992,0.0330004091090258,0.0430541643954311,1.47755428168993e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO2,Gamma-enolase,29694,0.0694273271363972,0.0046849872971722,0.0602447520339396,0.0786099022388547,1.6576526164918e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.0391556523004683,0.00264244249175742,0.0339764650166238,0.0443348395843129,1.68852082729665e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPR,Nucleoprotein TPR,24111,0.0506266746500704,0.00342092900232061,0.043921653805522,0.0573316954946188,2.44552671599119e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DMD,Dystrophin,24240,0.0547648210662794,0.00370656608263867,0.0474999515443076,0.0620296905882512,3.47362415148576e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEP1B,Meprin A subunit beta,29478,0.123470024570834,0.00836368477642095,0.107077202409049,0.139862846732619,3.82380782400807e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.0874736909532214,0.00594680027880237,0.0758179624067687,0.099129419499674,8.37356327381894e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0546386963212136,0.00371430333152526,-0.0619187308510031,-0.0473586617914241,8.86301163433893e-49
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0619209853518987,0.00421204612143253,0.0536653749538909,0.0701765957499064,1.01878765721065e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0376336056712006,0.00256098456524577,0.0326140759233189,0.0426531354190823,1.11153349730338e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR3,Toll-like receptor 3,29786,0.0641726667849539,0.00437322499740593,0.0556011457900383,0.0727441877798695,1.39888444961e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0588791333284528,0.00401534011454743,0.0510090667039399,0.0667491999529658,1.76968569404954e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD84,SLAM family member 5,29434,0.0327827039337753,0.00223884846392699,0.0283945609444784,0.0371708469230722,2.22181912642702e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0626023670886696,0.00427558956386755,0.0542222115434893,0.07098252263385,2.41686509079829e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOC1,Apolipoprotein C-I,24914,0.0392169706843683,0.00268137713840733,0.0339614714930899,0.0444724698756467,3.05465438918121e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0708467051424024,0.00484907022598653,0.0613425274994688,0.080350882785336,3.85128912100607e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0506163748950424,0.00346665972483771,0.0438217218343605,0.0574110279557244,4.39757620094226e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCRIB,Protein scribble homolog,24240,0.0945688986968213,0.00648865545013521,0.0818511340145563,0.107286663379086,6.51193183448601e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL25,C-C motif chemokine 25,29786,0.051233991507729,0.00351836106336444,0.0443380038235347,0.0581299791919233,7.17222554956263e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0507978023939046,0.00349128505266095,0.0439548836906892,0.0576407210971201,9.20995509599542e-48
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENR,Density-regulated protein,24229,0.0597296637473705,0.00411649833590374,0.0516613270089991,0.0677980004857418,1.6619681157564e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLTA,Clathrin light chain A,28916,0.0488283835184022,0.00336871392237896,0.0422257042305394,0.055431062806265,1.92154764979739e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIT2,Slit homolog 2 protein,28774,0.0539462059519014,0.00372704450973972,0.0466411987128115,0.0612512131909912,2.58532894725875e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0287703167830926,0.00198817214799682,0.0248734993730188,0.0326671341931664,2.92444604806693e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL14,C-C motif chemokine 14,29435,0.0409824704626475,0.00283399764597441,0.0354278350765376,0.0465371058487573,3.10338235685413e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD46,Membrane cofactor protein,29331,0.0296215785491284,0.00204985932729859,0.0256038542676231,0.0336393028306336,3.61388912272798e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0570068326155521,0.00394561701595755,0.0492734232642753,0.064740241966829,4.06007438960234e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.085129591863168,0.00589397829251417,0.0735773944098402,0.0966817893164957,4.28100390778528e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.0649255541939014,0.00450079190630597,0.0561040020575417,0.0737471063302611,5.1842991514777e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.0489707505467154,0.00339506957812728,0.0423164141735859,0.0556250869198448,5.73179651824684e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0544229819530537,0.00377457009917057,0.0470248245586794,0.061821139347428,6.1402772534804e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPAG1,Sperm-associated antigen 1,24867,0.0598080898751676,0.00414890435109953,0.0516762373470125,0.0679399424033227,6.40444258274539e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.0201380894895881,0.00139712622782237,0.0173997220830563,0.02287645689612,6.53325747711555e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB8,Serpin B8,29786,0.0580430458408264,0.00403030990126837,0.0501436384343404,0.0659424532473124,7.26522336160236e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0621437978482922,0.00431442316384861,0.0536875284471489,0.0706000672494355,7.67514431059648e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDK,Midkine,29455,0.052357666955944,0.00363858237336427,0.04522604550415,0.059489288407738,8.67381889629459e-47
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FST,Follistatin,29536,0.0519717416309681,0.00361613508101699,0.0448841168721748,0.0590593663897614,1.11225740100947e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA2,Integrin alpha-2,24381,0.0352749973174136,0.00245808988920945,0.0304571411345631,0.0400928535002641,1.63551245635143e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0746473491914735,0.00521477871402117,0.0644263829119921,0.084868315470955,2.55991302869605e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXNB2,Plexin-B2,29701,0.024449863422319,0.00170895607325506,0.0211003095187391,0.0277994173258989,2.82497084836827e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0938657030831257,0.0065591909301339,0.0810096888600632,0.106721717306188,2.87165592569524e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BGN,Biglycan,28750,-0.122590578915954,0.00858305448449052,-0.139413365705555,-0.105767792126352,4.02703939814309e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0742991816204422,0.00521312782946878,0.0640814510746834,0.084516912166201,6.17463441922999e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0534974054150977,0.00375714775003983,0.0461333958250196,0.0608614150051757,7.44941725386115e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH7,Protocadherin-7,24805,0.0355518524676626,0.00249621308986544,0.0306592748115264,0.0404444301237989,7.59134944755987e-46
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARFIP1,Arfaptin-1,24867,0.0701073721309273,0.0049344232928792,0.060435902476884,0.0797788417849705,1.23685675581436e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0231682543608988,0.00163206658102502,0.0199694038620898,0.0263671048597079,1.37769796757102e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0306488537404855,0.00215848208762019,0.0264182288487499,0.034879478632221,1.39480851963956e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0375987500693817,0.00265466996709957,0.0323955969338666,0.0428019032048969,2.34162617334466e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA2,Carbonic anhydrase 2,29368,0.0694886936195677,0.00491283120155589,0.0598595444645182,0.0791178427746173,2.85197972241388e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POMC,Pro-opiomelanocortin,24240,0.0716984251752429,0.0050712859786568,0.0617587046570756,0.0816381456934103,3.34586959337811e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL19,C-C motif chemokine 19,29694,0.124317784010712,0.00879752330458304,0.10707463833373,0.141560929687695,3.42938593751318e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.112342026875219,0.00795197054290745,-0.127927889139318,-0.0967561646111207,3.93897278800119e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0552566355159387,0.0039181352168435,0.0475770904909254,0.062936180540952,5.12346882281943e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX7,Syntaxin-7,24229,0.0502273472291559,0.00356040613321635,0.0432489512080518,0.0572057432502599,5.1714696637264e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TF,Serotransferrin,24966,0.021825136304381,0.00154805504242609,0.0187909484212259,0.0248593241875362,5.78016245678467e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0897441742908008,0.00637269644657817,0.0772536892555076,0.102234659326094,7.28713434929503e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFA,Protransforming growth factor alpha,29434,0.0470759634409261,0.00334875725143462,0.0405123992281142,0.053639527653738,9.64118791480475e-45
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0415739267026274,0.00295868696006933,0.0357749002608915,0.0473729531443633,1.05894624490725e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0295439185890163,0.00210472345473524,-0.0336691765602973,-0.0254186606177352,1.28872526941049e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0540663706971582,0.00385465388341942,0.0465112490856562,0.0616214923086603,1.49418717758654e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.118523923951858,0.00844955516717882,0.101962795824188,0.135085052079529,1.57229601440018e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0452929244186912,0.0032347008182701,-0.0516329380225006,-0.0389529108148818,2.09656883510145e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD302,CD302 antigen,29349,0.0305792533300288,0.00218440332316921,0.0262978228166172,0.0348606838434404,2.1999408611405e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.052632047032666,0.00376051443099599,0.0452614387479138,0.0600026553174181,2.45573629831982e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOLA1,BolA-like protein 1,24101,0.0547895680102658,0.00391887088235394,0.0471085810808521,0.0624705549396795,3.0345725377165e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.0663425449891702,0.00474809892130919,0.0570362711034042,0.0756488188749362,3.20607774599646e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0405845867949719,0.00290374315612689,0.0348932502089632,0.0462759233809806,3.22203338925069e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.0733079038354251,0.00525218291724714,0.0630136253176207,0.0836021823532295,3.89631378190675e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0977093367256196,0.00700566572727692,0.0839782319001568,0.111440441551082,4.80219181405655e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.049338691314143,0.00353872736072561,0.0424027856871208,0.0562745969411652,4.81391852765836e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAST,Gastrin,24845,0.130176552736135,0.009338785319445,0.111872533510022,0.148480571962247,5.35223347062243e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0388057210003563,0.00278529692764105,0.0333465390221798,0.0442649029785327,5.57307953891601e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF22,Kinesin-like protein KIF22,24111,0.122775983194175,0.00881279411138974,0.105502906735851,0.140049059652498,6.0329733814339e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FXN,"Frataxin, mitochondrial",29725,0.0730659496656177,0.00524717554386274,0.0627814855996467,0.0833504137315887,6.15449576702925e-44
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0408410890252425,0.00293976897435486,0.0350791418355069,0.046603036214978,1.02497668996023e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.0221949800485701,0.00159956965118818,0.0190598235322413,0.0253301365648989,1.2958776954403e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.0480133054339765,0.0034656507548776,0.0412206299544164,0.0548059809135366,1.65887511168202e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0428895701704517,0.00310036052669363,0.0368128635381322,0.0489662768027712,2.18897336104653e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOE,Apolipoprotein E,24966,0.0720585672547709,0.00520756837260401,0.061851733244467,0.0822654012650748,2.19675797864723e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL8,Interleukin-8,29218,0.0671338713948297,0.00485535727094767,0.0576173711437723,0.0766503716458871,2.40775576898015e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0676856648030114,0.00491119667393753,0.0580597193220938,0.077311610283929,4.75129093140825e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0615932186067928,0.00447512023169846,0.0528219829526638,0.0703644542609217,6.0701441806768e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPPB,Natriuretic peptides B,28916,-0.131984680570791,0.00959582664043158,-0.150792500786037,-0.113176860355546,6.54532044363315e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDGF,Hepatoma-derived growth factor,29688,0.092015173084185,0.00669298087293684,0.0788969305732288,0.105133415595141,7.08667090142588e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSB,Cathepsin B,29480,-0.0516210978397463,0.0037585408246985,-0.0589878378561553,-0.0442543578233372,8.56689324681177e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.069553373774239,0.00506314920865227,0.0596296013252806,0.0794771462231974,8.77058893050311e-43
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0276415319530594,0.00201570570814048,0.0236907487651041,0.0315923151410147,1.14464760841303e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOL1,Apolipoprotein L1,24951,0.0587943382927791,0.00430232952878224,0.0503617724163659,0.0672269041691923,2.31307390892892e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0222954847666441,0.00163442454245889,0.0190920126634247,0.0254989568698635,3.23088340343518e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0594291855628884,0.00436376217091235,0.0508762117079002,0.0679821594178766,4.16454282278273e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP8,Caspase-8,29632,0.0599720700639458,0.0044066844732997,0.0513349684962783,0.0686091716316132,4.71658584040899e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0211902927948312,0.00155735825406071,0.0181378706168722,0.0242427149727902,4.91184812079602e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0547999060957238,0.00402766486603335,0.0469056829582984,0.0626941292331492,5.2577654047493e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.0340836892717904,0.00250834220391585,0.0291673385521153,0.0390000399914654,6.68862680575924e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0419903217921812,0.00309569507324372,0.0359227594486235,0.0480578841357389,9.21810778241926e-42
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.083718027057005,0.00619606045147746,0.0715737485721092,0.0958623055419008,1.77844171715018e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASET2,Ribonuclease T2,29697,0.0256480573627609,0.00190269244509899,0.0219187801703669,0.0293773345551549,2.71840451276401e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0552089607581666,0.00409902878082002,0.0471748643477593,0.0632430571685738,3.17979572379004e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0609659899703068,0.00452537544172585,0.0520962541045241,0.0698357258360894,3.1855412521767e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0391100003447701,0.00290470856754449,0.0334167715523829,0.0448032291371573,3.56710000249218e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP3,Stromelysin-1,29443,-0.0472116065354447,0.00351191710745293,-0.0540949640660525,-0.040328249004837,4.45953124635726e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0573943403951769,0.00427888716046136,0.0490077215606727,0.0657809592296812,6.665034944744e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL20,C-C motif chemokine 20,29786,0.0842191798480669,0.00628393304129651,0.0719026710871258,0.0965356886090081,7.70019211339343e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS27,Serine protease 27,29395,0.0386348280486965,0.00288428940804655,0.0329816208089253,0.0442880352884678,8.53116072040157e-41
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0407563702131537,0.00304623811191674,0.0347857435137969,0.0467269969125105,1.05679546063994e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHI3L1,Chitinase-3-like protein 1,28935,0.0754078156528133,0.00564077031961,0.0643519058263777,0.0864637254792489,1.22235289767828e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPB6,Heat shock protein beta-6,29725,0.036774418847404,0.00275198229709033,0.031380533545107,0.0421683041497011,1.30538668266766e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0286943964969733,0.00214732869794889,0.0244856322489935,0.0329031607449532,1.31520107152329e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MARCO,Macrophage receptor MARCO,29478,0.0251871623914959,0.00188518085846126,0.0214922079089118,0.0288821168740799,1.34870518547736e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SBSN,Suprabasin,24905,-0.03298020710918,0.00247293211854228,-0.0378271540615229,-0.0281332601568371,1.95522776469893e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0343230685745914,0.00257415311317646,0.0292777284727655,0.0393684086764172,2.04613372318999e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CIT,Citron Rho-interacting kinase,24195,0.0433630066309825,0.00325310618040192,0.0369869185173948,0.0497390947445703,2.15924440946477e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.03447083037719,0.00258898128608925,0.0293964270564551,0.0395452336979249,2.50423761514655e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0417822547250747,0.00314029357650131,0.0356272793151321,0.0479372301350172,2.83991123945325e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0454563796219301,0.00341872461212969,0.0387556793821559,0.0521570798617043,3.18520793657079e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA4,Annexin A4,29341,0.0685264641177038,0.0051585321149277,0.0584157411724455,0.0786371870629621,3.74032400237959e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0371781412474489,0.00280246086046982,0.031685317960928,0.0426709645339698,4.72402127069715e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0695265449030895,0.00524293796229807,0.0592503864969853,0.0798027033091937,5.07627763897542e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0401967013835356,0.0030310152443174,0.0342559115046735,0.0461374912623977,5.31639017593282e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHPS,Deoxyhypusine synthase,24793,0.0386979879456458,0.00292341495982238,0.0329680946243939,0.0444278812668976,7.30334662023442e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_E,,29434,0.0275276812645493,0.00208022432719841,0.0234504415832404,0.0316049209458581,7.35340668319803e-40
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAEP,Glycodelin,29218,-0.124611908499307,0.0094351478105977,-0.143104798208078,-0.106119018790535,1.03656128646493e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0437028736096702,0.00330905546986882,0.0372171248887273,0.0501886223306131,1.04257707555448e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0632935853196466,0.0047996335054102,0.0538863036490426,0.0727008669902506,1.35361532206962e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA,Lymphotoxin-alpha,29434,0.0378775982518066,0.0028749264940797,0.0322427423234104,0.0435124541802028,1.57878492178933e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MET,Hepatocyte growth factor receptor,29507,-0.0186605933005768,0.00141673836313858,-0.0214374004923284,-0.0158837861088252,1.65519438269552e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL1,Fc receptor-like protein 1,29478,0.0428345708236237,0.00325414163995284,0.0364564532093161,0.0492126884379312,1.84977380917595e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMS,Spermine synthase,24101,0.0603940933365627,0.00459224831062578,0.0513932866477361,0.0693949000253892,2.2861338911363e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.031496726986625,0.00239991251544783,0.0267928984563473,0.0362005555169028,3.10586706934563e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP2,Retinol-binding protein 2,29349,-0.0721963918855744,0.00550157248251561,-0.082979473951305,-0.0614133098198439,3.141896199825e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENAH,Protein enabled homolog,28931,0.0447084954623453,0.00341758755852284,0.0380100238476405,0.0514069670770501,5.39407008086947e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.039499206265735,0.0030235159938878,-0.045425297613755,-0.0335731149177149,6.79059210571526e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0566574760891665,0.00433834536205204,0.0481543191795445,0.0651606329987885,7.52910620030971e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBS,Cystathionine beta-synthase,24240,0.0480319147493018,0.00367806688559409,0.0408229036535374,0.0552409258450662,7.63778946736038e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0447046425763775,0.00342488827868275,0.0379918615501593,0.0514174236025957,8.21355083662743e-39
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR3,Small proline-rich protein 3,24845,0.0635003320974364,0.00487395728240311,0.0539473758239263,0.0730532883709465,1.12840986707316e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XRCC4,DNA repair protein XRCC4,28774,0.0345306413292239,0.0026539753831839,0.0293288495781835,0.0397324330802644,1.36338119775212e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTN,Pleiotrophin,28916,0.0466202431207285,0.00358408838946425,0.0395954298773786,0.0536450563640785,1.42241638343093e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.075397153183536,0.00579653336386728,0.0640359477903562,0.0867583585767159,1.49764213747763e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0315658827284041,0.00242951402748546,0.0268040352345325,0.0363277302222756,1.71799107220398e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0506812798022115,0.00390010806002867,0.0430370680045553,0.0583254915998677,1.75847679357614e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX6,Syntaxin-6,28797,0.0623923998326922,0.00482282008453524,0.0529396724670031,0.0718451271983813,3.56036797677244e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COLEC12,Collectin-12,29454,0.0244166208824353,0.00188895569139123,0.0207142677273085,0.0281189740375621,4.07835420477296e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRG,Histidine-rich glycoprotein,24833,0.0290865641135627,0.00224977163648777,0.0246770117060467,0.0334961165210788,4.11777494140588e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0214316605798219,0.00165875656433146,0.0181804977137322,0.0246828234459116,4.37582894089215e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.032902323825705,0.00254671185759098,0.0279107685848267,0.0378938790665833,4.44191997060078e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0393353746669606,0.00305108222737829,0.0333552535012991,0.0453154958326221,6.30226512605975e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRSF1,G-rich sequence factor 1,23862,0.0746068665544273,0.00579612127963937,0.0632464688463341,0.0859672642625204,8.66205227167909e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0631399958886834,0.00490695557639692,0.0535223629589455,0.0727576288184214,9.06896792882807e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGR2,Anterior gradient protein 2 homolog,28553,0.0929374184609307,0.00722752223778238,0.0787714748748773,0.107103362046984,9.76951739237139e-38
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0536840513297421,0.00418044739848348,-0.0618777282307697,-0.0454903744287144,1.20721944842274e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.0172880501621139,0.0013469293788967,0.0146480685794764,0.0199280317447515,1.37113393100912e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNM1,Dynamin-1,24805,0.105125323402265,0.00820161149487073,0.0890501648723187,0.121200481932212,1.71832430229365e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD248,Endosialin,24938,-0.0369745709990609,0.0028860848122629,-0.0426312972310962,-0.0313178447670256,1.86041321319695e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0719955408943958,0.00562235502517199,-0.0830153567437329,-0.0609757250450587,1.92922529475528e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXN,Thioredoxin,24647,0.0402250134409927,0.00314131676270348,0.0340680325860939,0.0463819942958916,2.02004799918354e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAT,Catalase,24587,0.0491349928002313,0.00383795080729362,0.0416126092179358,0.0566573763825268,2.09355297492452e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0688611508854111,0.0053812602638003,0.0583138807683625,0.0794084210024597,2.26213155238517e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA4,Carbonic anhydrase 4,29820,-0.0217878085485787,0.00170384451255302,-0.0251273437931826,-0.0184482733039748,2.41631934042201e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0798559903381146,0.00624513352136409,0.0676155286362409,0.0920964520399882,2.55612134758458e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.0320486764838582,0.0025071271087173,0.0271347073507723,0.0369626456169441,2.55659444483222e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0680040076138855,0.00533633978441395,0.0575447816364341,0.0784632335913368,4.2441686468518e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0343052003531785,0.00269435997498939,0.0290242548021993,0.0395861459041577,4.90418940399589e-37
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.031207742157676,0.00246276997184493,0.0263807130128599,0.036034771302492,1.05769642325296e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0601723511960043,0.00475053520032255,0.0508613022033721,0.0694834001886365,1.1780976848643e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.103227676751822,0.00815834198241626,0.0872373264662864,0.119218027037358,1.39699947458429e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.0616961061727444,0.00488167570647779,0.0521280217880479,0.0712641905574408,1.68157850603605e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF2,Growth/differentiation factor 2,29478,0.0321921404512313,0.0025537565490039,0.0271867776151837,0.0371975032872789,2.43515102567408e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.0309284970560309,0.00245383630396566,0.0261189779002582,0.0357380162118036,2.58643395147252e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A12,Protein S100-A12,29023,0.0675560960130715,0.00537550785516211,0.0570201006169538,0.0780920914091892,3.96382268710374e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA6,Carbonic anhydrase 6,29372,-0.056815041845095,0.00452642075078205,-0.0656868265166278,-0.0479432571735622,4.80533878953806e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0427689850143627,0.00340756741111702,0.0360901528885733,0.049447817140152,5.03747150207988e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0557998540781647,0.00444714057920502,0.0470834585429229,0.0645162496134066,5.32188064166175e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0230682867542034,0.00184444318222177,0.0194531781170487,0.0266833953913581,8.45999793223606e-36
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELOB,Elongin-B,24111,0.0354968025902948,0.00284492268559313,0.0299207541265322,0.0410728510540573,1.28042876331598e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0455951650247478,0.00365904022680064,0.0384234461802185,0.0527668838692771,1.57021608102775e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0301592110682652,0.00242828873388714,0.0253997651498464,0.034918656986684,2.49717109491035e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0388377346771273,0.00313039605579755,-0.0449733109464905,-0.0327021584077641,2.94377120073121e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PER3,Period circadian protein homolog 3,24229,0.106796527315106,0.00861067718239084,0.0899196000376198,0.123673454592592,3.22859165013316e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0814485806436856,0.00657229313034846,0.0685668861082026,0.0943302751791685,3.65815158733086e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0565758152353178,0.0045839963280759,0.047591182432289,0.0655604480383466,6.84867992264504e-35
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAPK2,Death-associated protein kinase 2,24229,0.0473382162353587,0.00384998379288013,0.0397922480013136,0.0548841844694037,1.2121791002036e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0448290698641559,0.00365513266347179,0.0376650098437512,0.0519931298845606,1.7760669176335e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX6,Peroxiredoxin-6,29725,-0.0524504992620691,0.00428544520043261,-0.0608499718549171,-0.0440510266692212,2.32180825701683e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0296984136253297,0.00242865983188273,0.0249382403548396,0.0344585868958199,2.65995563017696e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSF,Cathepsin F,29566,0.0351267037762736,0.00287330944019146,0.0294950172734983,0.0407583902790488,2.76057994686732e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0472188548101273,0.00386264034185306,0.0396480797400953,0.0547896298801593,2.90332593145843e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMM2,Phosphomannomutase 2,24111,0.0527458257274874,0.00431525112136433,0.0442879335296133,0.0612037179253615,2.95525593736988e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0541340009459831,0.00443277032200966,0.0454457711148442,0.0628222307771221,3.37602582049918e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPA,Apolipoprotein(a),24484,-0.156347009064546,0.0128101407068136,-0.181454884849901,-0.131239133279192,3.67728368360995e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRP2,Neuropilin-2,29443,-0.0250097489469859,0.00205340448697965,-0.0290344217414661,-0.0209850761525058,4.8190751809929e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0440491267803471,0.00363273003170436,0.0369289759182065,0.0511692776424876,9.34045422166176e-34
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSG,Basigin,29760,0.017836928320504,0.00147190871152792,0.0149519872459093,0.0207218693950987,1.01558526958538e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN3,Calsyntenin-3,24845,0.026508263064827,0.00219089269208449,0.0222141133883413,0.0308024127413126,1.32445491299845e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX5,Sorting nexin-5,24240,0.025899123258341,0.00214448677393547,0.0216959291814274,0.0301023173352545,1.742410755906e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0357235913958245,0.00296366754550399,0.0299148030066367,0.0415323797850123,2.3092485514574e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0292632648192516,0.00243364913917686,0.024493312506465,0.0340332171320382,3.1569507145417e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGA11,Integrin alpha-11,29434,-0.0295511009435799,0.00245878817249266,-0.0343703257616656,-0.0247318761254943,3.3956295829206e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA4,Laminin subunit alpha-4,29581,0.028785255433272,0.00239526409240725,0.0240905378121538,0.0334799730543902,3.43340524724609e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.0373532355575577,0.00310836627593916,0.031260837656717,0.0434456334583985,3.45992080782742e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0321264815176663,0.00267431994993958,0.0268848144157847,0.0373681486195478,3.77428556298713e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0657688510901336,0.0054805946932652,0.0550268854913338,0.0765108166889334,4.39892721778174e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPL,Periplakin,24229,0.0281337984484257,0.00234735436289486,0.0235329838971517,0.0327346129996996,5.26015530725869e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0561082657668354,0.00468687585118717,0.0469219890985086,0.0652945424351623,5.99043338638039e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0374524495096288,0.00313107555067359,0.0313155414303086,0.043589357588949,6.99590364551353e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.0280813792245892,0.00234868603111107,0.0234779546036115,0.0326848038455669,7.17536587414348e-33
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0235708512079732,0.00197616838797133,-0.027444141248397,-0.0196975611675494,1.01105050688785e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.020425622595082,0.00171612991868412,-0.0237892372357028,-0.0170620079544611,1.36942077071113e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK7,Kallikrein-7,23801,0.0334108127822542,0.00280874797213308,0.0279056667568733,0.038915958807635,1.54911122424168e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0364726906350924,0.00307474515896575,0.0304461901235195,0.0424991911466653,2.28087934841256e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0459749225761879,0.00387968560348919,0.0383707387933491,0.0535791063590267,2.54533358033319e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0246777471254957,0.00208235322320235,0.0205963348080191,0.0287591594429723,2.60324419282252e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0415717753770896,0.00351248092119993,0.0346873127715377,0.0484562379826414,3.0290917424985e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0280556265629836,0.00237108480485891,-0.0327029527805071,-0.0234083003454602,3.23776754215554e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.0271556154064103,0.0022952133181796,0.0226569973027782,0.0316542335100423,3.29464794821737e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI2,Serpin I2,24805,0.0480926142343676,0.00407535672270371,0.0401049150578684,0.0560803134108669,4.70899985827799e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0295583883093763,0.00251171269363291,0.0246354314298558,0.0344813451888968,6.95203800396276e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.09990185689158,0.00849947645185313,0.0832428830459479,0.116560830737212,8.23882991928241e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0229923191560854,0.00195777945204907,-0.0268295668821015,-0.0191550714300692,8.91389325432982e-32
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0614237801081174,0.00525295274059981,0.0511279927365418,0.071719567479693,1.62768336442587e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0335248438961702,0.00287366038673288,0.0278924695381737,0.0391572182541666,2.22161463068731e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0437887699038806,0.00375793878487401,-0.0511543299222337,-0.0364232098855276,2.61573991069313e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.029153081145051,0.00250344309157346,0.024246332685567,0.034059829604535,2.84488055430694e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0820610761219955,0.00705116594432874,0.0682407908711111,0.0958813613728798,3.09239153450999e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0414312710286324,0.00356102689268218,0.0344516583189753,0.0484108837382895,3.32619426236344e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0703765761223094,0.00605089455153612,0.0585168228012986,0.0822363294433201,3.36521989771244e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPQ,Carboxypeptidase Q,24920,0.0307952255306363,0.00264721896381229,0.0256066763615642,0.0359837746997084,3.37096450074405e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0428156669775419,0.00368114754542113,0.0356006177885165,0.0500307161665674,3.46773361448683e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0318029968297977,0.00273483261265848,0.0264427249089871,0.0371632687506084,3.55213095059433e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0249916219194358,0.00215286359510533,0.0207720092730294,0.0292112345658422,4.35990351556127e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBD,Thrombomodulin,29478,0.0238417770080787,0.00205430071234428,0.0198153476118839,0.0278682064042735,4.50030837142866e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH1,Cadherin-1,28477,0.0333308690025849,0.00287661447623931,0.0276927046291558,0.0389690333760139,5.64011600542002e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP9,Caspase-9,24229,0.052368744380462,0.00452056130642975,0.0435084442198597,0.0612290445410643,5.95524146433543e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH5,Cadherin-5,29820,-0.0252005836200397,0.0021774291622441,-0.0294683447780381,-0.0209328224620413,6.53416820191461e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0359926978298945,0.00311071105540043,0.0298957041613096,0.0420896914984793,6.77756121767426e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0212945237250756,0.00184005216448171,0.0176880214826914,0.0249010259674598,6.79799556994069e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C5,Complement C5,24966,0.0125745265805792,0.00108734589351811,0.0104433286292837,0.0147057245318747,7.4810038530827e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0256385120057796,0.00221715196084659,0.0212928941625202,0.0299841298490389,7.5834937109568e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C7,Complement component C7,24374,-0.026908038301794,0.00233116980070574,-0.0314771311111772,-0.0223389454924107,9.65980057722657e-31
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0552044719394618,0.00479441740528032,0.0458074138251124,0.0646015300538113,1.29936743733096e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0293140473481163,0.00254725890542352,0.0243214198934862,0.0343066748027464,1.40052869003491e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TREML1,Trem-like transcript 1 protein,24951,0.0435714073999263,0.00378556058339343,0.0361517086564752,0.0509911061433774,1.40531273507857e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CX3CL1,Fractalkine,29218,-0.0278519866727627,0.00242112645030474,-0.03259739451536,-0.0231065788301654,1.47031980941563e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0189017084937098,0.00164441469781966,0.0156786556859833,0.0221247613014363,1.6345611302281e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.0235206183275573,0.00204735487742858,-0.0275334338873174,-0.0195078027677973,1.75468195053713e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0476086582323444,0.00414411968063099,0.0394861836583077,0.0557311328063811,1.76183595392642e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO2,Roundabout homolog 2,29694,0.0190327727872639,0.00165952507179933,0.0157801036465372,0.0222854419279906,2.19329285429431e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0199497719887414,0.00174199279469531,0.0165354661111385,0.0233640778663442,2.65419076046639e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0414695382272684,0.00362344019591341,0.0343675954432781,0.0485714810112587,2.97172028635062e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPF,Centromere protein F,24445,0.0445750709150986,0.00389571412203635,0.0369394712359073,0.0522106705942898,3.07654720318213e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFC1,Cryptic protein,28797,0.0386182278332287,0.00337607937499137,0.0320011122582456,0.0452353434082118,3.11094227716039e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.0489851374980139,0.00428159544368345,0.0405932104283943,0.0573770645676334,3.12554728520385e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO1,Roundabout homolog 1,29497,0.0196990571446497,0.00172751198417408,0.0163131336556685,0.0230849806336309,4.66316416206611e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0436973192950481,0.00383149089960719,0.036187597131818,0.0512070414582782,4.69953949894189e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0333124287594647,0.00292118192929101,0.0275869121780543,0.0390379453408751,4.77866044929893e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKK3,Dickkopf-related protein 3,29820,-0.0240433588467683,0.00211064258567598,-0.0281802183146932,-0.0199064993788434,5.31925273139506e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0195909791098913,0.00172635686347681,0.0162073196574767,0.0229746385623058,9.00576008199013e-30
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.047215522512129,0.00416826471389519,0.0390457236728944,0.0553853213513636,1.10633572195102e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0440606934116151,0.00389671884068686,0.0364231244838689,0.0516982623393614,1.42964764967191e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0306161052778641,0.00270995320850983,0.0253045969891848,0.0359276135665434,1.55538652124849e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0387283949056514,0.00343847161483467,0.0319889905405755,0.0454677992707274,2.2964173653172e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEK,Angiopoietin-1 receptor,29566,0.0175889398742909,0.00156607954093213,0.0145194239740639,0.0206584557745179,3.2844939431308e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.0213435684837942,0.00190062175515536,0.0176183498436897,0.0250687871238987,3.42232099414784e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0399856954512268,0.00356409222121342,0.0330000746976485,0.0469713162048051,3.76749830024198e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0513693634972414,0.0045792914524017,0.0423939522505341,0.0603447747439488,3.83553665169664e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPG,Macrophage-capping protein,29174,0.0468839082862621,0.00418010266267439,0.0386909070674203,0.0550769095051039,3.90584215520802e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHCY,Adenosylhomocysteinase,29478,0.0543010321923442,0.00484167895352119,0.0448113414434427,0.0637907229412458,3.92849868855431e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0304368027114101,0.00271444317432883,0.0251164940897255,0.0357571113330946,4.04743719928516e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMD,Osteomodulin,29581,-0.0346222857027113,0.0030930015362552,-0.0406845687137715,-0.0285600026916511,5.00509999252491e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSHB,Follitropin subunit beta,24240,0.0519589307689874,0.00465084712740557,0.0428432703992725,0.0610745911387023,6.58431483398867e-29
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY75,Lymphocyte antigen 75,29434,0.0309885219252012,0.00278868071514774,0.0255227077235116,0.0364543361268907,1.24711019386997e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0418729057588727,0.003776640830963,-0.0492751217875602,-0.0344706897301853,1.64604601277281e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK4,Kallikrein-4,29725,-0.0499515588010365,0.00451139228365752,-0.0587938876770052,-0.0411092299250678,1.94299771899979e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0179936558151932,0.00162803717361349,-0.0211846086754756,-0.0148027029549107,2.42581627585313e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0255024493351633,0.00231037252871489,0.0209741191788822,0.0300307794914445,2.83604484068363e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRN,Progranulin,29313,0.0194889501154983,0.00176841030932232,0.0160228659092265,0.02295503432177,3.45379994670629e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0354959615822472,0.00322461279054872,0.0291757205127717,0.0418162026517227,4.08838083726559e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE6,Ribonuclease K6,24828,0.0242727809257831,0.00220550858115097,0.0199499841067272,0.028595577744839,4.174755418436e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0338127183276546,0.00307566496585878,0.0277844149945714,0.0398410216607378,4.76109988313867e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAS2,Growth arrest-specific protein 2,24445,0.0416276126470042,0.00379599346577671,0.0341874654540818,0.0490677598399265,6.45485863270795e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.0257470004235857,0.00234909724012154,0.0211427698329475,0.0303512310142239,6.70561955249835e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0385193696710263,0.00351670442561056,-0.045412110345223,-0.0316266289968296,7.42207585274309e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.0188156325284886,0.00171878033887863,-0.0221844419926908,-0.0154468230642865,7.76873131520435e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,0.0482507484230907,0.00441245898314986,0.039602328816117,0.0568991680300645,8.85726670393233e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0286276603309763,0.00261980529732471,0.0234928419482198,0.0337624787137327,9.66624575759765e-28
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0522711558329774,0.00478864083293471,0.0428854198004254,0.0616568918655294,1.09543834782468e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD209,CD209 antigen,29527,-0.030392465411929,0.00279053318419842,-0.0358619104529579,-0.0249230203709001,1.43148788021081e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MPO,Myeloperoxidase,29443,0.0357605907861451,0.00329044090361967,0.0293113266150506,0.0422098549572397,1.84615627031763e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA1,Carbonic anhydrase 1,28867,0.0464043889818623,0.00428370595849824,0.0380083253032057,0.0548004526605188,2.71740887669056e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0266406342381239,0.00245984549663364,-0.0314619314115259,-0.021819337064722,2.79359905607107e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD276,CD276 antigen,29454,-0.0279204903609463,0.00257904323294971,-0.0329754150975278,-0.0228655656243649,2.92078951998891e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD93,Complement component C1q receptor,28353,-0.024411777263891,0.00225747652309448,-0.0288364312491562,-0.0199871232786258,3.34884035462961e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VGF,Neurosecretory protein VGF,24867,0.0234764402650824,0.00217972573949334,0.0192041778156755,0.0277487027144894,5.45018145911826e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.0323779181221506,0.00300688790690975,0.0264844178246075,0.0382714184196938,5.48121129005014e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.0384744110554424,0.00357633038336984,0.0314648035040375,0.0454840186068473,6.2291491569545e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0433112456353415,0.00403055678297343,-0.0512111369299695,-0.0354113543407136,6.96360479983631e-27
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0283590303966309,0.00264723083258036,0.0231704579647734,0.0335476028284884,1.01907544119975e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH15,Cadherin-15,29639,0.0443385040585424,0.00414519596222797,0.0362139199725756,0.0524630881445092,1.18413653973359e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2,Brorin,29114,0.03057472007062,0.00285905010884931,0.0249709818572753,0.0361784582839646,1.21681209405204e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR2,Folate receptor beta,29694,-0.0224339485193544,0.00209990458355273,-0.0265497615031178,-0.018318135535591,1.36188846525149e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300A,CMRF35-like molecule 8,24381,0.0229199609380099,0.00215250823575049,0.018701044795939,0.0271388770800809,2.03601088235111e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AZU1,Azurocidin,28534,0.0584520612699665,0.00549218179792658,0.0476873849460304,0.0692167375939026,2.11212842993514e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0187897225187834,0.0017663596785007,-0.0222517874886448,-0.0153276575489221,2.22279048113126e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA12,Serpin A12,28628,0.0852273835118257,0.00802511685797336,0.0694981544701979,0.100956612553453,2.69057397697131e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIT,Vitrin,24922,0.0285120552826223,0.00270400057065297,0.0232122141641425,0.0338118964011021,6.11532950457809e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALY,RNA-binding protein Raly,24793,0.0364124098936179,0.00345736672535968,0.029635971111913,0.0431888486753229,6.98961230502098e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.0220296480457715,0.00209389657812155,0.0179256107526533,0.0261336853388898,7.70512293196109e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0254204665986135,0.00241909930327926,-0.0301619012330408,-0.0206790319641861,8.79237796973706e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0420311309932202,0.00400265786875714,0.0341859215704562,0.0498763404159842,9.73448713034158e-26
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM,Paralemmin-1,24657,0.0225244175325952,0.00214768215447545,0.0183149605098233,0.0267338745553671,1.11355859225573e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0188634398274517,0.00179996353995597,0.015335511289138,0.0223913683657654,1.2115874170791e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.0409795150160837,0.00391121970874729,0.033313524386939,0.0486455056452284,1.24009128935413e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0268805527937874,0.002567663600471,-0.0319131734507106,-0.0218479321368642,1.3303597736491e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMB,RGM domain family member B,29694,0.02019753308967,0.00193110743400079,0.0164125625190285,0.0239825036603116,1.47555219367592e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0321021131378491,0.00306970073697852,0.0260854996933712,0.038118726582327,1.53074011508897e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYGD,Gamma-crystallin D,24845,0.0725167309060004,0.00695123173237101,0.0588923167105532,0.0861411451014476,1.99470038099667e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0366935379774752,0.00352003865692151,0.029794262209909,0.0435928137450413,2.17012221547813e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.044079158105859,0.00423116095754768,0.0357860826290655,0.0523722335826524,2.28308198925119e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0495376957206673,0.00475703925371976,0.0402138987833766,0.0588614926579581,2.43393022282913e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX2,Sorting nexin-2,24793,0.0606876769275217,0.00584353805158156,0.0492343423464218,0.0721410115086216,3.25418431563156e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0384777744966807,0.00370627091848137,0.0312134834964572,0.0457420654969042,3.32444646205662e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCOR1,REST corepressor 1,28916,0.0331927450804694,0.0032036256111646,0.0269136388825868,0.0394718512783521,4.12829963559276e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0350415021165804,0.00340219177437138,0.0283732062388125,0.0417097979943483,7.80758356444666e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0192791945693067,0.00187165467171218,0.0156107514127509,0.0229476377258626,7.85177600679193e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0179368904345674,0.00174185644671164,0.0145228517990126,0.0213509290701222,7.96303011045201e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0215810269898244,0.00209650600832477,-0.025690178766141,-0.0174718752135079,8.28084716654548e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST5,Cystatin-D,28890,0.0409688935412979,0.00398571659419193,0.0331568890166817,0.0487808980659141,9.67496199905506e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL21,C-C motif chemokine 21,29581,0.0299292253145906,0.00291185209502242,0.0242219952083467,0.0356364554208345,9.7041081542212e-25
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0273826764011609,0.00266501205647063,0.0221592527704784,0.0326061000318433,1.02528541315896e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0268895500351346,0.00262346223135332,0.0217475640616821,0.0320315360085871,1.33436476294807e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR1,Complement receptor type 1,24903,0.0263763593487121,0.00257986774427283,0.0213198185699374,0.0314329001274869,1.73228305455313e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0446392582096609,0.0043910748699213,0.0360327514646151,0.0532457649547066,3.14857255438433e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,-0.0192803649145631,0.00189853221047622,-0.0230014880470965,-0.0155592417820297,3.49394897447901e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0345300586036728,0.00340559224440774,0.0278550978046336,0.041205019402712,4.06238748690948e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMBS,Porphobilinogen deaminase,29725,0.0313226500973996,0.00308957457029888,0.0252670839396138,0.0373782162551854,4.09407869396397e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.0152365844191527,0.001503496827998,0.0122897306362766,0.0181834382020288,4.27283892905386e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ULBP2,UL16-binding protein 2,29218,0.0277213552119415,0.00273781085315213,0.0223552459397633,0.0330874644841197,4.67209287857089e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0368032939710603,0.00363714462474272,0.0296744905065646,0.0439320974355561,4.9954544011519e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LGALS4,Galectin-4,29454,0.0395843033912138,0.00391241885524801,0.0319159624349276,0.0472526443474999,5.05302472815325e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB2,Lamin-B2,24845,0.020349486872098,0.0020113792485567,0.0164071835449269,0.0242917901992691,5.16056167951355e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAX,Apoptosis regulator BAX,28722,0.0655055091602079,0.00647994766631917,0.0528048117342223,0.0782062065861935,5.53043282787637e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A14,Protein S100-A14,24867,0.0383896506212929,0.00379961761809885,0.0309424000898191,0.0458369011527666,5.92658769882436e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0407883320334299,0.00403782326244935,0.0328741984390292,0.0487024656278306,6.06790540661617e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0285134819601277,0.00282929442140129,0.0229680648941812,0.0340588990260743,7.68508729175316e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAM,Signal transducing adapter molecule 1,24793,0.0266378750962995,0.00264852965676067,0.0214467569690486,0.0318289932235504,9.44519634354312e-24
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL2,Fc receptor-like protein 2,29645,0.0355129767407404,0.00353646751345711,0.0285815004143644,0.0424444530671163,1.08793031963666e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0267773386645981,0.00266612465493344,0.0215517343409286,0.0320029429882677,1.08856645629196e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0246998963089485,0.0024597979436244,-0.0295211002784524,-0.0198786923394447,1.11220229123306e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE3,Eosinophil cationic protein,29343,0.0781515281331522,0.00779116766366347,0.0628808395123718,0.0934222167539326,1.2186960166268e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRH,Corticoliberin,28751,0.0625440822088858,0.00623538771049837,0.050322722296309,0.0747654421214626,1.22436379681093e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0260502638532553,0.00259730624094194,0.0209595436210091,0.0311409840855015,1.23180014916104e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGT,Angiotensinogen,24951,0.016631951359259,0.00165839072530915,0.0133815055376531,0.0198823971808649,1.26050118879659e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0263480305694952,0.00263777335306787,0.0211779947974822,0.0315180663415082,1.89065452487842e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0409151070708582,0.00412899605938287,0.0328222747944678,0.0490079393472486,4.1223164606152e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0301273639518476,0.00304182659031649,0.0241653838348273,0.0360893440688679,4.33979206882796e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0333502721518269,0.00336993210819325,0.0267452052197682,0.0399553390838857,4.69729252423335e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0187745332819408,0.00189741696141542,0.0150555960375665,0.022493470526315,4.76273996094771e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0359062000479212,0.00363111914861431,0.0287892065166372,0.0430231935792053,5.08340071485688e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP6,Gastrotropin,28872,0.0399054233841242,0.00403558840026536,0.0319956701196041,0.0478151766486443,5.08676738738047e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGBL1,Integrin beta-like protein 1,24938,0.0264472099767511,0.00267643941582286,0.0212013887217383,0.0316930312317639,5.52021556375763e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.082509739218372,0.00835585399482727,0.0661322653885106,0.0988872130482335,5.83707572817102e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0175757852462007,0.00178511503207934,0.0140769597833252,0.0210746107090763,7.76231956417355e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0295160726479134,0.00300472090383567,0.0236268196763954,0.0354053256194313,9.8349134960606e-23
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN8,Septin-8,24801,0.0226791100421353,0.00231112518164745,0.0181493046861063,0.0272089153981643,1.088506913207e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPB2,Coatomer subunit beta',24111,0.0303345325826663,0.00309227679516768,0.0242736700641377,0.036395395101195,1.12698987859078e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX1,Peroxiredoxin-1,28669,-0.0633339300268674,0.00647385062992385,-0.0760226772615181,-0.0506451827922166,1.44443538163548e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0300515354340228,0.00307822683295399,0.024018210841433,0.0360848600266127,1.76155807232967e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JAM2,Junctional adhesion molecule B,29694,0.0186845331866795,0.00191588588877678,0.014929396844677,0.022439669528682,1.94651916347953e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMPD3,AMP deaminase 3,24845,0.0494923343561151,0.00509207539600615,0.039511866579943,0.0594728021322871,2.72911620847446e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM3,Myomesin-3,24381,-0.0651601801531692,0.0067067612364512,-0.0783054321766135,-0.0520149281297248,2.83977526907033e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0178059854353049,0.00183394467172476,-0.0214005169918854,-0.0142114538787243,3.02540556283529e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A11,Protein S100-A11,29208,0.0316965165987514,0.00326518234074733,0.0252967592108866,0.0380962739866161,3.02910613337684e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAM,Integrin alpha-M,29443,-0.0220184619218008,0.0022691219054654,-0.026465940856513,-0.0175709829870886,3.1451691116512e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0201279901990894,0.00208013250541577,0.0160509304884745,0.0242050499097043,4.09995097349043e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0399332126925104,0.0041273687441477,0.0318435699539809,0.0480228554310399,4.15110704555013e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOBR,Apolipoprotein B receptor,24240,-0.029588916285607,0.00306360722433946,-0.0355935864453123,-0.0235842461259016,4.97256389607077e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0180686135974083,0.00187161185548765,0.0144002543606525,0.021736972834164,5.16682687246824e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0412496249769247,0.00427608129324283,0.0328685056421687,0.0496307443116806,5.55456456026693e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.0457916379277258,0.00476742265109104,0.0364474895315874,0.0551357863238643,8.18650386696501e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300C,CMRF35-like molecule 6,29694,0.0237923571940352,0.00248032130166511,0.0189309274427716,0.0286537869452988,9.25054223941948e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0264736045817788,0.00276098571212372,0.0210620725860164,0.0318851365775413,9.77664425052118e-22
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18BP,Interleukin-18-binding protein,29594,0.0211674347307316,0.00221446939895403,0.0168270747087817,0.0255077947526815,1.28148193034509e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0203785124751184,0.0021342329565762,0.016195415880229,0.0245616090700077,1.41625639928243e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.039934876996264,0.00420216392837491,0.0316986356966492,0.0481711182958789,2.21383004286941e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17D,Interleukin-17D,28931,0.0232992388494018,0.00245268063993255,0.018491984795134,0.0281064929036696,2.26602301582072e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMOX1,Heme oxygenase 1,29165,-0.0327245598515808,0.00344856080239428,-0.0394837390242736,-0.025965380678888,2.49596340510896e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0572277908854564,0.0060442499303366,0.0453810610219966,0.0690745207489161,3.0591820794355e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOM,Apolipoprotein M,29545,0.018818943294532,0.0019877962439484,0.0149228626563931,0.0227150239326708,3.07978910313048e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP12,Macrophage metalloelastase,29466,0.0360358527689649,0.00380886908507625,0.0285704693622155,0.0435012361757144,3.26809403856624e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EBI3_IL27,Interleukin-27,29674,-0.0209733357149279,0.00221871985523755,-0.0253220266311935,-0.0166246447986623,3.52997118123413e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNC,Tenascin,29594,-0.0322128246038459,0.00342195596370653,-0.0389198582927106,-0.0255057909149811,5.13164864813865e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0277725579443491,0.00295539435105395,0.0219799850162834,0.0335651308724149,6.00233623887701e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0402341728688243,0.00428286789852558,0.0318397517877141,0.0486285939499344,6.25748941566797e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0220786245277797,0.00235096371457134,0.0174707356472199,0.0266865134083396,6.41636492628265e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR2,Complement factor H-related protein 2,24789,0.0384547202456728,0.00409531873803472,0.0304278955191247,0.0464815449722208,6.50479680586754e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA12,Carbonic anhydrase 12,29349,-0.0218811389152484,0.00233806824246562,-0.026463752670481,-0.0172985251600158,8.63430128969113e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0486812072475036,0.00520187645943704,0.038485529387007,0.0588768851080002,8.7708031934401e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0259322961844411,0.00277238389316285,0.0204984237538419,0.0313661686150403,9.16634708790281e-21
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCT,Secretin,24195,0.0314605460840711,0.00337379720013483,0.0248479035718069,0.0380731885963354,1.20237475412625e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.068818583633265,0.00738056153188592,0.0543526830307686,0.0832844842357614,1.20754118446119e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0206252382918003,0.00221836573930498,-0.0249732351408381,-0.0162772414427625,1.53392492393775e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.0271009671226148,0.00292263524560949,0.0213726020412202,0.0328293322040093,1.93387735258169e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0296717777121584,0.00320274413115304,0.0233943992150984,0.0359491562092183,2.09266045349759e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0218483276659018,0.00235938557281714,0.0172239319431802,0.0264727233886234,2.17406185756296e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0240147432009623,0.00259659065169951,0.0189254255236313,0.0291040608782934,2.45760819742831e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0358145299303407,0.00388116564203059,0.0282074452719607,0.0434216145887206,2.94586575468118e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD59,CD59 glycoprotein,28277,0.0152729356764461,0.00165566359211045,0.0120278350359096,0.0185180363169826,3.03689484430941e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPE,Carboxypeptidase E,29468,-0.025534506865617,0.0027701805074201,-0.0309640606601604,-0.0201049530710736,3.23348709529342e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.0170658806585615,0.00185151101221745,0.0134369190746153,0.0206948422425076,3.24357780569106e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0302389635741818,0.00328609224021692,0.0237982227833566,0.036679704365007,3.78709615136244e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.019680064941311,0.00214126244798247,0.0154831905432654,0.0238769393393566,4.14570547895252e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GC,Vitamin D-binding protein,24966,0.0170775305089998,0.00185841986515206,0.0134350275733017,0.0207200334446978,4.25434616654133e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0185351416132524,0.00202329672890656,0.0145694800245955,0.0225008032019092,5.54516506381998e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0267848695475301,0.00293023711624873,-0.0325281342953776,-0.0210416047996826,6.58451719237682e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN1,Contactin-1,29820,-0.0178597865793732,0.00195627865420889,-0.0216940927416226,-0.0140254804171237,7.30591133720204e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300LF,CMRF35-like molecule 1,29725,0.0395043168817338,0.00432758760262673,0.0310222451805855,0.0479863885828822,7.37389481332181e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0276552478028505,0.00303706195433245,0.0217026063723589,0.0336078892333421,9.18001492691053e-20
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0517925587279476,0.0056967448458291,0.0406269388301225,0.0629581786257726,1.03689242355359e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0230190231107278,0.00253274137891015,0.0180548500080639,0.0279831962133917,1.0661197029129e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0549008980046841,0.00604164428911729,0.0430592751980143,0.066742520811354,1.09274117184237e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLVRB,Flavin reductase,29443,0.0424006719819979,0.00466901935494356,0.0332493940463085,0.0515519499176873,1.13833804113049e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.0344532207910305,0.00379557560173072,0.0270138926116383,0.0418925489704227,1.18319042059585e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS1,Nephrin,24229,0.0222282033072264,0.00244933627015707,0.0174275042177185,0.0270289023967342,1.21892269065155e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1,Programmed cell death protein 1,29661,0.0278893815288087,0.00307817007221166,0.0218561681872738,0.0339225948703435,1.37776547377358e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0219694408132709,0.00242451310188672,0.0172173951335729,0.0267214864929688,1.38303151419013e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0194402074768357,0.0021498510245783,0.0152264994686623,0.0236539154850092,1.62084780134424e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR15L,Protein GPR15L,24805,0.0397237054891315,0.00439505689028478,0.0311093939841733,0.0483380169940896,1.70506420926108e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0184121235638201,0.00204447040791313,-0.0224192855633298,-0.0144049615643103,2.26642669405032e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL3,Follistatin-related protein 3,29351,0.0205713198041107,0.00228920842870076,0.0160844712838572,0.0250581683243642,2.70854866026673e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENSA,Alpha-endosulfine,24793,0.0341026952490506,0.00379660994871995,0.0266613397495595,0.0415440507485417,2.83307440765625e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A13,Protein S100-A13,24229,0.0226780154588801,0.00252731121588961,0.0177244854757364,0.0276315454420237,3.08482885935244e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0187412557320121,0.00209289168856894,-0.0228433234416072,-0.014639188022417,3.60007455315992e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DGCR6,Protein DGCR6,24101,0.0281220303968543,0.00315013373228019,0.0219477682815851,0.0342962925121234,4.67189965334284e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PVALB,Parvalbumin alpha,29599,0.0716911106394409,0.00805311253996405,0.0559070100611114,0.0874752112177705,5.77613778995051e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSPN,Persephin,29434,0.0600574940531494,0.00675065808785445,0.0468262042009547,0.0732887839053441,6.0840688885502e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0635834883629235,0.00714977552636994,0.0495699283312384,0.0775970483946086,6.35202634192281e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CABP2,Calcium-binding protein 2,24195,0.0417509367009102,0.00469742534181348,0.0325439830309557,0.0509578903708646,6.64356719370278e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSM,Oncostatin-M,29293,0.0453003219409745,0.00510148931139272,0.0353014028906448,0.0552992409913043,7.07058456993375e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDM1,Nuclear protein MDM1,24195,0.0199714281978856,0.00225238741863433,0.0155567488573623,0.0243861075384089,8.037704168751e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFIC,Nuclear factor 1 C-type,24867,0.0283479790631083,0.00319967675464255,0.0220766126240089,0.0346193455022077,8.55297426609635e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK6,Kallikrein-6,29519,0.0194381667469125,0.00219688668184085,0.0151322688505045,0.0237440646433206,9.39227910998538e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0216549054148347,0.00244901917761494,0.0168548278267095,0.02645498300296,9.98974429871949e-19
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN3,CCN family member 3,29795,0.021458187636675,0.0024292381965378,0.0166968807714609,0.026219494501889,1.07091754522982e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.0229377721759489,0.0025983466306627,-0.0280305315720478,-0.01784501277985,1.12556319013152e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0423817842863666,0.00480078875140702,0.0329722383336088,0.0517913302391244,1.13602016649523e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0249601364212614,0.00283642658418904,0.0194007403162508,0.0305195325262719,1.44463879238837e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.00999252266123112,0.00113754396162819,0.00776293649643987,0.0122221088260224,1.65603306752361e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.0374067724642802,0.00426529874456771,0.0290467869249275,0.0457667580036329,1.89882943241898e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0173018793808951,0.00197534744450578,0.0134301983896638,0.0211735603721264,2.07393805594205e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRL,Prolactin,29694,-0.0476123582118389,0.00543788607860032,-0.0582706149258955,-0.0369541014977823,2.13438908442946e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0275009157168548,0.00314504517732589,-0.0336652042644135,-0.021336627169296,2.36314195533115e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0280296447541233,0.00320587237413333,0.0217461349008219,0.0343131546074246,2.40996757860063e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0222281176415294,0.00254911514484865,-0.0272243833254327,-0.017231851957626,2.95405987034907e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALCAM,CD166 antigen,29820,0.012235373197402,0.00140420611713083,0.00948312920782559,0.0149876171869784,3.09938801085304e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0224243588062466,0.00257729579849863,0.0173728590411893,0.027475858571304,3.50454476694533e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPOCK1,Testican-1,29218,0.0160064057459117,0.00184671825217304,0.0123868379716525,0.0196259735201708,4.64184720953563e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYZL2,Lysozyme-like protein 2,24016,0.0224590045935775,0.00259166582934341,0.0173793395680644,0.0275386696190906,4.75922659331918e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0191801684079374,0.00221516719923319,0.0148384406974404,0.0235218961184345,5.07002091482034e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0301448427977704,0.0034929340321872,0.0232986920946835,0.0369909935008573,6.43123070747304e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0279005208309934,0.00323556154755658,0.0215588201977825,0.0342422214642043,6.90082751191109e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0170484292634797,0.00197908209510691,0.0131694283570701,0.0209274301698892,7.38030079715224e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.0224906060108076,0.00261128558927805,0.0173724862558226,0.0276087257657926,7.55611203880454e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAM,Basal cell adhesion molecule,29443,-0.0148286069984465,0.00172727592655516,-0.0182140678144946,-0.0114431461823984,9.52644847877822e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD300E,CMRF35-like molecule 2,29642,0.0250835848750889,0.00292314668789874,0.0193542173668074,0.0308129523833704,9.85502770817089e-18
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.0177958533571886,0.00207962819558627,0.0137197820938395,0.0218719246205377,1.22363950337011e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1B,Interleukin-1 beta,28745,0.0345630390883534,0.00404420288546218,0.0266364014328475,0.0424896767438593,1.33274534483149e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.0113671673534901,0.00133021319153656,0.00875994949807839,0.0139743852089017,1.35335869836587e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0348252855749402,0.00407595620098787,0.026836411421004,0.0428141597288765,1.35744618962449e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0326959960248799,0.00382827010071442,0.0251925866274796,0.0401994054222801,1.39893895128164e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1A,Protein phosphatase 1A,28797,0.0190981791506506,0.00223674691086715,0.014714155205351,0.0234822030959502,1.42724644724705e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.0434991068095352,0.0051009842540829,0.0335011776715327,0.0534970359475377,1.56653807398246e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0270339384438092,0.00317494770534389,-0.0332568359462832,-0.0208110409413352,1.765263129493e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0330891873333389,0.0038896100409286,0.0254655516531189,0.040712823013559,1.86863590620781e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0327891535008385,0.00385883858891869,0.0252258298665579,0.0403524771351191,2.05054708750129e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTB,Lymphotoxin-beta,24793,0.0213159469631696,0.00251142058047199,0.0163935626254445,0.0262383313008947,2.22575581856348e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB6,Integrin beta-6,28931,0.0185242659268,0.00218394577306861,0.0142437322115855,0.0228047996420145,2.31720241292947e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B2M,Beta-2-microglobulin,24966,0.0189313444695794,0.00223396578055256,0.0145527715396964,0.0233099173994624,2.4932368950418e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0231490761031769,0.00273238975115766,0.0177935921909079,0.0285045600154459,2.51959156689706e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0204373716223787,0.00241277995943812,0.01570832290188,0.0251664203428775,2.55520343932706e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0156734401233437,0.00185940407024608,0.0120290081456614,0.019317872101026,3.6632115143209e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA1,Annexin A1,24281,0.0258407742329366,0.00307439040891958,0.0198149690314543,0.031866579434419,4.50389479683396e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0159694947612338,0.00190229860876022,-0.0196980000344039,-0.0122409894880638,4.9099577831346e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0220914015107195,0.00263622572715958,0.0169243990854867,0.0272584039359523,5.52566925249061e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CR2,Complement receptor type 2,29594,0.0280056945901529,0.0033420473272602,0.0214552818287229,0.0345561073515829,5.53345284573225e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0376330031989477,0.00452606623482997,0.028761913378681,0.0465040930192145,9.66224456761015e-17
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0153474409931725,0.00184746475548862,0.0117264100724149,0.0189684719139302,1.02055017331943e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0358473773499017,0.00432008456020265,0.0273800116119045,0.0443147430878989,1.10523765616392e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LUZP2,Leucine zipper protein 2,24793,0.0266449212232959,0.00322053253181082,0.0203326774609467,0.0329571649856451,1.36609913118722e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.0371241168702699,0.00449389079273445,-0.0459321428240294,-0.0283160909165104,1.50491077620188e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0127097930987419,0.00153988063034742,-0.0157279591342229,-0.00969162706326098,1.59961698769943e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR5,Complement factor H-related protein 5,24623,0.0247828918821033,0.00300284094009761,0.0188973236395119,0.0306684601246946,1.61928960614001e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.023461135568464,0.00284345862531389,0.0178879566628487,0.0290343144740792,1.63673591946185e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP1,"Fatty acid-binding protein, liver",29454,0.0556153632544749,0.00674597354543172,0.0423932551054287,0.0688374714035211,1.73064055610108e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK14,Kallikrein-14,29725,-0.0272147128199796,0.00330918993395302,-0.0337007250905275,-0.0207287005494316,2.04802533352824e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0254884580513907,0.0031003790736957,0.0194117150669472,0.0315652010358343,2.10036685418464e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.141285156154817,0.017214884013275,0.107543983488798,0.175026328820836,2.37384014709223e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0412276563529944,0.00502334367955445,0.0313819027410677,0.0510734099649212,2.3753816991326e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSH,Pro-cathepsin H,28852,0.0430468922997882,0.00526339146834899,0.0327306450218242,0.0533631395777522,2.9897565959522e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSR,Insulin receptor,24229,0.00998259423867184,0.00122062323415047,0.00759017269973691,0.0123750157776068,3.01930442843695e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.0567820731005738,0.00695683555540443,-0.0704174707891665,-0.0431466754119811,3.42386248756616e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNG,Interferon gamma,28931,0.0665917521368807,0.00817260153876446,0.0505734531209023,0.082610051152859,3.84237584172657e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0319178981295303,0.00391931446458476,0.0242360417789442,0.0395997544801164,4.01577573184709e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,XG,Glycoprotein Xg,29693,0.0188067671902677,0.00231055926912875,0.0142780710227754,0.0233354633577601,4.12341026519901e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0248772548379006,0.00306029013145349,0.0188790861802518,0.0308754234955495,4.4979413764716e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB37,Ras-related protein Rab-37,28931,0.0479945616204683,0.00590905282085927,0.0364128180915841,0.0595763051493524,4.75837571038234e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0230970951359706,0.00284346640881181,0.0175239009746994,0.0286702892972417,4.76926682965535e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0145326489319008,0.00179527870827758,-0.0180513952001249,-0.0110139026636768,5.99706807791515e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0237369569517824,0.00293463107055303,0.0179850800534985,0.0294888338500664,6.27252049661569e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMB,Granzyme B,29434,0.0378265387611434,0.00468584106478998,0.0286422902741551,0.0470107872481318,7.14677363306905e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP4,Guanylate-binding protein 4,28774,0.0284510006104538,0.00352684482858891,0.0215383847464196,0.0353636164744881,7.48378171246701e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD6,Programmed cell death protein 6,29478,-0.040487317986457,0.00502855941945429,-0.0503432944485874,-0.0306313415243266,8.48600809907604e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH1,Protocadherin-1,29713,0.0122620977117848,0.00152379018747884,0.00927546894432631,0.0152487264792433,8.79127720428318e-16
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPARCL1,SPARC-like protein 1,29489,-0.0158139434947689,0.0019716917110261,-0.01967845924838,-0.0119494277411577,1.09194687687008e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0444126063238722,0.00553974012258348,0.0335547156836086,0.0552704969641359,1.13143274401199e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0228746774186537,0.00285383272887795,0.0172811652700529,0.0284681895672544,1.14562324511191e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0445259067515403,0.00555695813123029,0.0336342688143289,0.0554175446887517,1.17295543582829e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GZMH,Granzyme H,28916,0.0437767800390933,0.00548803818675501,0.0330202251930535,0.0545333348851332,1.55736796315838e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0222377176217381,0.00279014241327169,0.0167690384917256,0.0277063967517507,1.64259443837893e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BOC,Brother of CDO,28916,-0.0133772003948496,0.0016826467425118,-0.0166751880101727,-0.0100792127795265,1.93121534008768e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRK1,Protein BRICK1,28774,0.025546621731627,0.00321353200828857,0.0192480989953814,0.0318451444678726,1.93766858518465e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA7,Carbonic anhydrase 7,24445,-0.0196600112141996,0.00247367352252521,-0.024508411318349,-0.0148116111100502,1.98166789025836e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.018454910997879,0.00232282728046089,-0.0230076524675823,-0.0139021695281756,2.02505737014414e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0275824124367687,0.00347794532770186,0.020765639594473,0.0343991852790643,2.27355640221186e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN8,Tetraspanin-8,24805,0.0570947235164418,0.00720093586104746,0.0429808892287888,0.0712085578040949,2.30559175626997e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.017445136108561,0.00220117790297363,-0.0217594447983893,-0.0131308274187327,2.37312304785689e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PZP,Pregnancy zone protein,24966,0.0303312992416309,0.00383236871832116,0.0228198565537215,0.0378427419295404,2.58497735474967e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0203847677961201,0.00258019637760994,0.0153275828960046,0.0254419526962356,2.87488933842731e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0234651549695275,0.00297171158754057,0.017640600257948,0.029289709681107,2.97718217352936e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0146558450447024,0.00185800222130727,0.0110141606909401,0.0182975293984646,3.17655063244819e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHISA5,Protein shisa-5,24938,0.0143358717024686,0.00182034173030403,0.0107680019110727,0.0179037414938645,3.53502872742097e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0347565604574451,0.00441585267451144,0.0261014892154027,0.0434116316994875,3.67018912070545e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLFM4,Olfactomedin-4,23498,0.0696286112105311,0.00885687481555343,0.0522691365720464,0.0869880858490158,3.95697008943128e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0194852213553326,0.00248012087920548,0.0146241844320898,0.0243462582785753,4.08260726618223e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SATB1,DNA-binding protein SATB1,24867,0.0167353736999709,0.00213529328666739,0.0125501988581028,0.020920548541839,4.77917794628624e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.015133227694354,0.00193334547662035,0.0113438705601781,0.0189225848285299,5.14294066323117e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0146709307443672,0.00187534805113811,0.0109952485641365,0.0183466129245979,5.32905578346894e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.0317401917846997,0.00405702887646397,0.0237884151868304,0.0396919683825691,5.34612559036413e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0233785434032675,0.00299837532822559,0.0175017277599453,0.0292553590465897,6.54623147176148e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.0150966561092257,0.00194415622088965,0.011286109916282,0.0189072023021694,8.46889036434141e-15
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0281366997449952,0.00364434717416239,0.0209937792836369,0.0352796202063534,1.20103908978891e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0256596300746192,0.00334201244218849,0.0191092856879298,0.0322099744613087,1.67666688236016e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0186140217741633,0.00242589102517581,0.0138592753648187,0.0233687681835078,1.74072954038413e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPO,Erythropoietin,29434,0.0417947474106274,0.00545323390714922,0.0311064089526149,0.0524830858686399,1.85460743997022e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0149220268079749,0.00194764827085563,-0.0187394174188519,-0.0111046361970978,1.90412096232769e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0374924124789103,0.00491226873367014,0.0278643657609168,0.0471204591969038,2.38917791141359e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL3,Insulin-like 3,24845,0.0412724132333475,0.00542900892300564,0.0306315557442564,0.0519132707224385,3.01426380324673e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0167810609949447,0.00221297944823687,-0.021118500713489,-0.0124436212764005,3.47735323280953e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS4,Thrombospondin-4,29518,0.0245969117219578,0.00324546149313009,0.0182358071954228,0.0309580162484927,3.58809203284586e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN10,Ataxin-10,28774,0.0395443018791612,0.0052240199482316,0.0293052227806273,0.0497833809776952,3.85261835714636e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0301736033779649,0.00399508226444521,0.0223432421396523,0.0380039646162775,4.41074174514813e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MATN3,Matrilin-3,29169,-0.017416123025365,0.00230776408545374,-0.0219393406328543,-0.0128929054178757,4.59261616518664e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB44,Ras-related protein Rab-44,24793,0.0228524847996,0.00303012540893627,0.0169134389980849,0.0287915306011151,4.79568144732914e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCP1,Plastin-2,24938,0.025714204579386,0.00341064977143332,0.0190293310273767,0.0323990781313953,4.88271429083001e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0557934590339669,0.00742591621902898,0.0412386632446701,0.0703482548232637,5.9277191914681e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRUNE2,Protein prune homolog 2,24445,0.0157958695988179,0.00210314299259981,0.0116737093333223,0.0199180298643136,6.08706758378979e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.0145128579299837,0.00193478131588666,0.0107206865508459,0.0183050293091216,6.50948241178739e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.020716212906029,0.00276306511247747,0.0153006052855732,0.0261318205264849,6.72006934898076e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE1,Ribonuclease pancreatic,24951,0.0130932764275028,0.00175215462843274,0.00965905335577462,0.0165274994992309,8.11642782080147e-14
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.031201292529803,0.00419136043019481,0.0229862260866212,0.0394163589729848,1.00708969607546e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLGN,Calmegin,24195,0.0240649106835256,0.00323411250911221,0.0177260501656657,0.0304037712013855,1.03284990687531e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.017297443281508,0.00232616597071683,0.012738157978903,0.021856728584113,1.07197034127384e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0181374320740366,0.00244200740434805,0.0133510975615144,0.0229237665865587,1.13873910436413e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0238318291966802,0.00322317753392889,0.0175144012301795,0.0301492571631808,1.46400491816134e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0146307259123796,0.00198526834576935,0.0107395999546717,0.0185218518700875,1.75683176989513e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKD1,Polycystin-1,24922,0.0140786048082324,0.00191071823277206,0.0103335970719992,0.0178236125444657,1.78289381093485e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0203643974071943,0.00276837643708696,0.0149383795905039,0.0257904152238848,1.95253594886914e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.0222058369647608,0.00303469919579281,0.0162578265410069,0.0281538473885147,2.59452692089084e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.0266306883362665,0.00364295495800793,0.019490496618571,0.033770880053962,2.74804964526238e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0210266581788601,0.00287961358739242,0.015382615547571,0.0266707008101493,2.92226427431572e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNU13,NHP2-like protein 1,24111,0.0328388839118667,0.00450096878305819,0.0240169850970726,0.0416607827266607,3.05707079773061e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNLY,Granulysin,29443,0.0273220855117044,0.0037453351411683,0.0199812286350145,0.0346629423883942,3.06278246345144e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.027548177470254,0.00377901424622843,0.0201413095476463,0.0349550453928617,3.18455414944868e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0121922821897002,0.00167344918383572,0.00891232178938214,0.0154722425900182,3.27922672355076e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLU,Clusterin,24966,0.0166217415390121,0.00228122528281358,0.0121505399846975,0.0210929430933267,3.2798763827656e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0140440745183134,0.00193202630044564,0.01025730296944,0.0178308460671869,3.70898318824344e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDI2,Protein DDI1 homolog 2,24381,0.0398539803121032,0.00550911534573237,0.0290561142344678,0.0506518463897386,4.82159490558367e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.0146829710940193,0.00203445447376558,0.0106954403254387,0.0186705018625998,5.43692533974001e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0250876605304759,0.00347623946250453,0.018274231183967,0.0319010898769848,5.47619375733044e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0171045725093736,0.00237639291590063,0.0124468423942084,0.0217623026245388,6.30189152767293e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0193780939134989,0.00269372632117055,0.0140983903240046,0.0246577975029931,6.48511854086621e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB2A2,Mammaglobin-A,24111,-0.0163270903967913,0.00227270100715747,-0.02078158437082,-0.0118725964227627,6.96674894286479e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0136745356086762,0.00190600021360706,-0.017410296027346,-0.00993877519000634,7.4309708775834e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0441793098014099,0.00615757960310158,0.0321104537793308,0.056248165823489,7.45154367251092e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROCR,Endothelial protein C receptor,24111,-0.0184879734576226,0.00257973991217623,-0.0235442636854881,-0.0134316832297572,7.90946589058937e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,0.0138818826445198,0.00193903853248907,0.0100813671208412,0.0176823981681984,8.30666172901697e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL1,Chordin-like protein 1,29536,0.0161727106114384,0.00226204110914746,0.0117391100375094,0.0206063111853674,8.90462449852426e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0129143735043106,0.00180980400197514,0.00936715766043933,0.0164615893481819,9.8460050445169e-13
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGA4,Pepsin A-4,24951,0.0363979354754475,0.00511176503417142,0.0263788760084715,0.0464169949424235,1.10511556924075e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.012779831773955,0.00179557759089819,-0.0162991638521155,-0.00926049969579459,1.12472285267308e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0178737876328777,0.00251198385287755,0.0129502992812377,0.0227972759845177,1.14104103444736e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.0153963537554267,0.00216524423084162,0.0111524750629771,0.0196402324478762,1.18597929854151e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN2,Prefoldin subunit 2,28774,0.0283384678453401,0.00399558802378319,0.0205071153187251,0.0361698203719552,1.34811582496388e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.032707452912053,0.00461586911873135,0.0236603494393395,0.0417545563847664,1.4189648669541e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.0185195818893669,0.00261793578528661,0.0133884277502052,0.0236507360285287,1.53824086083828e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN2,Alpha-actinin-2,24111,-0.0301353764335358,0.00426360893591327,-0.0384920499479258,-0.0217787029191458,1.61414039714299e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0232822691338647,0.00329480071136511,0.0168244597395891,0.0297400785281403,1.63312731386836e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCAN,Versican core protein,29694,-0.0152280645753704,0.00215745782696417,-0.0194566819162202,-0.0109994472345207,1.72205996228455e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCN5,CCN family member 5,29443,0.0196987960614506,0.00279204821782892,0.0142263815545059,0.0251712105683953,1.76009216186103e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0197796354346108,0.00280621384131113,0.0142794563056409,0.0252798145635806,1.85696027609482e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD1,Leiomodin-1,24867,-0.0179780204727982,0.00255272139587349,-0.0229813544087102,-0.0129746865368861,1.93475408064016e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA9,Carbonic anhydrase 9,29725,-0.0231131090485938,0.00328300840456264,-0.0295478055215366,-0.0166784125756511,1.96099597185231e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0197039009752013,0.00279991574186298,0.0142160661211498,0.0251917358292527,2.00275458917066e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG3,Desmoglein-3,29589,0.0172689697558897,0.0024547190556704,0.0124577204067757,0.0220802191050037,2.0358104912166e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL34,Interleukin-34,28722,0.0181883705140916,0.00259661397464864,0.0130990071237803,0.023277733904403,2.5305882746313e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0350727716828878,0.00500695032303557,0.0252591490497381,0.0448863943160375,2.53720953951067e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIF,Leukemia inhibitory factor,28774,0.0257708280215177,0.00369224268983423,0.0185340323494426,0.0330076236935928,3.02175829955555e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLIN3,Perilipin-3,29478,0.021255209786066,0.00305590743041287,0.0152656312224568,0.0272447883496752,3.58772332375024e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0150675489239237,0.00217005471098591,0.0108142416903913,0.0193208561574561,3.90912766307162e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP1,Caspase-1,28774,0.0338129181830403,0.00487863485708385,0.0242507938631559,0.0433750425029246,4.27242513016624e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0198140471675755,0.00286008960215852,0.0142082715473449,0.0254198227878062,4.38221450539227e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM2,Myomesin-2,24111,-0.0254298365404038,0.0036720007915376,-0.0326269580918175,-0.0182327149889901,4.45873516107398e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.040835590091354,0.0059055505350529,0.0292607110426503,0.0524104691400577,4.78091160942485e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTG,Protogenin,29725,0.0123546557425462,0.00178913152061973,0.00884795796213148,0.0158613535229608,5.10713570338913e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSHB,Thyrotropin subunit beta,29478,0.0381383632222822,0.00552322862459895,0.0273128351180683,0.0489638913264962,5.1190527066547e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0218335534518628,0.00316367583868581,0.0156327488080386,0.028034358095687,5.27904964773764e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0337859080780138,0.00489706425798246,-0.0433841540236594,-0.0241876621323682,5.35457403334223e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.0115095327682328,0.0016727785180668,0.00823088687282187,0.0147881786636437,6.0850791111014e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAP,Cartilage-associated protein,24195,0.0241458221835662,0.00351045394528163,0.0172653324508142,0.0310263119163182,6.20637401849265e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.02589901005087,0.00376678668339334,0.018516108151419,0.0332819119503209,6.29756954991986e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0439623891556996,0.00639593767802078,0.0314263513067789,0.0564984270046203,6.38963943322798e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA7A,Semaphorin-7A,29736,0.0136214331055018,0.00198519841952911,0.00973044420322475,0.0175124220077789,6.94780715802891e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF16,Fibroblast growth factor 16,24229,0.0236389986223423,0.00344504238811508,0.0168867155416368,0.0303912817030479,6.96647436879972e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0191106008873141,0.00279543336085064,0.0136315515000468,0.0245896502745813,8.2812349147741e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MBL2,Mannose-binding protein C,24610,-0.0530693512254922,0.00777166342284738,-0.0683018115342731,-0.0378368909167114,8.77613294937768e-12
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0172207439889906,0.00252982557334234,0.0122622858652396,0.0221792021127416,1.01866833459649e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG1,Arginase-1,29216,0.025258604215417,0.00371733383389614,0.0179726299009806,0.0325445785298534,1.10531496921532e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD7,T-cell antigen CD7,24177,0.0213218697540698,0.00314106963758769,0.015165373264398,0.0274783662437417,1.16256296072353e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFR,Epidermal growth factor receptor,29820,0.00798727075661563,0.00117700655091222,0.00568033791682768,0.0102942035964036,1.1736968834677e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH1,Neurexophilin-1,28774,0.01861754928083,0.00274467932698532,0.0132379777999388,0.0239971207617212,1.19866561536215e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KEL,Kell blood group glycoprotein,28774,0.0174884732012437,0.00257878638572043,0.0124340518852317,0.0225428945172558,1.21094079852281e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST7,Cystatin-F,29498,0.0451822489947464,0.00667756090331327,0.0320942296242524,0.0582702683652405,1.34605750496006e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.01932717172116,0.00286348828953864,0.0137147346736642,0.0249396087686557,1.51148572690465e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPP1,Osteopontin,29757,-0.0223274466290272,0.00331144580560438,-0.0288178804080118,-0.0158370128500427,1.58521769627372e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICOSLG,ICOS ligand,29349,0.00922294934342403,0.00137091987634522,0.00653594638578741,0.0119099523010607,1.75697915014699e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.03030803642284,0.00451878646873159,0.0214512149441261,0.0391648579015539,2.02875181543531e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRLB,Fc receptor-like B,28797,0.0294978573186948,0.00440098002552916,0.0208719364686577,0.038123778168732,2.08570367509562e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0267043092622403,0.00399759879040098,-0.0345396028914262,-0.0188690156330544,2.43057807413408e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX3,Syntaxin-3,24845,0.0184006967681552,0.00276076772767161,0.0129895920219189,0.0238118015143916,2.70089276827654e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECM1,Extracellular matrix protein 1,24349,0.0176167102164256,0.00264459621446284,0.0124333016360784,0.0228001187967728,2.77019041864957e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,0.0220570645934827,0.0033148466419964,0.0155599651751697,0.0285541640117956,2.90194851661987e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOA4,Apolipoprotein A-IV,24966,0.0169996617211322,0.00256981194575644,0.0119628303074496,0.0220364931348148,3.78715010492696e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP1,Dipeptidase 1,29163,-0.0230435326114553,0.00348621082732973,-0.0298765058330216,-0.0162105593898891,3.91190499876319e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0142474328794892,0.00215648471642571,0.0100207228352948,0.0184741429236836,3.9960002232733e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0189456135307331,0.00287669486967716,0.0133072915861658,0.0245839354753003,4.6120310341466e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,0.0141018721894463,0.00214172369638313,0.00990409374453538,0.0182996506343572,4.6597967048824e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDN1,Endothelin-1,24240,0.0138312393025231,0.00210192695613374,0.00971146246850094,0.0179510161365452,4.7919293191061e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN2,Calsyntenin-2,29786,-0.0186842336042392,0.00284290064523259,-0.0242563188688951,-0.0131121483395834,5.03809253140036e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPC1,Glypican-1,29725,0.013887097908472,0.00211441443905559,0.00974284560792309,0.018031350209021,5.18986443554561e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMS1,PMS1 protein homolog 1,24195,0.0239429800954068,0.00365554087046483,0.0167781199892957,0.0311078402015178,5.87799228178672e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,F3,Tissue factor,29541,-0.012845480283348,0.00196226466736002,-0.0166915190313737,-0.00899944153532239,5.99653940459454e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0154115058488025,0.00235421832977916,0.0107972379224354,0.0200257737751697,6.0112417070821e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO3,R-spondin-3,29725,0.0132906109410775,0.00203604818013005,0.00929995650802265,0.0172812653741324,6.78850293298199e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOSB,Protein fosB,28774,0.0181530197886222,0.00278392051599637,0.0126965355772693,0.0236095039999751,7.11548302163554e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST1,Cystatin-SN,21656,0.049118312386293,0.007552835935919,0.0343147539518917,0.0639218708206942,8.02959540008637e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDHR1,Cadherin-related family member 1,28774,0.0199790709666592,0.00307311720751094,0.0139557612399378,0.0260023806933807,8.09651840984627e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLASP1,CLIP-associating protein 1,24016,0.0341403465228343,0.00525420713295517,0.0238421005422422,0.0444385925034264,8.31472139782898e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0288372611624338,0.0044388303299965,0.0201371537156407,0.037537368609227,8.34957229608695e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTPN,Myotrophin,28916,0.0152449188103056,0.00235491225765178,0.0106292907853081,0.0198605468353031,9.7184798625938e-11
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0189472392047737,0.00293899903892377,0.0131868010884831,0.0247076773210643,1.16312753531942e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0127621229217223,0.00197971847580665,0.00888187470914122,0.0166423711343033,1.16609159703428e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0394160944076819,0.00611923513699401,0.0274223935391736,0.0514097952761901,1.20290134334733e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.00376344316822013,0.000584942428793915,-0.00490993032865621,-0.00261695600778406,1.26690075815131e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATXN2,Ataxin-2,24101,0.0513579180588144,0.00798620993786234,0.0357049465806043,0.0670108895370246,1.29293323264157e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF7,SLAM family member 7,29434,-0.0270726073515106,0.00421194895468351,-0.0353280273026903,-0.0188171874003309,1.31641608433241e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0121042448810429,0.00188713922184901,-0.015803037755867,-0.00840545200621888,1.44323474982934e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00808418636858137,0.00126583630352718,0.0056031472136681,0.0105652255234947,1.7232241430631e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD200,OX-2 membrane glycoprotein,29434,-0.0121661495777545,0.00190736183794989,-0.0159045787801363,-0.0084277203753727,1.81459672896605e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,0.0563096362479494,0.00884896127147585,0.0389656721558568,0.0736536003400421,2.00844064624819e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOB,Apolipoprotein B-100,24951,0.0102894475069459,0.00161804315348789,0.00711808292610963,0.0134608120877822,2.06331678250852e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.020158099404885,0.00317170734095251,0.0139415530166181,0.0263746457931519,2.11331748678715e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN4,Contactin-4,29443,-0.0109798794823765,0.00172813627615822,-0.0143670265836466,-0.00759273238110635,2.13413081666327e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL6,Interleukin-6,29349,0.0335472101400873,0.0052922267833453,0.0231744456447305,0.0439199746354441,2.34683351149122e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLC,Galectin-10,29426,-0.0301055831227165,0.00476308124629482,-0.0394412223654544,-0.0207699438799787,2.64263952154116e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK8,Kallikrein-8,28443,0.016334155106998,0.00258553479185978,0.0112665069149528,0.0214018032990432,2.69735554405246e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0203763163310206,0.00323081177502131,0.0140439252519789,0.0267087074100624,2.88768510868328e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0363020626175036,0.0057570395631434,0.0250182650737425,0.0475858601612646,2.90997400190978e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0133011318309995,0.00211264952072362,0.00916033877038118,0.0174419248916178,3.10815888379371e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRDX2,Peroxiredoxin-2,24556,0.027802260669152,0.00443141812272271,0.0191166811486155,0.0364878401896886,3.58000781304227e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGB1A1,Uteroglobin,29523,0.0248921387137257,0.003970305439993,0.0171103400513394,0.032673937376112,3.67035920158782e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0315884093197474,0.00507121518811486,-0.0415279910884525,-0.0216488275510423,4.77077992798417e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0256479272085527,0.00412902578695743,0.0175550366661161,0.0337408177509893,5.31425329022937e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.0137121796675891,0.00220922791925164,-0.0180422663893223,-0.00938209294585592,5.49526358171918e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNA1,Ephrin-A1,29390,0.0125898712607002,0.00202857026566617,0.00861387353999451,0.0165658689814059,5.49785095631727e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.0427417838353012,0.00688912049527564,0.0292391076645609,0.0562444600060414,5.58502459242335e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.0129274002664905,0.00208587950182372,0.00883907644291601,0.017015724090065,5.8112254074834e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0233568706999588,0.0037730158105837,0.0159617597112148,0.0307519816887029,6.0912855088722e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0460433732000206,0.00745853503640515,0.0314246445286665,0.0606621018713747,6.79658438482297e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0339150145263892,0.00551807301592351,0.0230995914151792,0.0447304376375993,8.06262553442734e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0146787493609634,0.00238977317186698,0.00999479394410411,0.0193627047778227,8.23777776518331e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.0147225787006359,0.00239913863429994,-0.0194248904238638,-0.010020266977408,8.55712213592565e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINI1,Neuroserpin,24329,0.0134917419913972,0.00220025292903109,0.00917924625049628,0.0178042377322982,8.81703980757476e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.0140594234697181,0.00229550284717142,-0.018558609050174,-0.00956023788926208,9.22157478036164e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDK2,Protein sidekick-2,24381,0.0170642277660453,0.0027868126239664,0.0116020750230712,0.0225263805090195,9.31127205911574e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0270074702010569,0.0044125185616274,0.0183589338202672,0.0356560065818466,9.45860283091232e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EGFLAM,Pikachurin,24805,0.013549315647727,0.0022162204088424,0.00920552364639588,0.0178931076490581,9.8798096326081e-10
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPS10,40S ribosomal protein S10,24111,-0.0184157367637989,0.00301996349916234,-0.0243348652221571,-0.0124966083054407,1.09037297610862e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAFB2,Scaffold attachment factor B2,24867,0.0119898402359282,0.00197452065710927,0.00811977974799401,0.0158599007238623,1.27936165970233e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.019185528623842,0.00315991581941653,0.0129920936177856,0.0253789636298984,1.28564165740311e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0174027125185652,0.00287409113275994,0.0117694938983557,0.0230359311387746,1.42180513913234e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRELP,Prolargin,29454,0.0101010113174942,0.00167086919351517,0.00682610769820449,0.013375914936784,1.50865210266994e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.015332018371944,0.00253627405572007,0.0103609212227326,0.0203031155211553,1.51149474484058e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0162061853682662,0.00268658344492368,0.0109404818162158,0.0214718889203166,1.63966957381466e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0135315127195032,0.00224557979948343,0.00913017631251566,0.0179328491264907,1.70659457853418e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VIM,Vimentin,28916,0.0504119131415288,0.00837709286475776,0.0339928111266036,0.066831015156454,1.78897439728986e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0451404028334104,0.00750784673064059,0.0304250232413549,0.059855782425466,1.84930093724505e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0143027540694711,0.00239105423960353,-0.0189892203790941,-0.00961628775984822,2.23829658248833e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,0.0313412362318572,0.00523977766874856,0.02107127200111,0.0416112004626043,2.24340217423484e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0162482015711639,0.00272273038779357,-0.0215847531312393,-0.0109116500110885,2.44010073134769e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN1,Nectin-1,24229,0.0138920837179037,0.00232897450179909,0.00932729369437752,0.0184568737414299,2.48191663991762e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC16,Mucin-16,29349,0.0808797673932375,0.0135655699509028,0.0542912502894681,0.107468284497007,2.51806390230991e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0366127815911108,0.00614661823981364,-0.0486601533411456,-0.0245654098410761,2.60601460632244e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.03051303721809,0.00513094899144259,0.0204563771948625,0.0405696972413175,2.76986191556328e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0141762421575738,0.00239191405562936,0.00948809060854023,0.0188643937066073,3.1309361882427e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGA,Fibrinogen alpha chain,24407,0.0130619985190596,0.0022238776782177,0.00870319826975289,0.0174207987683663,4.32160060679359e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15,Interleukin-15,29434,0.013840226632103,0.0023580338940298,0.00921848019980456,0.0184619730644014,4.42080112427722e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0132919533902822,0.00226992884905981,-0.0177410139344394,-0.00884289284612498,4.81254884705185e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0173894789568094,0.00297355530252816,-0.0232176473497646,-0.0115613105638542,5.03809757802892e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHAD,Chondroadherin,24381,0.0217623259233054,0.00372676196750972,0.0144578724669863,0.0290667793796244,5.3030695702796e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0166483601503673,0.00285667355220127,-0.0222474403126818,-0.0110492799880528,5.68257249056426e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSG4,Desmoglein-4,29242,0.0207349576937556,0.00355847383882292,0.0137603489696627,0.0277095664178486,5.70499425241142e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0252830369882137,0.00434047945483307,-0.0337903767196865,-0.0167756972567408,5.77268513825038e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0178739168565298,0.0030710358758259,0.0118546865399111,0.0238931471731486,5.94008941862656e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.0117470159030119,0.0020190183746954,0.00778973988860894,0.0157042919174149,6.02251178556869e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL,Podocalyxin,29349,0.00632658548667169,0.00108793597057304,0.00419423098434854,0.00845893998899485,6.11820977241549e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0241126249003228,0.00415287517193163,0.0159729895633368,0.0322522602373088,6.45587762526513e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACHE,Acetylcholinesterase,24381,0.0137661857594646,0.00237627197012179,0.00910869269802592,0.0184236788209033,6.99130090040044e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SNX18,Sorting nexin-18,24805,0.0185956507117245,0.00321062549994351,0.0123028247318353,0.0248884766916138,7.04314020833286e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLA2G1B,Phospholipase A2,29787,-0.0179199887298846,0.00309548060627998,-0.0239871307181934,-0.0118528467415759,7.14822793616416e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERC2,ERC protein 2,24195,0.0313605603861612,0.00542969633939969,0.0207183555609378,0.0420027652113846,7.75502520716136e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0117219249481378,0.00203350785453174,-0.01570760034302,-0.00773624955325557,8.29414941480338e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MILR1,Allergin-1,28931,-0.0208874866465479,0.00362764267648212,-0.0279976662924529,-0.013777307000643,8.60444284135865e-09
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.0086628408524716,0.00151274676048668,-0.0116278245030255,-0.00569785720191771,1.03697132943908e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0275463106394413,0.00481231209308414,0.0181141789369964,0.0369784423418862,1.05163597823859e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LXN,Latexin,29117,-0.0275856841969035,0.0048304690226226,-0.0370534034812438,-0.0181179649125632,1.13562279094441e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0130602180746243,0.00228975868126127,0.0085722910593522,0.0175481450898964,1.18562894239804e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0199783471807218,0.00351207194957687,0.0130946861595512,0.0268620082018925,1.29615210402877e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALB1,Calbindin,29349,0.0177911829015551,0.00313456169806437,0.011647441973349,0.0239349238297613,1.39333122789582e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAL,Galanin peptides,29581,-0.02625572510009,0.00463230157585627,-0.0353350361887683,-0.0171764140114117,1.45846920979789e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DSC2,Desmocollin-2,29135,-0.0139377633468684,0.00246788459230163,-0.0187748171477796,-0.00910070954595724,1.64164624581006e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.0179631189181604,0.00318687452441583,0.0117168448503053,0.0242093929860154,1.75357785651345e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0119135528740854,0.00211680285250012,0.0077646192831852,0.0160624864649857,1.83892984078475e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SDC1,Syndecan-1,29478,0.0162345210499053,0.00288782340183372,0.0105743871823113,0.0218946549174994,1.90779568656343e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNPY2,Protein canopy homolog 2,28916,0.0244784609933251,0.00437612580788701,0.0159012544098666,0.0330556675767836,2.24370524746477e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCN,Decorin,28916,-0.00919289269405913,0.00164460591191405,-0.0124163202814107,-0.0059694651067076,2.29480806091001e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.021020405408629,0.00376145586324762,0.0136479519166636,0.0283928589005943,2.31216904716564e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0207217748667081,0.00371741515844055,0.0134356411561646,0.0280079085772516,2.50834336888544e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.0168280232695823,0.00302326021797197,-0.0227536132968074,-0.0109024332423573,2.63066355922714e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP2,Guanylate-binding protein 2,28931,0.0238803763813238,0.00431014738809561,0.0154324875006565,0.0323282652619912,3.04231997411965e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL4,Delta-like protein 4,24240,0.0341649565523857,0.00619064833828413,0.0220312858093488,0.0462986272954226,3.44814387422098e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM3D,Protein FAM3D,24805,0.0335657962194761,0.00608393176995561,0.0216412899503631,0.0454903024885891,3.48038204347988e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0574055251103315,0.0104262590458753,0.0369700573804159,0.077840992840247,3.70506794629437e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FABP9,Fatty acid-binding protein 9,29434,0.0221681472511207,0.00402690087728244,0.0142754215316471,0.0300608729705942,3.72217319561821e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,0.0186105820984737,0.00338208109337597,0.0119817031554568,0.0252394610414906,3.7719970630598e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI3,Elafin,29014,0.0217493276201131,0.00395801144229492,0.013991625193215,0.0295070300470111,3.93962714092666e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,0.0107233997560998,0.00195185946041839,0.00689775521367975,0.0145490442985198,3.96289254641701e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AHNAK2,Protein AHNAK2,24240,0.0117592991607308,0.00214284805451629,0.00755931697387892,0.0159592813475828,4.11287309756883e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0230002036947472,0.00419197220172378,0.0147839381793686,0.0312164692101258,4.1351385962304e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.0112933462208631,0.00206017836445462,0.00725539662653208,0.0153312958151942,4.25286994901411e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RCC1,Regulator of chromosome condensation,24793,0.0202980053914111,0.00370609023240858,0.0130340685358902,0.0275619422469319,4.36966862756297e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH3,Cadherin-3,29694,0.0142274364738586,0.0026000788899633,0.00913128184953054,0.0193235910981867,4.48768862515071e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD48,CD48 antigen,29536,0.0117333820431438,0.002152099900386,0.00751526623838728,0.0159514978479004,5.01876933421695e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.0075929263283882,0.00139794376465243,-0.010332896107107,-0.00485295654966943,5.64054027717517e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.0138659952830075,0.00255459410128395,0.00885899084449096,0.0188729997215241,5.74920370451387e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0214077942369139,0.00395097781553117,0.0136638777184728,0.029151710755355,6.07096331391993e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMG4,Proteasome assembly chaperone 4,24229,0.021835592643007,0.00403913764329572,0.0139188828621474,0.0297523024238666,6.50555268524568e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.0142053335939944,0.00262801711953565,0.00905442003970448,0.0193562471482842,6.53009639904498e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRC1,Macrophage mannose receptor 1,24951,0.0110010804176859,0.00203638116633687,0.00700977333166564,0.0149923875037062,6.64050364981328e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0151357814870408,0.00280296680385425,0.00964196655148651,0.0206295964225952,6.71878934842187e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.0104776691403999,0.00194786349923623,-0.0142954815989029,-0.00665985668189684,7.54468767432726e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGA,Chromogranin-A,24938,-0.033882340188237,0.00631757413516417,-0.0462647854931588,-0.0214998948833152,8.24934216703242e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0100935140935915,0.00188261249264251,0.00640359360801219,0.0137834345791708,8.32946369835024e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.0207863242066999,0.00388392624937213,0.0131738287579305,0.0283988196554693,8.78351216993532e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0144972896599551,0.00271388184154691,-0.019816498069387,-0.00917808125052312,9.2807549681984e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GM2A,Ganglioside GM2 activator,24421,0.014755622641023,0.00276508130182041,0.00933606328945502,0.020175181992591,9.56471710267356e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0215057438993486,0.00403417713277421,0.0135987567191111,0.029412731079586,9.86164919202886e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD99,CD99 antigen,29443,-0.00752941161286371,0.00141254246475925,-0.0102979948437918,-0.00476082838193557,9.87194193056156e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.025105608491491,0.0047117168479371,0.0158706434695343,0.0343405735134477,9.98451517830078e-08
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0103204052351289,0.0019395756106928,0.00651883703817099,0.0141219734320868,1.04114292010249e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL3,Myosin light chain 3,24240,-0.027994663434361,0.00526708889145365,-0.0383181576616101,-0.0176711692071118,1.07590788262759e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.0246285378045515,0.00463767799922123,0.0155386889260779,0.0337183866830251,1.10269437556188e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,0.026229378534887,0.00495630291525731,0.0165150248209827,0.0359437322487913,1.21770331449728e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.00947201699171986,0.00179205687173776,-0.0129844484603259,-0.00595958552311385,1.26204381286724e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.026394024029561,0.00501491313740649,0.0165647942802443,0.0362232537788777,1.42640647806832e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.017230595094544,0.0032765499727058,0.0108085571480407,0.0236526330410474,1.46248893704577e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRDL2,Chordin-like protein 2,29478,0.0201637727822141,0.00383575497091788,0.0126456930392151,0.0276818525252132,1.4760903715092e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0143418021230526,0.00273219760701781,-0.0196969094328075,-0.00898669481329765,1.54070708512398e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0144273835450975,0.00275696476967474,-0.01983103449366,-0.00902373259653501,1.67850491197936e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEO1,Neogenin,24867,0.00824681060597473,0.00157810415058843,0.00515372647082141,0.011339894741128,1.74830665369494e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH12,Protocadherin-12,24867,0.0096068495619072,0.00183875587464872,0.00600288804759572,0.0132108110762187,1.75895016069349e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.0224916119391515,0.004307557874379,-0.0309344253729343,-0.0140487985053687,1.78970097399963e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEDD9,Enhancer of filamentation 1,24229,0.0125241474530789,0.00239983056148642,0.0078204795525655,0.0172278153535923,1.81606124144619e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.0128802952702423,0.00247192320651588,-0.0177252647550135,-0.00803532578547122,1.89454126660434e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LHB,Lutropin subunit beta,28797,0.0325218909414471,0.00625166936554072,0.0202686189849873,0.0447751628979069,1.9838368670949e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,0.0178445702839568,0.00343274795672652,0.0111163842887729,0.0245727562791408,2.02425067142121e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.013765535778677,0.00266058920433785,-0.0189802906191792,-0.00855078093817481,2.31127343893997e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.0106132656543546,0.00205944884581375,0.00657674591655962,0.0146497853921495,2.57429246423752e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.023979913911699,0.00467056313688083,0.0148256101634126,0.0331342176599854,2.8541855958847e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0136217044019968,0.00265806424460808,0.00841189848256497,0.0188315103214286,3.00345666025635e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.0129422618001097,0.00252913410220283,0.00798515895979219,0.0178993646404273,3.12356988741563e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX5,Syntaxin-5,24229,0.0150454524771216,0.00294084212348072,0.00928140191509936,0.0208095030391438,3.14404892980103e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.0129748229697009,0.00253749812528667,0.00800132664413903,0.0179483192952628,3.19037540553995e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0259311007735688,0.00511066135445993,0.0159142045188274,0.0359479970283103,3.9204520014783e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0179703949698592,0.00354439684972761,0.0110233771443931,0.0249174127953253,4.00102354159168e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0147944418664618,0.00292968141395354,0.00905226629511283,0.0205366174378107,4.45370757809197e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100G,Protein S100-G,24867,-0.0168597982899117,0.00334355616070525,-0.023413168364894,-0.0103064282149294,4.62778166381435e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0141946231598386,0.00281725656273255,0.00867280029688276,0.0197164460227944,4.72142310915758e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK11,Kallikrein-11,29296,0.0111247465494243,0.00221662502106799,0.00678016150813106,0.0154693315907176,5.23059067470792e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.0153555564913273,0.00306623144382359,0.00934574286143303,0.0213653701212215,5.53927582179286e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMMD9,COMM domain-containing protein 9,24793,0.0142056885339708,0.00284099498536738,0.00863733836265078,0.0197740387052909,5.7646305336209e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROBO4,Roundabout homolog 4,24240,-0.00647341963156727,0.00129718072726187,-0.00901589385700053,-0.00393094540613401,6.06792098751325e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0161374020307801,0.00323406558000109,0.00979863349397801,0.0224761705675823,6.08448911601766e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA11,Serpin A11,29820,-0.0146475726418363,0.00294163579223951,-0.0204131787946258,-0.00888196648904689,6.41384721967729e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.0113117629039102,0.00227471232044418,-0.0157701990519808,-0.00685332675583959,6.6347939490727e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXTL1,Exostosin-like 1,24111,0.017033967512887,0.00342727188169439,0.010316514624766,0.023751420401008,6.73685798348169e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0100837806179807,0.00205213066448291,-0.0141059567203672,-0.00606160451559416,8.98064104912702e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0205435501793457,0.00418894979878186,0.0123332085737332,0.0287538917849581,9.43057623377417e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0188840083622604,0.00385586087219158,0.0113265210527649,0.0264414956717559,9.76000164306615e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC3,Membrane primary amine oxidase,29594,-0.0106104099435472,0.00216841936997852,-0.0148605119087051,-0.0063603079783893,9.97541006001857e-07
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH6,Cadherin-6,29478,-0.0134631974310681,0.00275642376527051,-0.0188657880109983,-0.00806060685113794,1.04341278049388e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWF,von Willebrand factor,29820,-0.0254124434952114,0.00521087498755799,-0.0356257584708251,-0.0151991285195978,1.08370580381227e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0183398566256685,0.00376569530960634,0.0109590938188401,0.025720619432497,1.12164168688332e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0131513171339596,0.00270172636961176,0.00785593344952052,0.0184467008183986,1.13462710321464e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC1,Sialoadhesin,29581,0.0148395131813986,0.0030503272114134,0.00886087184702839,0.0208181545157689,1.15107877990365e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0112357084999165,0.00231298367410811,-0.0157691565011684,-0.00670226049866462,1.1939955890058e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPA4,Carboxypeptidase A4,23902,0.0153163096144566,0.00315766612816444,0.00912728400325429,0.0215053352256589,1.23915773498649e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C9orf40,Uncharacterized protein C9orf40,24805,0.0279494139948622,0.00577315990592976,0.0166340205792399,0.0392648074104845,1.29789830913067e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.0110551306077604,0.00229078279690153,0.00656519632583342,0.0155450648896874,1.40064127695391e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OPTC,Opticin,29349,-0.0156111607896962,0.00324201497780124,-0.0219655101461867,-0.0092568114332058,1.47736931949327e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0128172122422232,0.00266379786177833,0.00759616843313763,0.0180382560513087,1.50446365418999e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSN,Gelsolin,24845,-0.00657741370296948,0.00137048097537636,-0.00926355641470715,-0.00389127099123181,1.60108886922618e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00740403441860868,0.00154354418965384,0.00437868780688716,0.0104293810303302,1.62177015501926e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0239121838804289,0.0050136935686865,-0.0337390232750544,-0.0140853444858033,1.85708742360762e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.0209489347563852,0.0043967152485819,0.0123313728691647,0.0295664966436057,1.90226178890146e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17RA,Interleukin-17 receptor A,29443,0.0150532199473907,0.00316450575409856,0.00885078866935753,0.0212556512254239,1.9752507376528e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMNB1,Lamin-B1,24756,0.0200589070976823,0.00423287143517907,0.0117624790847314,0.0283553351106333,2.16137286423999e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.00863988472827256,0.00183288890074372,0.00504742248281486,0.0122323469737303,2.44245155704725e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,0.0229671935710989,0.00487609190121861,0.0134100534447104,0.0325243336974874,2.48648494753052e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDRG1,Protein NDRG1,28774,0.0227572672574027,0.00484801102420611,0.0132551656499588,0.0322593688648467,2.68956984589059e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA2,Ephrin type-A receptor 2,28347,0.0105822735559702,0.00226091803275111,0.00615087421177801,0.0150136729001624,2.87470196297253e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0126593420008542,0.00271206107524187,-0.0179749817083282,-0.00734370229338013,3.06089399510664e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTL1,Cytokine-like protein 1,24938,0.00810215321560268,0.0017374852779765,0.00469668207076875,0.0115076243604366,3.13020472262185e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.00769400591753969,0.00165271994973818,-0.0109333370190265,-0.00445467481605286,3.24827981049273e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.0162057346574589,0.0034817417502539,0.00938152082696125,0.0230299484879565,3.26222425934801e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.0206225134712833,0.00443070147472342,-0.0293066883617412,-0.0119383385808254,3.26274349626728e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0176446238034734,0.00380845411422201,0.0101800537395982,0.0251091938673485,3.62242301622833e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.0103955953501934,0.00224628991444569,0.00599286711787987,0.014798323582507,3.70979275556947e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPON1,Spondin-1,29497,0.0109003731632971,0.00235937238722102,0.00627600328434386,0.0155247430422503,3.8530446297973e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYMP,Thymidine phosphorylase,29301,0.0220753738473367,0.00477905141040566,0.0127084330829416,0.0314423146117318,3.86868090866762e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLN,Mesothelin,29293,0.0185700896206089,0.00402029268201937,0.0106903159638509,0.0264498632773669,3.87067451500372e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0184524310517192,0.00399624490656482,0.0106197910348521,0.0262850710685862,3.90176449223166e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0178949791597467,0.00387566376625016,0.0102986781778964,0.025491280141597,3.90505239390497e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF2,Trefoil factor 2,29536,0.0190942591158692,0.00414295296876008,0.0109740712970994,0.0272144469346389,4.06590453639116e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRSS53,Serine protease 53,24845,0.0123886227903522,0.00268864973580999,0.00711886930816456,0.0176583762725397,4.09074157452277e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF8,SLAM family member 8,28797,0.0177293331705567,0.00385319191395556,0.0101770770192038,0.0252815893219096,4.21840026165828e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00733024580866525,0.00160034422167065,0.00419357113419078,0.0104669204831397,4.65949007243024e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.0139238173542382,0.00304528885387228,0.00795505120064853,0.0198925835078279,4.84925852113807e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0285066042947917,0.00626034757526656,0.0162363230472692,0.0407768855423141,5.30130369447176e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0295232454269931,0.00650571621632902,0.0167720416429882,0.042274449210998,5.70517990057567e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.00898475743831176,0.00198787499840877,0.00508852244143057,0.012880992435193,6.21448857395494e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0167180637209808,0.00370173138710869,0.0094626702022478,0.0239734572397139,6.32331200827277e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.0103047080609791,0.0022828026223407,0.00583041492119136,0.0147790012007669,6.3844233686517e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.010862142860837,0.00240743499133184,-0.0155807154438474,-0.00614357027782656,6.44940044849041e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EP300,Histone acetyltransferase p300,24229,0.00980103135474514,0.00217433592962005,0.00553933293268984,0.0140627297768004,6.58728124075824e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0149987540042234,0.00332907659148761,0.00847376388490768,0.0215237441235391,6.65091763442056e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CENPJ,Centromere protein J,24445,0.0232451637486047,0.00517307586530895,0.0131059350525992,0.0333843924446103,7.03866823910931e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRAL,GDNF family receptor alpha-like,24025,-0.0202682895440566,0.00451106399203647,-0.029109974968448,-0.0114266041196651,7.05485408458319e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCG3,Secretogranin-3,29497,-0.0107118230160091,0.00239030085249267,-0.0153968126868947,-0.00602683334512348,7.4444182263432e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C8B,Complement component C8 beta chain,24966,0.00974717777049188,0.00218639093081665,0.00546185154609124,0.0140325039948925,8.30444995974657e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0165645871445203,0.00373762720147828,0.00923883782962289,0.0238903364594177,9.38305189764262e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0125686247073672,0.00283693746526903,-0.0181290221392945,-0.00700822727543986,9.44812921938401e-06
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.00906351220799491,0.00205925222796183,0.00502737784118971,0.0130996465748001,1.08030931380462e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ELAVL4,ELAV-like protein 4,24101,0.0267687695288152,0.00610298379807132,0.0148069212845954,0.038730617773035,1.15849222153777e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD55,Complement decay-accelerating factor,28490,0.00828000016676453,0.00188945468545027,0.004576668983282,0.0119833313502471,1.17897602526791e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRTN,Neurturin,28931,0.0155638661443223,0.0035566375019091,0.00859285664058045,0.0225348756480641,1.21296880970132e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP8,Neutrophil collagenase,29640,0.0226942917839522,0.00520094074040247,0.0125004479327634,0.0328881356351411,1.28431918426e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUK1,Guanylate kinase,24111,-0.0125935002206786,0.00288929481046592,-0.0182565180491918,-0.00693048239216543,1.31393059703224e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00864454360664685,0.00198607330891146,-0.0125372472921133,-0.00475183992118039,1.35098313087791e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.015043207560637,0.00347015531240577,-0.0218447119729523,-0.00824170314832166,1.46227707931399e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0165411352866338,0.00382380792815628,0.00904647174744754,0.0240357988258202,1.52562502018446e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.0305970802462759,0.00707351455506001,0.0167329917183583,0.0444611687741935,1.5274088757765e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.0131061453761832,0.00304483728266189,0.00713826430216587,0.0190740264502005,1.67988363495816e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0572584589274529,0.0133177085571065,0.0311557501555242,0.0833611676993815,1.71795909621852e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF3,Neurotrophin-3,29434,0.0106853386013287,0.00249636826283351,0.00579245680617506,0.0155782203964824,1.87186650812777e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HYAL1,Hyaluronidase-1,29265,0.00707217976276511,0.00165318476716196,0.00383193761912766,0.0103124219064026,1.89252759593243e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0192428092104553,0.00449884951644778,0.0104250641582177,0.028060554262693,1.89922376282729e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANPEP,Aminopeptidase N,29531,0.00860199254903031,0.00201568623548805,0.00465124752747374,0.0125527375705869,1.98268888977501e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.018986430006588,0.00445025953609652,0.0102639213158388,0.0277089386973372,1.99441857864069e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.021517186203126,0.00505075071899006,0.0116177147939055,0.0314166576123465,2.04999655747424e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD160,CD160 antigen,29786,0.0141994690175294,0.00336924228112933,0.00759575414651593,0.0208031838885429,2.51136219961888e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0126065548562227,0.00299349462081022,-0.0184738043130108,-0.00673930539943469,2.5481115329878e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD109,CD109 antigen,29443,-0.0102061498648549,0.00242371600159049,-0.0149566332279722,-0.00545566650173752,2.5505285991013e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0179915708188786,0.00427651332775934,0.00960960469647028,0.0263735369412869,2.59647356148335e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLPS,Colipase,29400,0.0214148157820457,0.00509315169554081,0.0114322384587857,0.0313973931053056,2.62283523973291e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0103254941625954,0.00247003823970493,0.00548421921277373,0.015166769112417,2.91972059406551e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.00883049062438655,0.00211437223597872,-0.0129746602069048,-0.00468632104186825,2.97178681826462e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCL28,C-C motif chemokine 28,29327,0.0177934935098623,0.0042624042911676,0.00943918109917378,0.0261478059205508,2.99475875226299e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00885397941022751,0.00212314385939661,0.00469261744581016,0.0130153413746449,3.05174772223096e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.00656382973153711,0.00157715652323219,-0.0096550565170722,-0.00347260294600203,3.16821554145344e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP10,Bone morphogenetic protein 10,24381,-0.00852653949797256,0.00205286493347263,-0.0125501547675789,-0.0045029242283662,3.28567500205177e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LEG1,Protein LEG1 homolog,23603,-0.0208964459155689,0.00503889170843593,-0.0307726736641033,-0.0110202181670345,3.37990414151252e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171B,Protein FAM171B,24793,0.00810259991003898,0.00195489257420568,0.00427101046459586,0.0119341893554821,3.41269652224455e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,0.011424843998516,0.00276121507186669,0.00601286245765733,0.0168368255393748,3.51932575053737e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTX1,Neuronal pentraxin-1,29443,0.0120715546386639,0.00292044413426962,0.00634748413549541,0.0177956251418323,3.58322990011555e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0107782317512384,0.00260846434680594,0.00566564163149872,0.015890821870978,3.60759723410234e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.0102135982506699,0.00247327465300995,-0.0150612165705694,-0.00536597993077045,3.64642969352943e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.0115953647106487,0.00280969168166249,0.00608836901459019,0.0171023604067072,3.68888087879033e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0206614403837641,0.00501701144890474,0.0108280979439109,0.0304947828236174,3.82971456181103e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PADI2,Protein-arginine deiminase type-2,28931,0.0166950680212746,0.00405887621318201,0.00873967064343787,0.0246504653991113,3.9124954684447e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNR,Tenascin-R,29218,-0.0124492355456268,0.00303102206502587,-0.0183900387930775,-0.00650843229817613,4.0144741995535e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD3,Bromodomain-containing protein 3,24111,0.01408450274891,0.00344929003363952,0.0073238942829765,0.0208451112148434,4.45429913169405e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0181505089224665,0.00444905449101136,-0.0268706557248487,-0.0094303621200842,4.52241338809399e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0215995948231234,0.00531775727228538,0.0111767905694441,0.0320223990768028,4.88476071350719e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0183532050259441,0.00453747800794625,0.00945974813036943,0.0272466619215187,5.25029424572291e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRG3,Proteoglycan 3,24938,-0.0145191838133481,0.00359279779842927,-0.0215610674982694,-0.00747730012842672,5.33398239426178e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.0308533976896514,0.00763751437494305,0.0158838695147631,0.0458229258645398,5.36806954932102e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUC2,Mucin-2,24938,0.0265989195254779,0.0065857896185168,0.013690771873185,0.0395070671777708,5.38780310613941e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00592792345084049,0.0014719213588335,-0.00881288931415415,-0.00304295758752684,5.65848841636826e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.00752343067972876,0.00187423492227979,-0.0111969311273971,-0.00384993023206037,5.98102272603135e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.00864146046398141,0.00215512749243105,0.00441741057881655,0.0128655103491463,6.09684335901414e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.0105534986587297,0.00263364771549162,0.00539154913636615,0.0157154481810933,6.16319362674285e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMOD4,Tropomodulin-4,24016,-0.0118016755424081,0.00295353591153414,-0.017590605929015,-0.00601274515580117,6.46744011416914e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN1,Prorelaxin H1,24867,-0.0197935948821679,0.00495877218382525,-0.0295127883624653,-0.0100744014018704,6.58084451054387e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.00819319017409922,0.00205265364972237,0.00416998902064338,0.0122163913275551,6.58119365400279e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNXB,Tenascin-X,29443,-0.0073945517296249,0.00185439855704886,-0.0110291729014407,-0.00375993055780913,6.69135186896521e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.00970566126269457,0.00243453889403917,-0.0144773574950114,-0.00493396503037779,6.72094451160153e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NTF4,Neurotrophin-4,28797,0.0112979798306765,0.00283805605038088,0.00573538997192995,0.016860569689423,6.88270698852884e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF1,Trefoil factor 1,29319,0.0225400204783658,0.00566883894882745,0.011429096138664,0.0336509448180676,7.02148923627448e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKCQ,Protein kinase C theta type,28931,0.0124572178275178,0.00313450367847676,0.0063135906177033,0.0186008450373322,7.07805844126077e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00841280205025379,0.0021185545221254,0.00426043518688802,0.0125651689136196,7.17752132017633e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDHB15,Protocadherin beta-15,24793,-0.0114139453303073,0.00288242419511013,-0.0170634967527232,-0.00576439390789147,7.52087541701298e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCC,Netrin receptor DCC,24195,0.00651136090096931,0.00164831592024676,0.00328066169728567,0.00974206010465295,7.82710109196291e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0208847212517447,0.00529199203302346,0.0105124168670187,0.0312570256364706,7.9493987596282e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP7,Retinoid-binding protein 7,24805,0.0170946597546887,0.00433297887179166,0.00860202116597708,0.0255872983434004,7.99381689712069e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.00897571691702384,0.0022800787160826,-0.0134446712005457,-0.00450676263350194,8.28404425077006e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.00994630496993247,0.0025302472783795,0.00498702030430864,0.0149055896355563,8.4803722881443e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.00981032481386166,0.00249788446292567,0.00491447126652734,0.014706178361196,8.60432732843986e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR1,Folate receptor alpha,29383,0.00812880126516347,0.00207461372126968,0.0040625583714749,0.012195044158852,8.94057503904227e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00733461661418649,0.00187404362532468,0.00366149110855011,0.0110077421198229,9.10630374168098e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0421612712249347,0.0107876339695143,0.0210175086446867,0.0633050338051828,9.3157289656194e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0828306708045178,0.0212149883998956,0.0412492935407223,0.124412048068313,9.46907860691238e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.0116997164412073,0.00300511146267174,0.00580969797437071,0.0175897349080439,9.9168627541099e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0120302306667722,0.00309157209189289,0.00597074936666208,0.0180897119668822,9.99758554621173e-05
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0127975437880293,0.00330014094395532,0.00632926753787685,0.0192658200381817,0.000105651203372242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,METAP1,Methionine aminopeptidase 1,28774,0.00832406480572654,0.00215030560215611,0.00410946582550057,0.0125386637859525,0.000108581152805036
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0196309292932157,0.00507526663652509,0.0096834066856265,0.0295784519008048,0.000110034094863392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0113634339136802,0.00293936505456697,-0.0171245894206314,-0.00560227840672891,0.00011094857285884
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0148020943883748,0.00384048774518292,-0.0223294503689333,-0.0072747384078163,0.000116399170090947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0155074939467896,0.00403126512633144,0.00760621429917994,0.0234087735943992,0.000119966734939892
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCDH17,Protocadherin-17,29478,0.00994657722655381,0.00258980011460616,0.00487056900192574,0.0150225854511819,0.00012295386605147
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.013541480235552,0.00353806198339519,-0.0204760817230066,-0.00660687874809746,0.00012978560469843
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENO1,Alpha-enolase,29392,0.0216364804584571,0.00566512996101361,0.0105328257348705,0.0327401351820438,0.000134139555726273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL5A1,Collagen alpha-1(V) chain,24381,0.0110948510009671,0.00290641181936346,0.00539828383501474,0.0167914181669195,0.000135215093538795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS5,Transmembrane protease serine 5,29079,-0.0104451660941452,0.00273678242639294,-0.0158092596498754,-0.00508107253841504,0.000135591117640185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0168986881005778,0.00444396868312974,-0.0256088667195121,-0.00818850948164348,0.000143531620340939
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.0208212104080921,0.00547901444955519,0.0100823420869639,0.0315600787292203,0.000144891902023727
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARTN,Artemin,28931,0.0122313362362668,0.00322050321336171,0.00591914993807789,0.0185435225344558,0.000146191214151983
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.00927057476508401,0.00244117513636119,0.00448587149781608,0.0140552780323519,0.000146404382005088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00790552492594428,0.00208730827450006,-0.0119966491439644,-0.00381440070792416,0.000152584480949138
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PKLR,Pyruvate kinase PKLR,29491,0.0175493558652146,0.00463746745007462,0.00845991966306833,0.0266387920673608,0.000154475142462874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DRAXIN,Draxin,29218,0.0116338927304085,0.00308186453056138,0.00559343825050823,0.0176743472103089,0.00016035464921852
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00807754447097469,0.00214246096848442,0.00387832097274523,0.0122767679692042,0.00016349305598083
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0144946108728939,0.00384816150805998,0.00695221431709628,0.0220370074286914,0.000165852270294238
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.00846758078515214,0.00225130507444809,-0.0128801387310704,-0.00405502283923388,0.000169507093224024
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0158810410324786,0.00422437529007483,-0.0241608166010252,-0.00760126546393189,0.00017073563004158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GDF15,Growth/differentiation factor 15,29820,0.0119845600242501,0.00319118507894903,0.00572983726951,0.0182392827789902,0.000173310649163829
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POF1B,Protein POF1B,24229,0.0124088047127316,0.00330433180087921,0.00593231438300832,0.0188852950424548,0.000173529109098362
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN2,Neuroligin-2,24101,-0.0127911409005936,0.00342639481593192,-0.0195068747398202,-0.00607540706136707,0.000189557951003806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00547914606033988,0.00146829062046108,0.00260129644423616,0.00835699567644359,0.000190664649996904
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD5,Sushi domain-containing protein 5,24273,-0.0092051257274683,0.00246957638869884,-0.014045495449318,-0.00436475600561858,0.000193896317714272
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0149544967091847,0.00401629475158629,0.00708255899607558,0.0228264344222939,0.000196955500629284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOM1,Myomesin-1,24101,0.0127605223569163,0.00343952021813418,0.00601906272937334,0.0195019819844593,0.000207748297289214
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMBN,Ameloblastin,28931,-0.00761865649447605,0.00205691906180118,-0.0116502178556064,-0.00358709513334575,0.000212691052584389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.0107062869885533,0.00289196263823407,-0.0163745337594921,-0.00503804021761455,0.000214312773175023
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0231098323120141,0.0062515450399015,0.0108568040338071,0.035362860590221,0.000218860433239635
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0123374481728444,0.00334029432197032,-0.0188844250439063,-0.0057904713017826,0.000221566049453438
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNN,Tenascin-N,24938,0.0115202427071234,0.00313033492358188,0.00538478625690288,0.0176556991573439,0.000233546763483388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00896208683556685,0.00243543416220936,-0.0137355377934972,-0.00418863587763651,0.000233766942605366
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00845460331534788,0.00230405429384007,0.00393865689942134,0.0129705497312744,0.000243505578432331
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0168491831871058,0.00459760154014826,0.00783788416841525,0.0258604822057964,0.000248005315910794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0231679340025089,0.00632368882991101,0.0107735038958834,0.0355623641091345,0.000249159125319169
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP9,Matrix metalloproteinase-9,29411,0.0158807796758589,0.00434557194957495,0.00736345865469196,0.0243981006970258,0.00025815813567235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0159873570657823,0.00437809161887795,0.00740629749278152,0.0245684166387831,0.000260992896249275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0162454054876375,0.00446073814643678,0.00750235872062142,0.0249884522546536,0.000271234544039349
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL6,Fc receptor-like protein 6,29434,0.0177138526480268,0.00488567492392245,0.00813792979713883,0.0272897754989148,0.000288697853959502
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFD,Complement factor D,24966,0.00508016255952895,0.00140680821530351,0.00232281845753407,0.00783750666152383,0.000305467405486813
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CFHR4,Complement factor H-related protein 4,24892,0.0190040926519165,0.00526640788461356,0.00868193319807393,0.0293262521057591,0.000308517727977522
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SH3GL3,Endophilin-A3,24307,0.0217397730827658,0.00603801688040012,0.00990525999718156,0.03357428616835,0.000318259904749476
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACAN,Aggrecan core protein,29192,0.00727539057151636,0.00203256193515145,0.00329156917861952,0.0112592119644132,0.000344917570085839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.00554934827122942,0.00155113080306966,-0.00858956464524595,-0.00250913189721289,0.000347401270405881
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MELTF,Melanotransferrin,24922,0.00762643812808409,0.00213216444373378,0.00344739581836588,0.0118054804378023,0.00034841494564832
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,0.0161746208808312,0.00452301094310752,0.00730951943234045,0.0250397223293219,0.00034947583723504
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00540434508800404,0.00151131041540295,0.00244217667381424,0.00836651350219383,0.000349541634373704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYT1,Synaptotagmin-1,24845,0.0101753466397359,0.0028454696508364,0.0045982261240965,0.0157524671553752,0.000349578994769039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.0125451075560906,0.00350960664086696,-0.0194239365721898,-0.00566627853999135,0.000351570320890386
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGMA,Repulsive guidance molecule A,29694,-0.00808096446455088,0.00226084896971294,-0.0125122284451882,-0.00364970048391352,0.000351715854817434
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0157981379173055,0.00442563316103391,-0.0244723789129319,-0.00712389692167899,0.000358099157309098
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00824344183630731,0.00231607935551139,0.00370392629950498,0.0127829573731096,0.000372669740662322
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00475851186216893,0.00134351175437908,0.00212522882358593,0.00739179490075192,0.000398061642805728
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH4,Myosin-4,24111,-0.0119060478471288,0.00336437402546019,-0.0185002209370307,-0.00531187475722678,0.000402615567910132
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0121661416802339,0.00344562635550572,-0.0189195693370251,-0.00541271402344267,0.000414930460453518
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.00533531589901095,0.00151155015306405,0.00237267759900541,0.00829795419901649,0.00041666579438432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RYR1,Ryanodine receptor 1,24111,-0.0086619909674716,0.00245827236624235,-0.0134802048053066,-0.00384377712963658,0.000426500085822204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.0147505317590169,0.00419504663887588,0.0065282403468202,0.0229728231712137,0.000438470635102898
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSTN1,Calsyntenin-1,28774,0.0130402687192689,0.00371414462890846,0.0057605452466083,0.0203199921919295,0.000447149921461743
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0142295848190602,0.00406179279626336,0.00626847093838406,0.0221906986997364,0.000460404338460602
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLMP,CXADR-like membrane protein,29725,0.00531258801754726,0.00152141922448759,0.00233060633755159,0.00829456969754294,0.000480360002792928
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00797888923822122,0.00228685966699537,-0.0124611341855321,-0.0034966442909103,0.000485665016309824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.0065725368394154,0.00188434921130865,-0.0102658612935804,-0.00287921238525044,0.000487581930643275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0123002828061516,0.0035324205113861,-0.0192238270084683,-0.0053767386038348,0.000498195946900988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR4,Proline-rich protein 4,24203,-0.0174763694240345,0.00502158073507461,-0.0273186676647807,-0.00763407118328825,0.000501823636292656
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0143540894953651,0.00413093646354771,-0.0224507249639186,-0.00625745402681159,0.000512011043336399
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.00503630965170579,0.00145406933323601,-0.00788628554484837,-0.00218633375856321,0.000533758326399291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPN1,Epsin-1,24445,0.0108980236639762,0.00314925715136925,0.00472547964729243,0.0170705676806599,0.000540081547373145
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00719331104950567,0.00208246541512424,-0.0112749432631492,-0.00311167883586216,0.000552819205377068
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0129720844073817,0.00376643491134714,0.00558987198114134,0.0203542968336221,0.00057386520395446
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0168983925715429,0.0049094711145869,0.00727582918695263,0.0265209559561333,0.000578383306856202
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,-0.012446307898851,0.00362603345207552,-0.019553333464919,-0.00533928233278294,0.000599051788385806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.00597206891650245,0.00174824172525226,-0.00939862269799689,-0.00254551513500802,0.00063624059839232
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00744584619192864,0.00218120655231215,0.00317068134939682,0.0117210110344605,0.000641873142131195
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HCG22,Protein PBMUCL2,24111,-0.0135886607201864,0.00399503086506979,-0.0214189212157232,-0.00575840022464962,0.000671527905081315
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00689853763238538,0.00202815822916469,-0.0108737277615482,-0.00292334750322259,0.000671553602328308
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0211998796547496,0.00623324601964892,0.00898271745623774,0.0334170418532615,0.000672251625005807
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRXN3,Neurexin-3,24195,0.008599686952137,0.00254373524675047,0.00361396586850607,0.0135854080357679,0.000724073836771527
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.0076816083728872,0.00227505386812234,0.00322250279136741,0.012140713954407,0.000735240511703892
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RALB,Ras-related protein Ral-B,24229,0.00718462676304246,0.00212921637650228,0.003011362665098,0.0113578908609869,0.000741182239829764
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.0106432045767228,0.00316174383084742,-0.0168402224851838,-0.00444618666826188,0.000763163824405065
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00662449194405806,0.00197157508124983,0.0027602047848084,0.0104887791033077,0.000780402690323016
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCA2A,Guanylin,29333,-0.00826511127516437,0.00246036881636572,-0.0130874341552412,-0.00344278839508756,0.000782403925327425
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAG,S-arrestin,24101,-0.0127651724958309,0.00380709517912056,-0.0202270790469072,-0.0053032659447546,0.000800651601371078
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPH3,Neurexophilin-3,24229,0.00729551919353179,0.00217824647443942,0.00302615610363052,0.011564882283433,0.000811506086999141
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH23,Cadherin-23,24845,-0.00639353897254469,0.00191029980734496,-0.0101377265949408,-0.00264935135014858,0.000818486575685943
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYH7B,Myosin-7B,24016,-0.0106723854096747,0.00319750738733562,-0.0169394998888525,-0.00440527093049692,0.000845970775797375
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00725733529138127,0.00218606203729643,0.00297265369828028,0.0115420168844823,0.000902043799388776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA3,Carbonic anhydrase 3,29761,0.0143070257413587,0.00431190084986713,0.00585570007561909,0.0227583514070982,0.000907627714653728
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN5,Contactin-5,29511,-0.00879508095311053,0.00266234338855576,-0.0140132739946798,-0.00357688791154123,0.000955958170423151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00630627391522955,0.00191351964252558,-0.0100567724145797,-0.00255577541587942,0.000983345727255103
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.00665655452105414,0.00202117726773864,0.0026950470762864,0.0106180619658219,0.000991197677193
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NINJ1,Ninjurin-1,28797,0.0130980641518127,0.00398037687819327,0.00529652547055391,0.0208996028330715,0.00100073049695858
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.0089977468185955,0.00274197095665598,0.00362348374354977,0.0143720098936412,0.00103406895621299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYO6,Unconventional myosin-VI,24867,0.00882262008046231,0.00269064435887597,0.0035489571370654,0.0140962830238592,0.00104319167264678
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.00757041352805153,0.00231705670318819,-0.0121118446663004,-0.00302898238980268,0.00108746271921497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.015955659049025,0.00489592252472435,0.00635965090056528,0.0255516671974847,0.00111947737692541
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD70,CD70 antigen,29434,-0.0099439866460641,0.00307423795050019,-0.0159694930290445,-0.00391848026308372,0.0012193984619719
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00633151515352355,0.00196059689735095,0.0024887452347157,0.0101742850723314,0.00124196876293892
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0161754361962422,0.0050314346514729,0.00631382427935528,0.0260370481131291,0.00130640086744221
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTNNA1,Catenin alpha-1,24101,-0.008139301589306,0.00253294161951117,-0.0131038671635479,-0.0031747360150641,0.00131355639975242
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RETN,Resistin,29362,0.00975217353231629,0.0030351689693491,0.00380324235239205,0.0157011047122405,0.00131471593618364
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00763293498041572,0.00238173342397364,-0.0123011324914041,-0.00296473746942738,0.00135311772815473
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL3A1,Collagen alpha-1(III) chain,24938,0.00537231051274704,0.00167751128195993,0.00208438840010559,0.0086602326253885,0.00136388638698487
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WIF1,Wnt inhibitory factor 1,29725,-0.00783651135988589,0.00244703067966068,-0.0126326914920208,-0.00304033122775096,0.00136404012547948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.0063242460184312,0.00197701508750429,0.00244929644692279,0.0101991955899396,0.00138106614451804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBLN2,Fibulin-2,24938,-0.00720489999489857,0.0022606825910877,-0.0116358378734305,-0.00277396211636669,0.00143911097449997
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0192598800484625,0.00608326865409315,0.00733667348643994,0.0311830866104851,0.00154720592451796
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00754903619880903,0.00238957843262461,0.00286546247086479,0.0122326099267533,0.00158424568857015
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.00907238714169395,0.00287401532502165,0.00343931710465152,0.0147054571787364,0.00159733341119706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSC1,Hamartin,24229,0.0170504709930262,0.00540624371187538,0.00645423331775048,0.027646708668302,0.00161329841354585
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FSTL1,Follistatin-related protein 1,24240,-0.0051917665588594,0.001646189406731,-0.00841829779605215,-0.00196523532166665,0.00161351447615614
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL19,Interleukin-19,28654,0.0159451137263181,0.00506250624799116,0.00602260148025538,0.0258676259723807,0.00163635194156857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.0113477410608671,0.00360485867268963,-0.0184132640593388,-0.00428221806239548,0.00164647516144117
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.00909503443713692,0.00289165097657369,0.00342739852305248,0.0147626703512214,0.0016612710516385
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.0113558740447715,0.00363304619852788,-0.0184766445938862,-0.00423510349565687,0.00177582897180666
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.0103221725060283,0.00330407872058263,0.00384617821368637,0.0167981667983703,0.00178579626984087
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.0106629477514734,0.00341612766960104,0.00396733751905534,0.0173585579838914,0.00180227676854407
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0110859527293594,0.00355506766691287,0.00411802010221022,0.0180538853565087,0.00182073677470734
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0111995082887422,0.00360117705879571,0.00414120125350258,0.0182578153239818,0.00187296950079084
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JUN,Transcription factor AP-1,28931,0.0112194003107605,0.00360763265991783,0.00414844029732158,0.0182903603241995,0.00187328398976124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00652898329846048,0.00209942073764704,0.00241411865267227,0.0106438479442487,0.00187369435575162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.0158794879663229,0.00511335702924502,0.00585730818900263,0.0259016677436431,0.00190142196302651
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLSPN,Claspin,28719,0.00775582214464006,0.00249758566451647,0.00286055424218778,0.0126510900470923,0.00190253302820546
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0105700650600958,0.0034154670004583,0.00387574973919754,0.0172643803809941,0.00197158417279873
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.010667513378595,0.00344774065992627,-0.0174250850720505,-0.00390994168513949,0.00197664090357322
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THBS2,Thrombospondin-2,29443,0.00830941644139988,0.00268731129613496,0.00304228630097535,0.0135765465818244,0.0019893636330934
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0127157961274075,0.00413102916084632,0.00461897897214874,0.0208126132826663,0.00208547096572826
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPS,Calcyphosin,24845,0.0209514508906868,0.00682274385375545,0.00757887293732614,0.0343240288440475,0.00213698984684372
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.00881129262300598,0.00287856217478207,0.00316931076043312,0.0144532744855788,0.00220838257869853
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TJP3,Tight junction protein ZO-3,24101,-0.00938764717470646,0.00308853469314917,-0.0154411751732788,-0.00333411917613409,0.00237213661464094
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0121600746866691,0.0040059733538772,0.00430836691306979,0.0200117824602684,0.00240362155626596
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.0110778488954765,0.00366046661396503,-0.018252363458848,-0.00390333433210505,0.00247787762890014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RLN2,Prorelaxin H2,24326,0.0247172601438614,0.00817086514539328,0.00870236445889055,0.0407321558288322,0.00248853193493916
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0164944019152843,0.00545272241243242,-0.0271817378436518,-0.00580706598691673,0.00248899690359109
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.00972616155392057,0.00321690333064895,0.00342103102584862,0.0160312920819925,0.00250119123476997
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CST6,Cystatin-M,28830,0.0106010937840632,0.00351029562131963,0.00372091436627671,0.0174812732018497,0.00252995797778423
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B4,Protein ATP1B4,24016,-0.00910165899356142,0.00303040369662208,-0.0150412502389407,-0.00316206774818215,0.00267214505104847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00611864284909861,0.00203798337622128,0.00212419543170491,0.0101130902664923,0.00268170262239298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00796115992979966,0.00266291274653678,0.00274185094658756,0.0131804689130118,0.00279576733216087
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTN2,Contactin-2,29725,0.00953848131926495,0.00320618404764165,0.00325436058588733,0.0158226020526426,0.00293199147530816
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0116848064968678,0.00394650292985002,0.00394966075436177,0.0194199522393738,0.0030713153486723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.010875318796419,0.00368224546822256,0.00365811767870279,0.0180925199141352,0.00314550615443177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0133903251604057,0.00454328551002691,-0.0222951647600584,-0.00448548556075293,0.00320891010443857
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSB,Lupus La protein,28774,0.0125907389848759,0.00428695469555099,0.00418830778159593,0.0209931701881558,0.00331678492393323
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AKAP12,A-kinase anchor protein 12,24381,-0.00453965056195989,0.00155043107107281,-0.00757849546126259,-0.00150080566265719,0.0034147388982401
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAM1,Neural cell adhesion molecule 1,29594,-0.00633483123759065,0.0021700748284548,-0.0105881779013621,-0.00208148457381923,0.00351222099914537
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK1,Kallikrein-1,29199,-0.0266209424966725,0.00916075251041826,-0.0445760174170922,-0.00866586757625266,0.00366382672368958
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00823825282755872,0.00283820531420486,0.00267537041171721,0.0138011352434002,0.0037038189638503
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY6D,Lymphocyte antigen 6D,29283,0.0080079151346808,0.00276121740064925,0.00259592902940827,0.0134199012399533,0.00373274310796246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.00599642574365513,0.00207431567878644,-0.0100620844740766,-0.00193076701323371,0.00384543561534431
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPA33,Cell surface A33 antigen,29349,0.0280050633833239,0.00969234753380406,0.00900806221706791,0.0470020645495798,0.00386261105533453
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL1,Interferon lambda-1,28774,0.00940890145961899,0.00325870400577294,0.00302184160830403,0.015795961310934,0.00388835808477961
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEFL,Neurofilament light polypeptide,28674,0.0093011337932765,0.00322272200844053,0.00298459865673306,0.0156176689298199,0.00390325576925305
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00912185401061544,0.00316140523981495,0.00292549974057814,0.0153182082806527,0.0039128894982945
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.00969189543482164,0.00336799388406988,0.00309062742204468,0.0162931634475986,0.00400942225376212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA10,Annexin A10,28774,0.0169733871955187,0.00590224455588387,0.00540498786598631,0.0285417865250511,0.00403363149992457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00752372264009571,0.00262547383756616,0.00237779391846604,0.0126696513617254,0.00416492410314478
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNG,Uracil-DNA glycosylase,24793,0.00709900279961135,0.0024800297684542,0.00223814445344112,0.0119598611457816,0.00420709607358306
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.00624988075871966,0.00218767597909309,0.00196203583969721,0.0105377256777421,0.00428153931648445
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.0086653266940984,0.00304854590471023,0.00269017672086635,0.0146404766673305,0.0044800345963654
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0139023669900468,0.00489219925862656,0.00431365644313879,0.0234910775369549,0.00448993707740772
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00462605175786363,0.0016339549096827,0.00142350013488554,0.00782860338084172,0.00464048842943133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00523476855386194,0.0018505494578701,-0.00886184549128734,-0.00160769161643654,0.00467655124138587
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.0078344534097588,0.00277017351928994,-0.0132639935075671,-0.00240491331195051,0.0046857163792828
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TG,Thyroglobulin,24793,-0.022727718494612,0.00804359964155461,-0.038493173792059,-0.00696226319716493,0.00472349600478085
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00700671077872047,0.00248467255714803,0.00213675256671032,0.0118766689907306,0.00480594686709359
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLNS1A,Methylosome subunit pICln,24195,0.00677785783696618,0.00241707750213719,0.00204038593277728,0.0115153297411551,0.00504889992644027
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.00677635977867763,0.00241731612985639,0.0020384201641591,0.0115142993931962,0.00506226034216768
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00931799207298839,0.00332494156016644,-0.0158348775309146,-0.00280110661506216,0.00507561039307779
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNW1,Interferon omega-1,24111,-0.00725842308100049,0.00259758307946422,-0.0123496859167504,-0.00216716024525063,0.00520534893525807
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0186309215300843,0.00666922883862778,0.00555923300637385,0.0317026100537948,0.00521719157414589
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAN,Brevican core protein,29218,-0.00679675426944342,0.00244241670673438,-0.0115838910146428,-0.00200961752424404,0.00539268189210844
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.013328400598887,0.00479762083913123,0.00392506375418977,0.0227317374435842,0.00547155118377437
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00958378074474594,0.00345019380225176,-0.0163461605971594,-0.0028214008923325,0.00547787918136429
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0234319366261209,0.00848955643738368,0.00679240600884886,0.0400714672433929,0.00578218877677634
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NMI,N-myc-interactor,24706,0.0143161582839676,0.0051906987519243,0.00414238873019593,0.0244899278377392,0.00581917230042517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00854363293063333,0.0030999693102779,-0.014619572778778,-0.00246769308248864,0.00585502053283933
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0127027767145459,0.00461468826887814,-0.021747565721547,-0.00365798770754473,0.00591527318637369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0119598849397891,0.00437502836734683,-0.0205349405397889,-0.00338482933978932,0.00626782224371741
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.00966595215842671,0.00353807179530215,-0.0166005728772189,-0.00273133143963451,0.00629918361507496
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0191122655911598,0.00699814913425526,0.00539589328801944,0.0328286378943001,0.00631783588174324
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSLNL,Mesothelin-like protein,24195,-0.00738883037587138,0.0027165344340444,-0.0127132378665984,-0.00206442288514434,0.00653389680958329
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0249718950677566,0.00922131500676785,-0.0430456724810216,-0.00689811765449164,0.00677160966948774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX9,Transcription factor SOX-9,24195,0.00531633801628813,0.00196912675139895,0.00145684958354619,0.00917582644903006,0.00694199320192034
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.00326707305808921,0.00121186830382396,0.000891811182594258,0.00564233493358417,0.0070246276976408
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.00694056640749092,0.00258270483925573,0.00187846492254969,0.0120026678924322,0.00720748437126725
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00782332528623192,0.00292568893092672,0.00208897498161556,0.0135576755908483,0.00749910012379868
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,0.0113106371799491,0.00423302676122637,0.00301390472794539,0.0196073696319528,0.00754422380975611
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00832168913507727,0.00312407288934655,-0.0144448719981965,-0.00219850627195803,0.00773307802742603
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERVV_1,,24111,-0.00884702142775224,0.00332608245956237,-0.0153661430484945,-0.00232789980700999,0.00782173413133969
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.0120177551320195,0.00452942444494054,-0.0208954270441029,-0.003140083219936,0.00797699878117025
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1B,Lithostathine-1-beta,29820,0.0107386814802053,0.00404986108709036,0.00280095374950821,0.0186764092109024,0.00801496734251146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALM3,Paralemmin-3,24111,0.0140785887752833,0.00532097490591092,0.00364947795969786,0.0245076995908687,0.00815348941651869
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYB5A,Cytochrome b5,24016,0.0137802359580347,0.00520898262949719,0.00357063000422023,0.0239898419118492,0.00816293416165341
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA6C,Semaphorin-6C,24229,0.00498174560938996,0.00188676455160627,0.00128368708824167,0.00867980413053825,0.008287008582009
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBX2,Chromobox protein homolog 2,24111,-0.00763985902363535,0.00290378796275561,-0.0133312834306363,-0.00194843461663435,0.00851888259362948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.0044161869079419,0.00168104263013702,0.00112134335287334,0.00771103046301047,0.00861823459421744
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP13,Collagenase 3,28774,-0.00617596432075729,0.00235468562876509,-0.0107911481531369,-0.00156078048837771,0.00872461215011449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GKN1,Gastrokine-1,28114,0.00529253727292841,0.00202011810459129,0.00133310578792948,0.00925196875792734,0.00879990219920185
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_DRA,,29322,-0.00680360153047356,0.00259961445981562,-0.0118988458717122,-0.00170835718923494,0.00887108404530953
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD58,Lymphocyte function-associated antigen 3,29409,-0.00331767797831337,0.00126774702199104,-0.00580246214141581,-0.000832893815210925,0.00887550202119912
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEF,Thyrotroph embryonic factor,24111,0.00807958893600993,0.00308786347564301,0.00202737652374964,0.0141318013482702,0.00888754284926731
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.00799754037260888,0.00306049902951714,0.00199896227475529,0.0139961184704625,0.00897575586817577
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00568404468851927,0.00218051792573217,-0.00995785982295432,-0.00141022955408421,0.0091465072444259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.00865518318086488,0.00332224547662817,-0.0151667843150561,-0.00214358204667366,0.00918616821947408
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.00808617539308003,0.00310452695766907,0.00200130255604866,0.0141710482301114,0.00920253743527554
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPM1B,Protein phosphatase 1B,24229,0.0117228915765435,0.00450216991083087,0.00289863855131495,0.020547144601772,0.00922443420534625
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTTG1,Securin,24445,0.00775478696724424,0.00298201324992374,0.0019100409973937,0.0135995329370948,0.00931384713167218
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN1,Tetraspanin-1,28916,0.0105714908569869,0.00407914762550179,0.00257636151100337,0.0185666202029704,0.0095580720699257
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,-0.00600095078470377,0.00233266956519647,-0.0105729831324889,-0.00142891843691869,0.010100617419841
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00623360335914079,0.00242611200484622,-0.0109887828886394,-0.0014784238296422,0.0101940295976679
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.00687407609383635,0.00268145430038303,0.00161842566508561,0.0121297265225871,0.0103662457336448
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36G,Interleukin-36 gamma,24149,0.0125609167731651,0.00490082329560781,0.00295530311377379,0.0221665304325564,0.0103825608380628
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,0.00921889366461243,0.00360553299518625,0.00215204899404738,0.0162857383351775,0.0105676472427876
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA3G,Semaphorin-3G,24381,0.00813365477002182,0.00318433409600998,0.00189235994184227,0.0143749495982014,0.0106470430388063
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.00444576091508315,0.00174308371486915,0.00102931683393962,0.00786220499622668,0.0107613867756083
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0106268419279495,0.0041689323414261,0.00245573453875438,0.0187979493171447,0.0108076406013455
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00689992616870893,0.00270890638954802,0.00159046964519482,0.012209382692223,0.0108675090769893
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GLI2,Zinc finger protein GLI2,24229,-0.00609798508687677,0.00240397128140397,-0.0108097687984285,-0.001386201375325,0.0111987503130003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00587075625401584,0.00231571671891782,0.00133195148493692,0.0104095610230948,0.0112450677545924
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00714124521690513,0.00281908617525001,0.0016158363134151,0.0126666541203952,0.011309475982855
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00629698698187465,0.00249486439284388,-0.0111869211918487,-0.00140705277190065,0.0116096278471351
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00818646142952615,0.00325973912871051,0.00179737273725355,0.0145755501217987,0.0120312365089769
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00945405579850483,0.00377644850262629,-0.0168558948636524,-0.00205221673335729,0.0123063723005774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.0072563958956517,0.00290178525311883,-0.0129438949917646,-0.00156889679953879,0.0124025518026366
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MN1,Transcriptional activator MN1,24195,-0.0105862590559326,0.00426947902144777,-0.0189544379379702,-0.00221808017389497,0.013162691887784
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK3,Prostate-specific antigen,24938,-0.0157405070076885,0.00640247755967395,-0.0282893630246495,-0.00319165099072758,0.0139585311917045
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TTN,Titin,24111,-0.0118721643947277,0.00483907397288953,-0.0213567493815911,-0.00238757940786421,0.0141584782751846
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00955312005118216,0.00389536420396857,-0.0171880338909606,-0.00191820621140375,0.0141964160765992
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0101005014061715,0.00413071970517064,0.00200429078403702,0.0181967120283059,0.0144836160393986
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OTOA,Otoancorin,24101,-0.00941937494703259,0.00387309638940785,-0.017010643870272,-0.00182810602379319,0.0150228952357291
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.00754975519819233,0.0031076061364072,-0.0136406632255504,-0.00145884717083423,0.0151292317969122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00659083904243927,0.00271347248901041,0.00127243296397887,0.0119092451208997,0.0151495762489788
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,0.0060730868121199,0.00250480630406593,0.00116366645615067,0.0109825071680891,0.0153323393259667
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00946151755518342,0.00391863538344874,-0.017142042906743,-0.00178099220362389,0.01576453101806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK15,Kallikrein-15,24754,0.00897751505771171,0.00372785920355767,0.00167091101873868,0.0162841190966847,0.0160376669802011
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17C,Interleukin-17C,28931,-0.0121842733561236,0.00506634966857066,-0.0221143187065221,-0.00225422800572507,0.0161813086384952
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTO1,Protein LTO1 homolog,28931,0.00710671696428124,0.00296161179181702,0.00130195785231987,0.0129114760762426,0.0164187776595303
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STX1B,Syntaxin-1B,24195,0.00718542287630788,0.00300192846123487,0.00130164309228753,0.0130692026603282,0.0166914024447703
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOP56,Nucleolar protein 56,24111,0.0191295078827569,0.00799961979283737,0.00345025308879566,0.0348087626767181,0.0167963536760009
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACE,Angiotensin-converting enzyme,24951,-0.0044727183283124,0.00188441189200534,-0.00816616563664287,-0.000779271019981929,0.0176262356876366
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.0134395341238611,0.00569635219984763,0.00227468381215973,0.0246043844355624,0.0183147849911673
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REST,RE1-silencing transcription factor,24016,-0.00595897964289005,0.00252797697879597,-0.0109138145213301,-0.00100414476444995,0.0184206759157557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.00480818799202688,0.00204003653955297,0.000809716374503055,0.00880665960955071,0.0184353110215332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.0100919851424719,0.004282972861652,0.00169735833363398,0.0184866119513098,0.0184644496395828
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00826612071686633,0.00353264897006469,-0.0151901126981931,-0.00134212873553953,0.019295891868458
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.014237792312694,0.0061145406445739,0.0022532926493292,0.0262222919760589,0.0198915766835405
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00793888266652427,0.00341343694911303,-0.0146292190867858,-0.00124854624626274,0.0200388405080824
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RTKN2,Rhotekin-2,24111,-0.0086536381595982,0.00373152549752081,-0.015967428134739,-0.00133984818445741,0.0204000066545504
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAV,Integrin alpha-V,29725,-0.00275774884163752,0.00119257967772559,-0.00509520500997967,-0.000420292673295364,0.0207611761488341
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MUCL3,Mucin-like protein 3,24016,-0.00730335209816544,0.00316474774368861,-0.0135062576757951,-0.00110044652053577,0.0210231700044562
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0163033041236698,0.00709978000790231,-0.0302188729391583,-0.00238773530818131,0.0216666353448846
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNLZ,DNL-type zinc finger protein,24101,-0.0149511751720649,0.00651281288036953,-0.0277162884175892,-0.00218606192654064,0.0217041318785278
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,-0.00695031351049896,0.00303832020653157,-0.0129054211153008,-0.000995205905697087,0.0221706932117465
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0116384110503226,0.00509450828872979,-0.021623647296233,-0.00165317480441224,0.0223507365630933
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THY1,Thy-1 membrane glycoprotein,29694,0.00466908448337107,0.00205179217765052,0.000647571815176058,0.00869059715156608,0.0228762909548754
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB118,Beta-defensin 118,24101,0.0094452167697757,0.00415330909521231,0.00130473094315958,0.0175857025963918,0.0229661757980031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0125274602895351,0.00551622121451647,0.00171566670908281,0.0233392538699874,0.0231544263598505
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.00426421565816135,0.00188707385918004,-0.00796288042215422,-0.000565550894168474,0.0238486662323271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.00989339235684177,0.00439101307003735,0.00128700673956856,0.018499777974115,0.0242602984384037
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR4,Toll-like receptor 4,24229,0.00459045422098935,0.00204255463694039,0.000587047132586188,0.00859386130939252,0.0246229105449755
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.00595761044426347,0.00265543745564235,0.000752953031204464,0.0111622678573225,0.0248702004449649
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD82,CD82 antigen,24445,-0.00664084272072361,0.00299798273344767,-0.012516888878281,-0.000764796563166181,0.0267621338715447
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0089798278734712,0.00405844346242409,0.00102527868711999,0.0169343770598224,0.0269326076835551
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFF3,Trefoil factor 3,29426,0.00736190720987777,0.0033292361041024,0.000836604445837056,0.0138872099739185,0.0270234081809711
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.00913127610096131,0.00413566571985469,0.00102537129004612,0.0172371809118765,0.0272567503455567
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00477193784475472,0.00216922871226506,-0.00902362612079423,-0.000520249568715199,0.0278283089397388
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDS,Iduronate 2-sulfatase,29786,0.00139502108751156,0.000638769062417986,0.000143033725172305,0.00264700844985081,0.0289758394175869
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.0103127504293873,0.004726946571309,0.0010479351496217,0.019577565709153,0.0291417141581018
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAPPA,Pappalysin-1,28931,0.0073850665352867,0.00339324196613269,0.000734312281666638,0.0140358207889068,0.0295331041966515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0130933143736865,0.00605366688030075,0.00122812728829701,0.024958501459076,0.0305606955796289
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.0133076546259153,0.00616945602754173,-0.0253997884398971,-0.00121552081193351,0.0310120183265172
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00597307766078264,0.00277367597854722,0.000536672742830091,0.0114094825787352,0.0312902173212785
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.00512816889073685,0.00238658853669309,0.000450455358818394,0.0098058824226553,0.0316629774540211
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0121136513823107,0.00564486612751727,0.00104971377237688,0.0231775889922446,0.0318845912784029
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.00522112401931585,0.00244694713473105,0.000425107635242986,0.0100171404033887,0.0328731395081937
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMCN2,Hemicentin-2,24343,0.00881480788113151,0.00415011131542709,0.00068058970289441,0.0169490260593686,0.0336807778769453
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRING1,SREBP regulating gene protein,24016,0.00907239856125248,0.00429268518130334,0.000658735605897931,0.017486061516607,0.0345721012706144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0101058470123217,0.00478912180966672,0.000719168265374893,0.0194925257592685,0.0348541990756088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYOC,Myocilin,29443,-0.00691386138932284,0.00328118298969811,-0.0133449800491311,-0.000482742729514539,0.0351152193118804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,-0.00870239868866106,0.00413777958174028,-0.016812446668872,-0.00059235070845012,0.0354604643241419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BEX3,Protein BEX3,24016,-0.00715144859233126,0.00340505652045504,-0.0138253593724231,-0.00047753781223937,0.0357178144275723
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.017409308276147,0.00831766881667494,0.00110667739546415,0.0337119391568299,0.036354679735205
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00476399537177856,0.0022889305611979,-0.00925029927172645,-0.000277691471830666,0.0374133021333795
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0184585260677191,0.00887379771127083,0.00106588255362827,0.0358511695818099,0.0375237461565162
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MTR,Methionine synthase,24111,0.00975138792395482,0.004702100788271,0.000535270378943655,0.018967505468966,0.0381051002506206
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0052613404689204,0.00253703934609486,0.000288743350574469,0.0102339375872663,0.0381055327033334
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INHBB,Inhibin beta B chain,24381,0.00773599990676887,0.00373210758626195,0.00042106903769544,0.0150509307758423,0.0381992056935788
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNNI3,"Troponin I, cardiac muscle",28916,0.012542217961192,0.00605520343494519,0.000674019228699382,0.0244104166936845,0.03833846350288
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFAP,Glial fibrillary acidic protein,28753,0.00688116882976645,0.00332637309946648,0.00036147755481215,0.0134008601047208,0.0385859690082429
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DPEP2,Dipeptidase 2,29349,-0.00434450305024891,0.00210438169225496,-0.00846909116706862,-0.000219914933429193,0.0389787860398089
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NXPE4,NXPE family member 4,24111,-0.00509806497628806,0.00247825593273437,-0.00995544660444741,-0.000240683348128698,0.0396856112412724
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00549478637502376,0.0026757047450545,-0.0107391676753306,-0.00025040507471693,0.0400266701714961
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPLX2,Complexin-2,24016,-0.00454454627110725,0.00221902029407215,-0.00889382604748865,-0.000195266494725839,0.0405711786131561
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00640306818115626,0.00313766610691802,0.000253242611596945,0.0125528937507156,0.0412901812324331
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.00871735487950902,0.00427321001506367,0.000341863249984219,0.0170928465090338,0.0413591063431445
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD2,T-cell surface antigen CD2,24111,0.00563222397059965,0.00276943226358746,0.000204136733968217,0.0110603112072311,0.0419917073559284
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL33,Interleukin-33,28931,0.0057024654599148,0.00280428747899691,0.000206062001080857,0.0111988689187488,0.0420130575694923
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00410998034075223,0.00202326447009115,0.000144381979373583,0.00807557870213089,0.0422292959040142
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHPK,Sedoheptulokinase,24445,-0.00600265282675392,0.00299115271435407,-0.0118653121468879,-0.000139993506619944,0.0447816907033368
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1,DNA topoisomerase 1,24805,0.0163617604683817,0.00815690441226786,0.000374227820336703,0.0323492931164267,0.044880040333435
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.0046871049635816,0.00233975039564799,0.000101194188111543,0.00927301573905165,0.045159827299414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00481304124429882,0.00240757317738174,-0.00953188467196703,-9.41978166306076e-05,0.0456041088990536
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00481166881597423,0.00241590288404121,-0.00954683846869501,-7.64991632534445e-05,0.0464171577532466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL11,Interleukin-11,28931,0.00893239960308361,0.00449184504428385,0.000128383316287266,0.01773641588988,0.0467568333790967
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00470045012087041,0.00236369993531637,-0.0093333019940905,-6.75982476503276e-05,0.0467568346813611
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPHS2,Podocin,24229,-0.0147997879056445,0.00744393405077318,-0.02938989864516,-0.000209677166129107,0.0468044057989053
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDNRB,Endothelin receptor type B,24229,0.00652803480231406,0.0032927018779854,7.43391214626703e-05,0.0129817304831654,0.0474259883725299
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.00477312018183994,0.00241201282446532,4.55750458879106e-05,0.00950066531779196,0.0478391923588591
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CORO6,Coronin-6,24101,-0.00536066500272907,0.00270992583078983,-0.0106721196310771,-4.92103743810002e-05,0.0479221140967334
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH22,Cadherin-22,24445,-0.00406862818233518,0.00205982851078401,-0.00810589206347184,-3.13643011985235e-05,0.0482536701622912
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM25,Transmembrane protein 25,24867,-0.00641878218874015,0.00325482080892388,-0.0127982309742309,-3.93334032493444e-05,0.0486110129496969
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00377012874180766,0.0019120069859373,2.25950493705587e-05,0.00751766243424476,0.0486419140904732
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.0070878088970995,0.0036198023852656,-7.003778021074e-06,0.0141826215722201,0.0502338501167705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00391194988650844,0.00201270635261822,-3.29545646232761e-05,0.00785685433764015,0.0519520484496235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX33,Testis-expressed protein 33,24445,-0.00546335311541428,0.00281095161681858,-0.0109728182843787,4.61120535501323e-05,0.0519557077616161
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00975078587636067,0.00505814513755148,-0.0196647503459616,0.000163178593240226,0.053899286846272
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL36A,Interleukin-36 alpha,24229,-0.00807162081238749,0.00419611067649371,-0.0162959977383152,0.00015275611354019,0.054416979312497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00898839990402536,0.00468737583555423,-0.0181756565417116,0.00019885673366093,0.0551765952156006
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00839524129617657,0.00439568714039008,-0.0170107880913411,0.000220305498987976,0.0561603399798422
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.0106087652373848,0.00555590067274649,-0.0214983305559679,0.000280800081198324,0.056214757597613
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NECTIN4,Nectin-4,29566,-0.00438250936797337,0.00229690309442553,-0.00888443943304741,0.000119420697100666,0.0563998695301934
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00765948028984731,0.00401446773080243,-0.00020887646252545,0.0155278370422201,0.0564067591679262
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00829419484025012,0.0043493575950704,-0.000230546046087868,0.0168189357265881,0.0565313878003492
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00354757442270859,0.00186152754415198,-0.000101019563829295,0.00719616840924647,0.056696814035225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.00499891361624552,0.00262479214256447,-0.000145678983180841,0.0101435062156719,0.0568549868398847
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00543994787625408,0.00286948655008189,-0.0110641415144146,0.000184245761906424,0.0579995886149144
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN15,Tetraspanin-15,24111,-0.00690974281954679,0.003646046971001,-0.0140559948827088,0.000236509243615181,0.0580867813600592
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR1,Toll-like receptor 1,24229,0.00360168602925279,0.00190076552804927,-0.000123814405723779,0.00732718646422936,0.0581227505013574
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RELB,Transcription factor RelB,24229,0.0067089902769285,0.00355828999546902,-0.000265258114190786,0.0136832386680478,0.0593805992619645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.0056024995575816,0.0029740574583774,-0.0114316521760013,0.000226653060838105,0.0596054278975676
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.015943658468352,0.00853713947602882,-0.000789134904664444,0.0326764518413685,0.0618349360776644
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.011230892957638,0.00605052996608771,-0.0230899316911699,0.000628145775893945,0.0634396754065163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESPL1,Separin,24016,-0.00741191097288124,0.00399840937975623,-0.0152487933572034,0.00042497141144097,0.0637922222928952
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FRMD7,FERM domain-containing protein 7,24195,0.00446972005369269,0.00241834276375942,-0.000270231763275767,0.00920967187066114,0.0645773082422149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VASN,Vasorin,29065,-0.00364548637569383,0.00197710541413268,-0.00752061298739389,0.000229640236006232,0.0652151395688862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCLRE1C,Protein artemis,24016,-0.00413130566088748,0.00224291311924695,-0.00852741537461151,0.000264804052836548,0.0654966293803382
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.0102741716581661,0.00559783731314137,-0.000697589475591004,0.0212459327919231,0.0664613350111566
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00756204560372405,0.00413304806213656,-0.0156628198055117,0.000538728598063601,0.067314130865774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.00875618381661205,0.0048199356193242,-0.0182032576304875,0.000690889997263385,0.0692815783278047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.0101047565584735,0.00561558424169612,-0.000901788555250858,0.0211113016721979,0.0719637653303845
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00790097523355586,0.00439490277549742,-0.000713034206419081,0.0165149846735308,0.0722277491385428
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00635578598085964,0.0035440745005698,-0.00059060004025716,0.0133021720019764,0.0729286167359506
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGM2,Phosphoglucomutase-2,24195,0.00776308414288203,0.00433976489778921,-0.000742855056784824,0.0162690233425489,0.0736553606001088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00475934794981277,0.00267938689873759,-0.000492250371712905,0.0100109462713384,0.0756968850005014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00678896598982159,0.00383457718813491,-0.000726805298922843,0.014304737278566,0.076663752681396
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00357617294230995,0.00202505699270791,-0.000392938763397562,0.00754528464801746,0.0774145730776822
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00927227884531317,0.00528660679594084,-0.0196340281653572,0.00108947047473087,0.0794571448831157
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00591927068359792,0.00337560925172884,-0.0125354648169864,0.000696923449790597,0.0795218772617414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00446316076347697,0.0025467415018419,-0.000528452580133147,0.00945477410708709,0.0797007758796307
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0157443029462603,0.00899761979638878,-0.00189103185466167,0.0333796377471824,0.0801583484976235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FBN2,Fibrillin-2,24195,0.00754864204665163,0.00435734840415804,-0.000991760825498124,0.0160890449188014,0.0832162756797367
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REG1A,Lithostathine-1-alpha,29353,-0.00608750815673172,0.00353751402563359,-0.0130210356469736,0.000846019333510121,0.0852897625460648
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.00858585048458894,0.00500214531464043,-0.0183900553012842,0.00121835433210631,0.0860955114681978
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00876349257648892,0.00510712862391187,-0.0187734646793562,0.00124647952637835,0.086187092005588
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00313091863374934,0.00183338493026839,-0.00672435309707539,0.000462515829576713,0.087700175762412
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0180660574117455,0.0106076166351864,-0.00272487119321987,0.038856986016711,0.0885579124307585
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DEFB116,Beta-defensin 116,24101,-0.00947127569991658,0.0055662428773208,-0.0203811117394653,0.00143856033963219,0.0888514788039938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00579300382342395,0.00341543955377391,-0.000901257701972909,0.0124872653488208,0.089875603034155
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00621195892461644,0.00366300003822734,-0.013391438999542,0.000967521150309138,0.0899240894220848
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00365160924444789,0.00215625237334284,-0.000574645407304072,0.00787786389619986,0.090371471136003
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL4,Myosin light chain 4,24240,0.00635302020622866,0.00375140065128823,-0.000999725070296275,0.0137057654827536,0.0903720142599695
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00625213797141785,0.00369386503140444,-0.0134921134329706,0.000987837490134861,0.0905496620127831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.010534883518936,0.0062284134872483,-0.00167280691607069,0.0227425739539426,0.0907687445405047
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00354101766818738,0.00209522328922598,-0.000565619978695541,0.00764765531507029,0.0910308515966932
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00600419460458092,0.00355345559526596,-0.0129689675713022,0.000960578362140359,0.0911025264296764
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COPE,Coatomer subunit epsilon,28774,0.00573755639739549,0.00340706499022554,-0.000940290983446568,0.0124154037782375,0.0921891763566882
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00467860788615799,0.00279488514000964,-0.000799366988260916,0.0101565827605769,0.0941454981746776
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL1A,Interleukin-1 alpha,28931,0.0066078796643007,0.00400478586422146,-0.00124150062957337,0.0144572599581748,0.0989546656605944
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINB5,Serpin B5,28916,0.00576451317939206,0.00349909232210488,-0.00109370777193352,0.0126227341307176,0.0994803576728869
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00265989402601082,0.00161475105682526,-0.000505018045366685,0.00582480609738833,0.0995179953188798
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLAU,Urokinase-type plasminogen activator,29443,-0.00343700536242819,0.0020897994930067,-0.00753301236872133,0.000659001643864944,0.100051048364273
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00986797977081023,0.00600976493549602,-0.0216471190443824,0.00191115950276198,0.100604745529848
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00482912482047489,0.00295550583740535,-0.000963666620839582,0.0106219162617894,0.10228161220506
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00691009470476216,0.00425705986850286,-0.0152539320470278,0.00143374263750346,0.104557980662911
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRR5,Proline-rich protein 5,24229,0.00552879967126228,0.00343361264931855,-0.00120108112140207,0.0122586804639266,0.107367453018925
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00489803921313682,0.00304220601581068,-0.0108607630041258,0.00106468457785213,0.107404275464414
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RRP15,RRP15-like protein,24101,-0.0105597124725529,0.00656491539370369,-0.0234269466442121,0.00230752169910636,0.107737286501112
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD10,Frizzled-10,24195,0.00696383304849474,0.00434294034925189,-0.00154833003603897,0.0154759961330284,0.108841016785092
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MSMB,Beta-microseminoprotein,29313,0.0080165375422606,0.0050021302012887,-0.00178763765226525,0.0178207127367865,0.109028311210938
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.00441269013967681,0.00275993896431294,-0.000996790230376558,0.00982217050973017,0.109868075482494
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTRC,Chymotrypsin-C,29456,0.00731835347682868,0.00458980569254508,-0.00167766568055968,0.016314372634217,0.110839295950858
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN2,Transcobalamin-2,29757,-0.00343276446199879,0.00215656027493697,-0.00765962260087524,0.000794093676877671,0.111445299199328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTN4,Alpha-actinin-4,28931,0.00364932338261061,0.00230312365338353,-0.000864798978021117,0.00816344574324233,0.113088551873139
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.0123364727880355,0.00780342815391555,-0.002958246393639,0.02763119196971,0.113913060958545
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00822432627233772,0.00525185141506113,-0.0185179550458575,0.00206930250118208,0.117365004262765
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00309034547476791,0.00198383524156449,-0.000797971598698482,0.00697866254823431,0.119300097871407
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD1,Glutamate decarboxylase 1,24016,-0.00291691312830881,0.00187629748325124,-0.00659445619548124,0.000760629938863629,0.120051873488466
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.00839416836568327,0.00540345027368649,-0.0189849309021088,0.00219659417074225,0.120320915732796
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGF,Beta-nerve growth factor,29218,0.00135565186766276,0.000873973776633011,-0.000357336734537943,0.00306864046986346,0.120880019399856
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A3,Protein S100-A3,24793,0.00492093258919547,0.00319967956530897,-0.00135043935881012,0.0111923045372011,0.124074724760391
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STC2,Stanniocalcin-2,29396,0.0028568340035011,0.00186429976193768,-0.000797193529896741,0.00651086153689895,0.125437030886595
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00479282792617127,0.00312818696708638,-0.0109240743816606,0.00133841852931803,0.125500359236828
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,0.00385916650490758,0.00252684693830616,-0.00109345349417249,0.00881178650398765,0.126705717017133
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB7,Integrin beta-7,29725,0.00502143376059838,0.00329353353297595,-0.00143389196403448,0.0114767594852312,0.127361013623432
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00552515284851204,0.00362936011995912,-0.0126386986836319,0.00158839298660784,0.127934771453113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00678995731089479,0.00449203632404272,-0.00201443388422893,0.0155943485060185,0.130660009566517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.00294124009068521,0.00194839741935076,-0.000877618851242291,0.0067600990326127,0.131166193416335
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00394503759831152,0.00261496398817713,-0.00118029181851565,0.00907036701513868,0.131404034704864
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF9,Fibroblast growth factor 9,23970,0.00443883649895522,0.00294247136627406,-0.00132840737894194,0.0102060803768524,0.131429500029178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00345496958230777,0.00230404774828011,-0.00797090316893678,0.00106096400432124,0.133751451049712
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCN1,Transcobalamin-1,24546,0.00368742128283567,0.00246034737250448,-0.00113485956727312,0.00850970213294446,0.133953935101804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVPL,Envoplakin,24445,-0.00361713661976694,0.00244635632869859,-0.00841199502401618,0.0011777217844823,0.139265156831107
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00559855553526643,0.00381150202069335,-0.0130690994958254,0.00187198842529254,0.141884183641997
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00628031791459319,0.00428747451765758,-0.00212313214001566,0.014683767969202,0.142986931335251
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGN,Mimecan,29443,0.00442504544272718,0.00302524954336724,-0.00150444366227261,0.010354534547727,0.143558994676124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00336013086024577,0.00229930031658118,-0.00786675948074489,0.00114649776025335,0.143926738829078
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00310262483027745,0.00213579288259811,-0.00728877888016975,0.00108352921961484,0.146325087922369
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL25,Interleukin-25,23913,0.00361314047819906,0.00249500269604989,-0.00127706480605872,0.00850334576245683,0.147587962600183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRNN,Cornulin,28580,0.00692900316624098,0.00480561713445768,-0.00249000641729608,0.016348012749778,0.149354241540534
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.009608452373132,0.00666557564846613,-0.00345607589786162,0.0226729806441256,0.149455346793924
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.00899007492757736,0.00625977410245335,-0.0212592321683859,0.00327908231323121,0.150967726578691
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.0051380982286979,0.00357857756031982,-0.0121521102469247,0.00187591378952894,0.151074104068992
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PMCH,Pro-MCH,24111,-0.00863743376326962,0.00603106602415795,-0.0204583231706192,0.00318345564407995,0.152111849555459
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4,Interleukin-4,28931,0.00944156413141189,0.00660705836511108,-0.00350827026420583,0.0223913985270296,0.15301165401282
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANXA5,Annexin A5,28650,0.00312161441561691,0.00219000121886457,-0.00117078797335764,0.00741401680459146,0.154054264884815
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.00288406212705578,0.00202782343746726,-0.00109047181038004,0.00685859606449161,0.154967884736716
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF20,Fibroblast growth factor 20,24229,-0.00449850204285736,0.00316421401030526,-0.0107003615030557,0.00170335741734094,0.155131839338037
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,0.00608422654060592,0.00428202284184903,-0.00230853822941817,0.01447699131063,0.155363386734965
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00501634671912691,0.00353500987852934,-0.0119449660810444,0.00191227264279059,0.155898171161439
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00265148410183325,0.00187396915844977,-0.00102149544872831,0.00632446365239481,0.157107634133675
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBM25,RNA-binding protein 25,24016,-0.00472492708208883,0.00334976064328477,-0.011290457942927,0.00184060377874932,0.158397155169931
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.00486895063709921,0.00345614469861505,-0.0019050929721863,0.0116429942463847,0.158910775654706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,REN,Renin,29478,-0.00769218995043071,0.00546377803898281,-0.018401194906837,0.00301681500597559,0.159185497275352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00356806910264777,0.0025444727282699,-0.00855523565005677,0.00141909744476122,0.160843841820551
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.00807417499771355,0.00578506546163864,-0.0194129033025253,0.00326455330709818,0.162819893083747
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00410972518786974,0.00294819589701734,-0.00988818914602372,0.00166873877028423,0.163336450686475
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GFRA3,GDNF family receptor alpha-3,29157,-0.00280935683016683,0.00202396121370558,-0.00677632080902976,0.0011576071486961,0.165132812136878
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00540278655842836,0.0039174335848069,-0.0130809563846499,0.00227538326779317,0.167856590294696
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEMA4C,Semaphorin-4C,29349,-0.00278122962973404,0.00202177850402328,-0.00674391549761968,0.00118145623815159,0.168945113574449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.0056141688543696,0.00409608447697145,-0.0136424944292336,0.00241415672049444,0.170506753461522
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.00277579719250781,0.00202810166266824,-0.00119928206632194,0.00675087645133756,0.171113576746186
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0044657755609077,0.0032708866020306,-0.0108767133008877,0.00194516217907226,0.172165853133225
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,-0.00471637266815709,0.00345905753395244,-0.0114961254347039,0.0020633800983897,0.1727401940054
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.00620346843988812,0.00457025588186631,-0.00275423308856985,0.0151611699683461,0.174680592513306
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00528703946539558,0.00389866812085085,-0.00235435005147209,0.0129284289822632,0.175075570940527
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.00408874597007748,0.00302626003236216,-0.0100202156335073,0.00184272369335235,0.176679613232415
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00484957866859985,0.00359492407998632,-0.00219647252817333,0.011895629865373,0.177347311395922
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.00823855843360457,0.00612674703683652,-0.0202469826258042,0.00376986575859502,0.178738853041347
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00690697940825808,0.00514149186061943,-0.00317034463855601,0.0169843034550722,0.179161435876055
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.00996487374185199,0.00743765899446301,-0.00461293788729551,0.0245426853709995,0.180327416135198
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00427647873552087,0.003196362589982,-0.0105413494118856,0.00198839194084384,0.180934948292688
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC4A1,Band 3 anion transport protein,24938,0.0045046617914138,0.00336778881471253,-0.00209620428542276,0.0111055278682504,0.181048030584179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF7,Fibroblast growth factor 7,24016,-0.00756827331762624,0.00572553842764988,-0.01879032863582,0.00365378200056752,0.186232427584014
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NENF,Neudesin,24793,0.0104579717677466,0.00791881528391123,-0.00506290618871944,0.0259788497242126,0.186630780102799
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTF,Ciliary neurotrophic factor,24101,-0.00323026754718643,0.00246073249208176,-0.00805330323166669,0.00159276813729383,0.189287796754978
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.00435388951503911,0.00333895313908857,-0.0108982376676527,0.00219045863757449,0.192256738465903
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.00241953211625238,0.00186648361696127,-0.00123877577299171,0.00607784000549646,0.194882409723393
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00347141330016266,0.00268727495029634,-0.00873847220274349,0.00179564560241818,0.196439897966272
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00737576633241363,0.00575108896973109,-0.0038963680482593,0.0186479007130866,0.199680011778955
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SOX2,Transcription factor SOX-2,24826,0.00219505679588421,0.00171712812027891,-0.00117051431986245,0.00556062791163087,0.201144968616219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PROK1,Prokineticin-1,29434,0.00564553525611362,0.00441654551499606,-0.00301089395327866,0.0143019644655059,0.201164516259805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEPTIN7,Septin-7,24445,0.00484718394942122,0.00379918963823257,-0.00259922774151462,0.0122935956403571,0.202021809332312
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.00669408490521226,0.00528148419865829,-0.00365762412415799,0.0170457939345825,0.20500209942794
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00728907693259397,0.00575315780836067,-0.0185652662369809,0.00398711237179295,0.205178422012005
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00325732730911322,0.0025724944515759,-0.00178476181597555,0.00829941643420198,0.205448838572894
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00569407415146218,0.00451171629846577,-0.0145370380964551,0.00314888979353073,0.206938023153572
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.0032190869490516,0.00255375260267321,-0.0017862681521879,0.00822444205029109,0.207489539894092
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00442267538553917,0.00350964246602619,-0.00245622384787217,0.0113015746189505,0.207625488713008
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00376149007518754,0.00298918765507449,-0.00962029787913353,0.00209731772875846,0.208271818226328
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.00823746457497202,0.00658288995665945,-0.00466499974008051,0.0211399288900245,0.210820890058916
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.0030394034448663,0.00243678132656794,-0.00173668795520687,0.00781549484493946,0.212298353769862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.00232489436623106,0.00186534322339524,-0.00598096708408574,0.00133117835162361,0.212643355041742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CGN,Cingulin,24195,0.00357781061945662,0.00287811286669657,-0.00206329059926866,0.0092189118381819,0.21383938825608
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CBLN1,Cerebellin-1,24101,-0.00853200508340107,0.00689002448099196,-0.0220364530661453,0.00497244289934316,0.215612190731692
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL10,Interleukin-10,28931,0.00726671425867221,0.00588827260392517,-0.00427430004502112,0.0188077285623655,0.217175860354575
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.00448422822092244,0.00363517202225746,-0.0116091653845471,0.00264070894270219,0.217376190015287
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00365218950745221,0.00297770755746983,-0.00948849632009308,0.00218411730518866,0.220016452289338
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL31,Interleukin-31,24229,-0.00502718234140589,0.0041012848630263,-0.0130657006729374,0.00301133599012566,0.220301713316772
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00506751879883672,0.00413886694421796,-0.00304466041183048,0.0131796980095039,0.220823397432855
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00425465652215201,0.00348319576364981,-0.0110817202189056,0.00257240717460163,0.221915946990831
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHH,Sonic hedgehog protein,24229,-0.00374990894078676,0.00309778963450491,-0.00982157662441638,0.00232175874284285,0.226094624201839
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.004082900222481,0.00337825215434945,-0.00253847400004393,0.0107042744450059,0.226832480524163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,-0.00569400925308236,0.0047181542402765,-0.0149415915640243,0.00355357305785957,0.22750741924005
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD177,CD177 antigen,29413,-0.0108911149645868,0.0092001711800665,-0.0289234504775172,0.00714122054834354,0.236503865557524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00398307867731167,0.00337710355983192,-0.00263604429995889,0.0106022016545822,0.238236114348122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00470583419567392,0.00399368728106171,-0.00312179287520703,0.0125334612665549,0.238681111442988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HRAS,GTPase Hras,24421,0.00828693113659369,0.0071030864436827,-0.0056351182930244,0.0222089805662118,0.24335658137818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00528801945753185,0.00454656795436054,-0.0036232537330148,0.0141992926480785,0.244808655410699
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00819186793350273,0.00707383461182629,-0.00567284790567681,0.0220565837726823,0.246854316214507
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00390573053878686,0.00337310138562636,-0.00270554817704079,0.0105170092546145,0.246912257687524
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.00500442780046496,0.00432206009764617,-0.0134756655918514,0.00346680999092154,0.246922237265424
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,0.00381565671768121,0.00330098732392346,-0.00265427843720876,0.0102855918725712,0.247725841783494
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.00246022988752823,0.00212898683359317,-0.00663304408137085,0.00171258430631438,0.247861456912175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC51B,Organic solute transporter subunit beta,24111,0.0063466203591498,0.00550525249915663,-0.0044436745391972,0.0171369152574968,0.248991594791823
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00519312584416946,0.00451071904414538,-0.0140341351706944,0.00364788348235548,0.249626185793821
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00367151055203311,0.00319086294364825,-0.00992560192158367,0.00258258081751745,0.249894926612294
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00514243662161633,0.0045184902089019,-0.0037138041878314,0.0139986774310641,0.255095257808942
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00310076631016599,0.00272549701776845,-0.00844274046499214,0.00224120784466017,0.255261896151396
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDSN,Corneodesmosin,29676,-0.00353320543009815,0.00311795110876037,-0.00964438960326847,0.00257797874307216,0.257147077225753
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.00567566203608215,0.00502868830587927,-0.0155318911156055,0.00418056704344121,0.25905361215508
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.00307046735404203,0.00274210004007494,-0.00230404872450484,0.00844498343258891,0.262831283103823
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB5,Integrin beta-5,29566,0.00302890438035967,0.00270810033585187,-0.00227897227790999,0.00833678103862932,0.263379281858062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EVI2B,Protein EVI2B,24016,-0.00329578042425934,0.00296267916941031,-0.00910263159630354,0.00251107074778487,0.265963403713275
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.00413047862763397,0.00372673864139624,-0.0114348863647706,0.00317392910950265,0.267727455690553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00408933983271363,0.00369677697505936,-0.01133502270383,0.00315634303840271,0.268655086405283
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00214647110295406,0.0019571467455011,-0.00598247872413622,0.00168953651822811,0.272766164393313
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00520609426542587,0.00475167855652722,-0.0145193842362192,0.00410719570536749,0.27325055181113
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB1,Integrin beta-1,29474,0.00170814207402298,0.00156047651197561,-0.00135039188944921,0.00476667603749517,0.273688370841641
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DUOX2,Dual oxidase 2,28916,0.00551692874391327,0.00513197436264971,-0.00454174100688016,0.0155755984947067,0.282378790549933
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00257804445834646,0.00240046878897565,-0.00212687436804581,0.00728296328473873,0.282842667785893
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC8,Histone deacetylase 8,24229,0.00474033015715895,0.0044206098051651,-0.00392406506096464,0.0134047253752825,0.283584793806695
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NPTN,Neuroplastin,28797,0.00629716203313143,0.00587303775024013,-0.00521399195733922,0.0178083160236021,0.283632245487502
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UNC5D,Netrin receptor UNC5D,24229,-0.00202796259861877,0.00190225500331347,-0.00575638240511316,0.00170045720787563,0.286396544171297
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLHL41,Kelch-like protein 41,24867,0.00381051385562494,0.00358189752333053,-0.00321000529010291,0.0108310330013528,0.287418101752553
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.00392687148367264,0.00370424478790851,-0.0111871912679733,0.00333344830062803,0.289109246189968
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ABO,Histo-blood group ABO system transferase,24951,-0.0109684840896908,0.0103827334177707,-0.0313186415885213,0.00938167340913981,0.29078850435346
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TCP11,T-complex protein 11 homolog,24445,-0.00451564757464365,0.00427931519722142,-0.0129031053611976,0.00387181021191035,0.291332099015158
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPT,Microtubule-associated protein tau,28774,0.00398626516683208,0.00380532768693706,-0.00347217709956457,0.0114447074332287,0.294855496340087
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AREG,Amphiregulin,29349,0.00340079625496273,0.0032802554935958,-0.00302850451248504,0.0098300970224105,0.29986215506744
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRYBB2,Beta-crystallin B2,24845,0.00515888900142221,0.00498238333112832,-0.00460658232758929,0.0149243603304337,0.300480114692964
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00516988150591288,0.00499945271616072,-0.0149688088295879,0.00462904581776213,0.30110470712519
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00323359224048624,0.00314572046485359,-0.00293201987062679,0.00939920435159927,0.303991168206671
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00306741771646965,0.00300910954534161,-0.00283043699239991,0.00896527242533921,0.308034116177354
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RBP1,Retinol-binding protein 1,24195,0.00508499259304541,0.0050037748062054,-0.00472240602711718,0.014892391213208,0.309529420666191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PI16,Peptidase inhibitor 16,24951,-0.0017936742599369,0.00176587057414943,-0.00525478058526978,0.00166743206539599,0.309760673310392
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF75D,Zinc finger protein 75D,24445,0.00437855454788607,0.00433501902989664,-0.00411808275071134,0.0128751918464835,0.312484811350417
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2B,Alpha-amylase 2B,27585,-0.00356113422803839,0.00352884497482163,-0.0104776703786888,0.00335540192261201,0.312911514130311
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PALLD,Palladin,24229,-0.00290085146977869,0.00287700754920509,-0.00853978626622066,0.00273808332666328,0.313326416874779
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.00996550159396576,0.0099297143910378,-0.0294277418003998,0.00949673861246832,0.315579244081378
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGFL4,Insulin growth factor-like family member 4,24229,0.00542950042303353,0.00542886042631633,-0.00521106601254647,0.0160700668586135,0.317263454077027
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00628047765195244,0.00629305565446691,-0.00605391143080271,0.0186148667347076,0.31828879482228
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.00309051348162991,0.00313247247047434,-0.00923015952375961,0.0030491325604998,0.323844502141455
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00406508406425245,0.00412127559402688,-0.00401261610004023,0.0121427842285451,0.323961874317702
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0187600191684788,0.0190298504181848,-0.0560585259881209,0.0185384876511633,0.324230984710361
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.00370771277516632,0.00378386554412481,-0.0111240892416509,0.0037086636913183,0.327157985061497
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCAN,Neurocan core protein,29694,-0.00262336142156111,0.0026850842078396,-0.00788612646892673,0.00263940362580452,0.328570818900578
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00292353674619475,0.00300108968319019,-0.00880567252524752,0.00295859903285802,0.329987623739063
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00634500682199168,0.00653082335892778,-0.0191454206054901,0.00645540696150677,0.331285285116526
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00677110140925839,0.00697099344787744,-0.0068920457485814,0.0204342485670982,0.3313961312639
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TBR1,T-box brain protein 1,24195,0.00338063278369311,0.00348477156986353,-0.00344951949323941,0.0102107850606256,0.331998359560972
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH17,Cadherin-17,29478,0.00473728119196881,0.00488347843736433,-0.00483433654526528,0.0143088989292029,0.332023109646183
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DAND5,DAN domain family member 5,24229,-0.00380077830886645,0.00392210039361706,-0.0114880950803559,0.00388653846262299,0.332521408795151
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00189666911838248,0.00196244414454585,-0.00194972140492739,0.00574305964169236,0.333812147118644
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ASPN,Asporin,24922,0.00191065163928548,0.00198231390982189,-0.00197468362396544,0.00579598690253639,0.335130902390835
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00511949449539844,0.00531457562649059,-0.00529707373252312,0.01553606272332,0.335410081530764
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HLA_A,,24867,0.00225898899010612,0.00235488221644867,-0.00235658015413329,0.00687455813434552,0.337427558003338
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHIT1,Chitotriosidase-1,29579,0.0104960160737426,0.0109583239266388,-0.0109822988224695,0.0319743309699548,0.338165310943393
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NEB,Nebulin,24111,-0.00261178701169426,0.00273227730246593,-0.00796705052452747,0.00274347650113896,0.339131768079859
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00313544625992847,0.00328599740361906,-0.00957600117102184,0.00330510865116489,0.340000070163219
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.00349063894285541,0.00368686346649214,-0.01071689133718,0.00373561345146919,0.34375997678742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.00207084397003918,0.0022011367398917,-0.00638507198022691,0.00224338404014855,0.346811874064389
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GJA8,Gap junction alpha-8 protein,24016,0.00420563167654927,0.00448549016158126,-0.00458592904015001,0.0129971923932485,0.348455307931982
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.00275677007743664,0.00294718208547806,-0.00853324696497363,0.00301970681010035,0.349594087499747
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OSTN,Osteocrin,24195,-0.0028080708720174,0.00301542412070135,-0.00871830214859206,0.00310216040455725,0.351740903685818
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00170328774954286,0.00182987467535797,-0.00528984211324448,0.00188326661415877,0.351954622287064
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANK2,Ankyrin-2,24111,-0.00481667839331326,0.00520051446470499,-0.015009686744135,0.00537632995750852,0.354355135238726
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL9,Interleukin-9,24445,-0.00378321982268958,0.0040929642275402,-0.0118054297086684,0.00423899006328922,0.355327446823964
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,-0.00309906939581112,0.00335417635377078,-0.00967325504920185,0.00347511625757961,0.355524732725714
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00364751490817403,0.0039560836701736,-0.00410640908536622,0.0114014389017143,0.356535549877295
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD5L,CD5 antigen-like,24833,0.00313205783361777,0.00340151713075348,-0.00353491574265904,0.00979903140989458,0.357172883748031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.00517944501301914,0.00563099415312699,-0.00585730352710977,0.016216193553148,0.357681112142084
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.00313790610969634,0.00342040269255019,-0.00356608316770203,0.00984189538709472,0.358936373588578
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00380241611233042,0.00415975817831109,-0.00435070991715932,0.0119555421418202,0.360675864221377
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FZD8,Frizzled-8,24101,0.00288534536184943,0.00317367540954108,-0.00333505844085108,0.00910574916454993,0.363280321560645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00363255008050269,0.00401173186558322,-0.0114955445370458,0.00423044437604041,0.365219233775236
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.0020693319600322,0.00229433477756214,-0.00242756420398959,0.00656622812405399,0.367101000247792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GH2,Growth hormone variant,28797,0.0106962794782996,0.0119059779646967,-0.012639437332506,0.0340319962891052,0.368982139997914
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00316188689228804,0.00352572355027118,-0.00374853126624348,0.0100723050508196,0.36983183687746
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00490379394042748,0.00550994902128349,-0.00589570614128816,0.0157032940221431,0.373480415034729
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00421270353896778,0.00474376652798104,-0.0135104859338106,0.00508507885587507,0.374522530451033
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KLK12,Kallikrein-12,28797,-0.00875000650864068,0.00997073120724959,-0.0282926396748499,0.0107926266575685,0.380184880222073
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.00136643846991202,0.00156272464963663,-0.00169650184337577,0.00442937878319981,0.381911903560329
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00500360632609691,0.0057345689595556,-0.0162433614868259,0.00623614883463207,0.382925709615995
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00231965048606703,0.00266416474339301,-0.00754141338311733,0.00290211241098327,0.383934426469947
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00321720171115966,0.00369940391177345,-0.0104680333782356,0.0040336299559163,0.384498105375131
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00418606169629308,0.00482936728340925,-0.0136516215717752,0.00527949817918905,0.386064075656669
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRTN3,Myeloblastin,28671,0.00295234957473354,0.00341411157807973,-0.00373930911830272,0.0096440082677698,0.387183806870672
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOLR3,Folate receptor gamma,29461,-0.011582817481096,0.0134759830996805,-0.0379957443564697,0.0148301093942777,0.390063122978943
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00208923955160375,0.00245318628177492,-0.0068974846638826,0.0027190055606751,0.39442062073271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00437665391231281,0.00515347323992262,-0.0144774614625611,0.00572415363793552,0.395743310864737
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDCL2,Phosducin-like protein 2,24016,0.00324666131485573,0.00382540677244758,-0.00425113595914152,0.010744458588853,0.396051096061075
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00181948086715261,0.00214610188738005,-0.00602584056641751,0.00238687883211228,0.396553432946674
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ICAM2,Intercellular adhesion molecule 2,29820,0.00193075936337425,0.00228831786896741,-0.00255434365980187,0.00641586238655037,0.398818051130658
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00144760458684008,0.00171585129974486,-0.00481067313434001,0.00191546396065985,0.398864457640012
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.00418445695308112,0.00499393948379201,-0.0139725783413135,0.00560366443515122,0.402091195721377
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,0.00303560444858198,0.00362356435625115,-0.00406658168967027,0.0101377905868342,0.402185077996259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MMP15,Matrix metalloproteinase-15,24922,0.00295271986781916,0.00354446453271141,-0.00399443061629521,0.00989987035193353,0.404823931610681
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00501805686058451,0.00605540395236518,-0.00685053488605124,0.0168866486072203,0.40728766828124
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.00395319976925721,0.00480006386222506,-0.0133613249392183,0.00545492540070392,0.410189296288814
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRND,Prion-like protein doppel,24845,-0.00304693196490783,0.00371179213648863,-0.0103220445524255,0.00422818062260988,0.411723113066706
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL22,Interleukin-22,24793,0.00397067511103916,0.00487252616498775,-0.00557947617233682,0.0135208263944151,0.41513109511614
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00290333237443251,0.0035633670540854,-0.0098875318004399,0.00408086705157488,0.415210807015149
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.00687917144749787,0.00853378717812992,-0.00984705142163677,0.0236053943166325,0.420185921831754
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDAN1,Codanin-1,24845,0.00130308537248931,0.00162563321787618,-0.001883155734548,0.00448932647952663,0.422799955529295
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.00233331141147697,0.00291845729069496,-0.0080534877012391,0.00338686487828516,0.424007503737601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPRR1B,Cornifin-B,24445,0.0048932270561802,0.00616924272835563,-0.00719848869139684,0.0169849428037572,0.427689432282522
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00274833913856645,0.00346636406335954,-0.00954241270275114,0.00404573442561825,0.42786754088936
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.0028353893662577,0.00360493000140506,-0.00423027343649622,0.00990105216901162,0.431564375805535
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPB41L5,Band 4.1-like protein 5,24195,0.00353867129757913,0.0045356860255057,-0.00535127331241205,0.0124286159075703,0.435290003536966
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00284308674485752,0.00364745330316909,-0.00999209521906892,0.00430592172935389,0.43570819933612
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00200839396315313,0.00258189515955956,-0.00706890847588987,0.00305212054958361,0.43664844376789
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00217730515810491,0.0028234414000989,-0.00335663998608894,0.00771125030229876,0.440623841156427
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.0020840533261492,0.0027102845198153,-0.00739621098498718,0.00322810433268878,0.441933644643327
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KHDC3L,KH domain-containing protein 3,24016,-0.00373661423810198,0.00487340960576256,-0.0132884970653966,0.00581526858919264,0.443246566761143
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TSPAN7,Tetraspanin-7,24101,-0.00519035884395665,0.006792873363246,-0.0185043906359188,0.00812367294800551,0.44482177683201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MYL6B,Myosin light chain 6B,24195,0.0050533875052571,0.00661787251527284,-0.00791764262467766,0.0180244176351919,0.445114896035184
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00297373047863842,0.00391597391048969,-0.00470157838592137,0.0106490393431982,0.447629924412298
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.00349457660140271,0.0046508049003508,-0.0126101542060903,0.00562100100328487,0.45242289413082
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SUSD4,Sushi domain-containing protein 4,24793,-0.0022598539036853,0.00301847431898689,-0.00817606356889959,0.003656355761529,0.454060692364212
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGB2,Integrin beta-2,29274,-0.00153722152467713,0.00206720858674847,-0.00558895035470414,0.00251450730534988,0.457111236578671
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EXOSC10,Exosome component 10,24111,-0.0032467077037837,0.00437314971420266,-0.0118180811436209,0.00532466573605351,0.457840988142597
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00335690791833912,0.0045396776818137,-0.012254676174694,0.00554086033801573,0.459635111132293
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00131587092671935,0.00178858117782472,-0.0048214900352558,0.0021897481818171,0.461916218972774
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00298681139781245,0.0040876413820567,-0.0109985885066436,0.00502496571101867,0.46497372854417
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ISM2,Isthmin-2,24938,-0.00228624491329161,0.00316665528201913,-0.0084928892660491,0.00392039943946589,0.470316821982505
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00183179645995291,0.00254918959576628,-0.00316461514774899,0.00682820806765481,0.472405621239897
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FAM171A2,Protein FAM171A2,24867,0.00816639386605814,0.0114131208731638,-0.0142033230453428,0.0305361107774591,0.474290308218862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.00335882983414995,0.00470647625114839,-0.0058658636181009,0.0125835232864008,0.475442449936056
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00204560518462451,0.0028933663541732,-0.00771660323880398,0.00362539286955496,0.479574257813419
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,AMY2A,Pancreatic alpha-amylase,28334,-0.00239574873681798,0.00344612895843315,-0.00915016149534695,0.004358664021711,0.486935697217685
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00166345651920004,0.00241183403854937,-0.00306373819635672,0.0063906512347568,0.490385730730971
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD27,CD27 antigen,29566,0.00203294824267824,0.00298920868393608,-0.00382590077783647,0.00789179726319295,0.496449137296271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN4,Prefoldin subunit 4,24016,0.00262391468616894,0.00385995837970586,-0.00494160373805455,0.0101894331103924,0.496651611240736
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAP1,Antigen peptide transporter 1,24445,-0.00288790263001599,0.00432913175890661,-0.0113730008774729,0.00559719561744096,0.504723584762501
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF12,Fibroblast growth factor 12,24229,0.00224897431084435,0.00337326139562871,-0.00436261802458793,0.00886056664627662,0.504966165333226
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHC1,SHC-transforming protein 1,24016,-0.00560569094803258,0.00841262616029201,-0.0220944382222049,0.0108830563261398,0.505198565071039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IFNL2,Interferon lambda-2,24101,0.00297002719284863,0.00446533638364519,-0.00578203211909594,0.0117220865047932,0.505974002092422
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HBZ,Hemoglobin subunit zeta,24922,0.0050444698805263,0.00762567502323984,-0.00990185316502378,0.0199907929260764,0.508290616123316
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTNL10,Butyrophilin-like protein 10,24016,-0.00192007513825606,0.00294890738264086,-0.00769993360823214,0.00385978333172002,0.514979076964804
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.00672793157657119,0.0103538286022787,-0.0135655724838951,0.0270214356370375,0.515826779599704
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCGN,Secretagogin,28931,-0.00205567417214773,0.00317330839934576,-0.00827535863486542,0.00416401029056996,0.517118441051515
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELENOP,Selenoprotein P,24966,0.00105454429556412,0.00162801665671651,-0.00213636835160025,0.00424545694272848,0.517154007294957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSMA1,Proteasome subunit alpha type-1,28797,0.00214615013989012,0.00333538111335379,-0.0043911968422833,0.00868349712206354,0.519937437817895
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.00275636642483282,0.00429548459475496,-0.00566278338088691,0.0111755162305525,0.521081055955292
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TAGLN3,Transgelin-3,24016,-0.00277595263345438,0.00435798111306725,-0.0113175956150662,0.00576569034815743,0.52414307573182
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00252351893983254,0.0039690632013017,-0.0103028828143839,0.0052558449347188,0.524914728845806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00222091516908397,0.00350324681272803,-0.00464544858386297,0.00908727892203092,0.52611353704601
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFRC,Transferrin receptor protein 1,29565,-0.00174121974567458,0.00277068018053838,-0.0071717528995298,0.00368931340818063,0.529717408066977
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MB,Myoglobin,29820,-0.00235460084145012,0.00377102170460892,-0.0097458033824836,0.00503660169958336,0.532374076227457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCIN,Adseverin,24101,0.00330756584306829,0.00529845164154094,-0.00707739937435196,0.0136925310604885,0.532468409329843
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00183815573906267,0.00295884172680577,-0.00396117404547664,0.00763748552360197,0.534446430249256
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CTSV,Cathepsin L2,29618,0.00183723607798354,0.00297682208645916,-0.00399733521147641,0.00767180736744349,0.53712052611836
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00185399565436519,0.00301946157037622,-0.0040641490235722,0.00777214033230257,0.539210825553321
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.00221429282196019,0.00367266348833656,-0.00498412761517948,0.00941271325909986,0.546571998782062
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,-0.00193456718438435,0.00325199100420084,-0.00830846955261799,0.0044393351838493,0.551923559893001
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00115720470481448,0.00196470869112122,-0.00269362432978312,0.00500803373941208,0.555868751031948
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.0026802507290024,0.00456356475288539,-0.00626433618665296,0.0116248376446578,0.556997590952313
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00394433579241549,0.00674382255504625,-0.0171622280003062,0.00927355641547516,0.55863302221059
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00205964041159987,0.00352369329644266,-0.00896607927262749,0.00484679844942775,0.558880590799925
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HSP90B1,Endoplasmin,28626,0.00278869334027234,0.00482763806728515,-0.00667347727160656,0.0122508639521512,0.563503839657862
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00285006360346476,0.00501339137225676,-0.00697618348615849,0.012676310693088,0.569707472686088
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00204945522095728,0.00362165118449792,-0.00504898110065865,0.0091478915425732,0.571474013127203
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UPK3A,Uroplakin-3a,24101,-0.00200457978486377,0.00355227065594489,-0.00896703027051575,0.00495787070078822,0.572548827732456
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYTH3,Cytohesin-3,24016,0.00297998874375372,0.00528831288945156,-0.00738510451957135,0.0133450820070788,0.573096579474159
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DBH,Dopamine beta-hydroxylase,24919,0.00431848895387843,0.00786338218644726,-0.0110937401315582,0.0197307180393151,0.582880156725712
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DLL1,Delta-like protein 1,29566,-0.0011778206034642,0.00214844014990451,-0.00538876329727704,0.00303312209034865,0.583544114883802
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITGAX,Integrin alpha-X,24445,0.0021133508933727,0.00385948425475969,-0.0054512382459563,0.0096779400327017,0.583989864344471
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRTAC1,Cartilage acidic protein 1,29820,-0.00118092136441783,0.00216149884808525,-0.00541745910666492,0.00305561637782926,0.584833764482761
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.00140869835513691,0.0026313901890122,-0.00656622312560081,0.003748826415327,0.592416952131361
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00290150522600427,0.00552287998769027,-0.0137263500018772,0.00792333954986866,0.599337026731708
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WNT9A,Protein Wnt-9a,28931,0.00108646077319547,0.00207650937499261,-0.00298349760179004,0.00515641914818099,0.600828679844098
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RUVBL1,RuvB-like 1,28797,0.00388272658783993,0.00744383565260366,-0.0107071912912632,0.0184726444669431,0.601950826808952
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,S100A16,Protein S100-A16,28722,0.00230186116094339,0.00442446712200702,-0.00637009439819037,0.0109738167200772,0.60288828961492
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.00170080893373569,0.00327284703620257,-0.00471397125722135,0.00811558912469274,0.60329642833761
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00645285295490574,0.0124230822700457,-0.0308020942041953,0.0178963882943838,0.603469406343693
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RSPO1,R-spondin-1,29218,-0.00129307754710299,0.00251871857458747,-0.00622976595329444,0.00364361085908846,0.607684472695048
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PSCA,Prostate stem cell antigen,24805,0.0091754604917001,0.0186822584125747,-0.0274417659969464,0.0457926869803466,0.623337227297605
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BSND,Barttin,24016,-0.00119628538162811,0.00244350440236892,-0.00598555401027119,0.00359298324701497,0.624437200172792
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MORN4,MORN repeat-containing protein 4,24016,0.00274323935409145,0.0056576586912643,-0.00834577168078657,0.0138322503889695,0.62777168700805
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL5,Interleukin-5,28931,0.00487889475341855,0.0102301003781778,-0.0151721019878099,0.024929891494647,0.633425806476985
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.00223092950681123,0.00469202299932438,-0.00696543557186456,0.011427294585487,0.634453578044585
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SHD,SH2 domain-containing adapter protein D,24059,0.00291995457465548,0.00614424683682768,-0.00912276922552677,0.0149626783748377,0.634624561806406
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00254589004075618,0.00537752522006392,-0.0130858394720815,0.0079940593905691,0.63590962364675
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC1A4,Neutral amino acid transporter A,24195,0.00171055832374146,0.00372542126565013,-0.00559126735693279,0.00901238400441571,0.646124576564179
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00107816837729452,0.00235310424515703,-0.00353391594321326,0.0056902526978023,0.646820214862306
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.00119101958573183,0.00264701665222732,-0.00637917222409739,0.00399713305263372,0.652751322588263
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NLGN1,Neuroligin-1,24195,-0.00221813214424152,0.00493505858228766,-0.0118908469655253,0.00745458267704229,0.653100858271102
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGLON5,IgLON family member 5,24016,-0.00302258280462264,0.00672918004490806,-0.0162117756926424,0.0101666100833972,0.653309116054045
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53BP1,TP53-binding protein 1,24229,0.00277308780677871,0.00629788336271318,-0.00957076358413912,0.0151169391976965,0.659708850121909
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SLC39A14,Zinc transporter ZIP14,28774,-0.00105506905194026,0.00241050052296509,-0.00577965007695184,0.00366951197307132,0.661609169871383
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SEZ6L,Seizure 6-like protein,29566,-0.000858142308878867,0.00197580641256934,-0.00473072287751478,0.00301443825975704,0.664055553651645
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.00151357682722213,0.00351072717461411,-0.00839460208946579,0.00536744843502153,0.666378321912684
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00174473805629248,0.00407337377453568,-0.00972855065438241,0.00623907454179744,0.66841652100813
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASP4,Caspase-4,24445,-0.00513316011257979,0.0121349670679897,-0.0289176955658395,0.0186513753406799,0.672294833140557
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HDAC9,Histone deacetylase 9,24101,-0.0019557469129408,0.00467587587911019,-0.0111204636359968,0.00720896981011517,0.675758404775175
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,-0.00140315258431864,0.00335676295864751,-0.00798240798326776,0.00517610281463049,0.675945137991889
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GAGE2A,G antigen 2A,24016,0.00189305400334846,0.00458275604429128,-0.00708914784346245,0.0108752558501594,0.679550231475517
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TEX101,Testis-expressed protein 101,24195,0.00149095416170891,0.0036521234224576,-0.00566720774630799,0.0086491160697258,0.683098828514332
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BRD2,Bromodomain-containing protein 2,24101,0.0010176711035748,0.00250264740057713,-0.00388751780155639,0.00592286000870598,0.684277622459201
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNPO1,Transportin-1,24445,0.00102981184806668,0.0025521811103035,-0.00397246312812817,0.00603208682426154,0.686582015025597
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.0013664140181993,0.00339739084861602,-0.0052924720450881,0.0080253000814867,0.687543983717073
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00148407200179441,0.00375140753024449,-0.00586868675748479,0.0088368307610736,0.692400556712826
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF6,Fibroblast growth factor 6,24229,-0.00115784145841359,0.00296740859535547,-0.0069739623053103,0.00465827938848312,0.696402403323249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.00115861922512752,0.00296966361036752,-0.00697915990144786,0.00466192145119281,0.696427831517871
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ESR1,Estrogen receptor,24229,0.00161875331866298,0.00415008771523168,-0.00651541860319111,0.00975292524051708,0.696500937461719
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MLLT1,Protein ENL,24016,-0.00194341936828814,0.00498787150041996,-0.0117196475091113,0.00783280877253498,0.696814364147631
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17A,Interleukin-17A,28879,0.00116715429759827,0.00307353490688313,-0.00485697411989267,0.0071912827150892,0.704138766320607
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,UBQLN3,Ubiquilin-3,24111,-0.00135769287680098,0.00362848901118867,-0.00846953133873078,0.00575414558512882,0.708276799386749
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.00120310041064058,0.00322046664143413,-0.00751521502785148,0.00510901420657031,0.708720408109729
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL17F,Interleukin-17F,28931,-0.0020493609407051,0.00551617300882343,-0.012861060037999,0.00876233815658883,0.710254017828552
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.000973997521167308,0.00264228478923421,-0.00615287570806636,0.00420488066573175,0.712414635644738
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF830,Zinc finger protein 830,24793,-0.00209302661137494,0.00570989528065819,-0.013284421361465,0.00909836813871512,0.713949412933457
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAG,Myelin-associated glycoprotein,24195,-0.00123886070627995,0.00342188073882844,-0.0079457469543837,0.0054680255418238,0.71732464713122
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HEBP1,Heme-binding protein 1,28916,-0.00138298374175005,0.00383073576289453,-0.00889122583702333,0.00612525835352322,0.7180848873907
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00157670844077034,0.00456892588247713,-0.00737838628888483,0.0105318031704255,0.730026804905031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20,Interleukin-20,28931,-0.0012116117883099,0.00352509320987431,-0.00812079447966354,0.00569757090304375,0.731066461959988
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00189884663528462,0.00557185812954571,-0.0128196885691942,0.00902199529862498,0.733262880880496
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENPEP,Glutamyl aminopeptidase,24111,0.00109111763356085,0.00321047485641817,-0.00520141308501876,0.00738364835214047,0.73396359788856
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.000673566781572978,0.00198336928747775,-0.00456097058502938,0.00321383702188342,0.734154647641598
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LY96,Lymphocyte antigen 96,29218,-0.000866128095837115,0.00255555247566111,-0.0058750109481329,0.00414275475645867,0.734672360215449
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EPGN,Epigen,24793,-0.00114567500083899,0.00345793823548238,-0.00792323394238446,0.00563188394070647,0.740407574185271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.000733856104766433,0.00225173443444997,-0.0036795433867555,0.00514725559628836,0.74449704848429
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.000806602257823938,0.00247496414606011,-0.00565753198410176,0.00404432746845388,0.744498820028547
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TET2,Methylcytosine dioxygenase TET2,24421,0.00233360834004897,0.00723605348937229,-0.0118490564991207,0.0165162731792187,0.74707867956968
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,-0.00388945829660916,0.0123512028943527,-0.0280978159695404,0.0203188993763221,0.752835879914736
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,0.000672512152436004,0.00214017475688388,-0.00352223037105641,0.00486725467592841,0.75334720288207
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL3,Interleukin-3,24016,-0.00135448540871976,0.00436674704183794,-0.00991330961072213,0.0072043387932826,0.756425411537006
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TLR2,Toll-like receptor 2,24445,0.000513921635860542,0.00165874376189475,-0.00273721613745318,0.00376505940917426,0.756696062836562
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.00173571349648127,0.00563908746343921,-0.0127883249248221,0.00931689793185958,0.758236852070034
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00142607485305468,0.00465210327973704,-0.0105441972813393,0.00769204757522991,0.759193013676996
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.00121787950635823,0.00401643984115429,-0.00909010159502064,0.00665434258230419,0.76172206287763
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL21R,Interleukin-21 receptor,24229,0.0012016932760137,0.00396603677163121,-0.00657173879638347,0.00897512534841087,0.761895513056135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.0018824585680211,0.00622106733497879,-0.0140757505445795,0.0103108334085373,0.762201786776166
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.00128711254344358,0.00427213375302057,-0.00708626961247674,0.00966049469936391,0.763202415875453
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ACRV1,Acrosomal protein SP-10,24229,0.00165520194620952,0.00553207979363146,-0.00918767444930815,0.0124980783417272,0.764789510621663
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.00117289824197758,0.00392360851862355,-0.00886317093847974,0.00651737445452457,0.764993309327941
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00133574843981091,0.00460106496948533,-0.00768233890038035,0.0103538357800022,0.771579391301039
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARG2,"Arginase-2, mitochondrial",24793,0.000906426394972637,0.00312317790873287,-0.00521500230614379,0.00702785509608906,0.771646029253539
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MAGEA3,Melanoma-associated antigen 3,24445,0.00177098585120546,0.00613469004585845,-0.0102530066386771,0.013794978341088,0.772825783010874
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PDIA2,Protein disulfide-isomerase A2,24016,-0.000841424971865797,0.00294078289143217,-0.00660535943907285,0.00492250949534126,0.774786555135756
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CXCL12,Stromal cell-derived factor 1,28931,0.000798152348364285,0.0028812039563941,-0.00484900740616816,0.00644531210289673,0.781766401832177
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00146099694874223,0.00529530279645817,-0.0118397904298002,0.00891779653231577,0.782623884812788
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2BP,LRP2-binding protein,24195,0.00163067048762397,0.00596319787125476,-0.0100571973400354,0.0133185383152833,0.7845052716204
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.000802006050021125,0.00294177451422491,-0.00496387199785971,0.00656788409790196,0.785142569730061
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SKIV2L,Helicase SKI2W,24111,-0.000780622651823494,0.00288587745911878,-0.00643694247169631,0.00487569716804932,0.78677985292623
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LPO,Lactoperoxidase,28452,0.00114604339791938,0.00433102870442574,-0.00734277286275507,0.00963485965859383,0.791310073718726
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CRX,Cone-rod homeobox protein,28916,-0.00199538214748909,0.00771644491258645,-0.0171196141761585,0.0131288498811804,0.795954775382672
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.000906706811098263,0.00355470925142472,-0.00606052332169418,0.00787393694389071,0.798669634047379
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.000663328638424958,0.00261527330713549,-0.0044626070435606,0.00578926432041052,0.799778590260739
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LAYN,Layilin,29163,0.000634201963063501,0.00251172241298592,-0.00428877396638891,0.00555717789251591,0.800658839497116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSD1,Tryptase delta,24867,0.000671153191329082,0.00269421994661878,-0.00460951790404373,0.00595182428670189,0.803278883955772
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,STEAP4,Metalloreductase STEAP4,24101,-0.00129281708454303,0.00534289187565009,-0.0117648851608172,0.00917925099173116,0.808805826181549
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,-0.000521985640754054,0.00221845247886071,-0.00487015249932104,0.00382618121781293,0.81398351244864
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,0.000993176986054572,0.00432955436279321,-0.00749274956502011,0.00947910353712926,0.818564073788975
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.00109726504205065,0.0048303485466566,-0.0105647481934976,0.00837021810939628,0.820300737155793
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PXDNL,Peroxidasin-like protein,24793,0.000940193892837178,0.00416946290086388,-0.00723195339285603,0.00911234117853039,0.821595914588632
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,-0.000235876951091539,0.00106604026946653,-0.00232531587924593,0.00185356197706285,0.824888245156031
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,-0.000940191740012634,0.00425099951281856,-0.00927215078513701,0.00739176730511174,0.824962275867705
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SCN3B,Sodium channel subunit beta-3,24101,-0.000730387596134983,0.00332698659848329,-0.00725128132916223,0.00579050613689227,0.826235742424394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,-0.000480972420467982,0.00231295312810945,-0.0050143605515625,0.00405241571062654,0.835271793360806
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,0.00096504950969244,0.00474585654177804,-0.00833682931219253,0.0102669283315774,0.838866550984913
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TXK,Tyrosine-protein kinase TXK,24445,0.00106813211173671,0.00537289076712793,-0.00946273379183403,0.0115989980153075,0.842420642456533
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,EFNB2,Ephrin-B2,24195,-0.000817458382669513,0.00416560042978174,-0.00898203522504173,0.0073471184597027,0.844423790971696
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.000584052515912807,0.00305996023398828,-0.00541346954270422,0.00658157457452983,0.848629583104246
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.000739718316106805,0.00389351094750198,-0.00837099977321069,0.00689156314099708,0.849320285654346
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.000431410250568459,0.00228595758593662,-0.00404906661786732,0.00491188711900424,0.850312114231935
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2,Interleukin-2,28931,0.000425478352919889,0.0022724984869262,-0.00402861868145546,0.00487957538729524,0.851482148577352
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.000539289293434734,0.00290747904280083,-0.00623794821732436,0.00515936963045489,0.852851134510569
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PCARE,Photoreceptor cilium actin regulator,24101,0.00109995065707963,0.00610858494616241,-0.0108728758373987,0.013072777151558,0.857101986356819
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00063188190520979,0.00352129643564929,-0.0075336229190824,0.00626985910866282,0.857589175517235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FGF3,Fibroblast growth factor 3,24229,0.000387911837582203,0.00216344624812365,-0.00385244280874016,0.00462826648390457,0.857701496609071
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,-0.00046204126335936,0.00270396379717224,-0.00576181030581694,0.00483772777909823,0.864323067790187
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HMMR,Hyaluronan mediated motility receptor,23975,0.000587463393045313,0.00349329805887744,-0.00625940080235447,0.00743432758844509,0.866451983412394
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,FOS,Proto-oncogene c-Fos,23970,-0.000425496859353714,0.00255945936129509,-0.00544203720749209,0.00459104348878466,0.867965692328249
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PFDN6,Prefoldin subunit 6,24195,-0.000776888900872075,0.00471858635890523,-0.0100253181643263,0.00847154036258217,0.869225244625679
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,-0.000705878684592598,0.00431940132340525,-0.00917190527846688,0.00776014790928168,0.870188700316636
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.000628399555882687,0.00389270188821863,-0.00700129614502582,0.0082580952567912,0.871755935190999
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NME3,Nucleoside diphosphate kinase 3,29497,0.000273957597945681,0.0017179241571016,-0.00309317374997345,0.00364108894586482,0.873299578062741
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPSG1,Tryptase gamma,24229,0.00030659072388991,0.00192685263758815,-0.00347004044578287,0.00408322189356269,0.873579774732038
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NRN1,Neuritin,24867,-0.000399909477485015,0.00257390602493789,-0.00544476528636329,0.00464494633139326,0.87653037508954
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADA2,Adenosine deaminase 2,29328,-0.000476730665849322,0.00307489936756226,-0.00650353342627134,0.0055500720945727,0.876791294626461
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NCLN,Nicalin,28931,-0.000560882186180176,0.00376535069582747,-0.00794096955000202,0.00681920517764167,0.881587168143106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ZNF174,Zinc finger protein 174,24229,-0.000395518328514576,0.00272511954467158,-0.00573675263607087,0.00494571597904172,0.884603145070534
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.000600678909941578,0.00416306528138076,-0.00755892904156471,0.00876028686144787,0.885274530175167
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,0.000274946010558747,0.00204696626477629,-0.00373710786840278,0.00428699988952027,0.893151426016661
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CASQ2,Calsequestrin-2,24111,-0.000463585906898611,0.00352370828299504,-0.00737005414156889,0.00644288232777167,0.895331887544816
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CLINT1,Clathrin interactor 1,24016,-0.000443490160246219,0.00343930487963128,-0.00718452772432352,0.00629754740383108,0.897400180532116
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.000366064548901289,0.00285914396664952,-0.00596998672353435,0.00523785762573177,0.898123989954345
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CHGB,Secretogranin-1,29590,-0.000364599018250222,0.00295737886565976,-0.00616106159494336,0.00543186355844292,0.901882640478454
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,HK2,Hexokinase-2,28916,-0.000240722289314812,0.00197366583296564,-0.00410910732192747,0.00362766274329785,0.902925925546978
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,0.000548792317438224,0.00457783551569708,-0.00842376529332805,0.0095213499282045,0.904578778636895
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.000341327464317516,0.00290657002072879,-0.00535554977631092,0.00603820470494595,0.90651782625431
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CDH4,Cadherin-4,24101,0.000387059265311952,0.00346961835461288,-0.00641339270972929,0.0071875112403532,0.911175814665115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL24,Interleukin-24,28931,-0.00038150532979332,0.00350785808594157,-0.00725690717823881,0.00649389651865217,0.913395711944719
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PGR,Progesterone receptor,24229,-0.000735513025187609,0.00733663660498443,-0.0151153207709571,0.0136442947205819,0.920145036230689
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ANGPT2,Angiopoietin-2,29725,-0.000259501866248814,0.00273925580456325,-0.00562844324319279,0.00510943951069516,0.924526400213271
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ENG,Endoglin,29820,-0.000116455221110722,0.00123713620145444,-0.00254124217596142,0.00230833173373998,0.925004216941837
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.00025583130397309,0.00289620634960758,-0.00542073314125778,0.00593239574920395,0.92961255117235
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,-0.000310664688223023,0.0035420305945998,-0.00725304465363864,0.0066317152771926,0.930109429834371
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,-0.000278327610726964,0.00321500204387454,-0.00657973161672106,0.00602307639526713,0.93101280487247
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,PODXL2,Podocalyxin-like protein 2,29566,-0.000162098026124496,0.00200524064277107,-0.00409236968595578,0.00376817363370679,0.93557197601279
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,0.000444332693426665,0.00556505367180483,-0.0104631725033108,0.0113518378901641,0.936362377495543
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.000624037568269342,0.0081682200102968,-0.0166337487884511,0.0153856736519124,0.939102910315766
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LCN15,Lipocalin-15,24867,-0.000316016628738374,0.00448595478821264,-0.00910848801363514,0.0084764547561584,0.943839413434511
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LMOD2,Leiomodin-2,24101,0.000302449569972586,0.00456803480808822,-0.00865089865388033,0.0092557977938255,0.947211187452865
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.000154647479734183,0.00248116709766418,-0.00470844003168762,0.00501773499115598,0.95030173287017
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,SELL,L-selectin,24966,-9.84133662032277e-05,0.00166943008270035,-0.00337049632829591,0.00317366959588945,0.95299218427975
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,OMP,Olfactory marker protein,24101,0.000208886297591323,0.00356013048058762,-0.00676896944436041,0.00718674203954306,0.953212433958178
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL13,Interleukin-13,28931,-0.000203166424921151,0.00346715028416149,-0.00699878098187768,0.00659244813203537,0.95327308708349
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.000160639871946083,0.00286764978201655,-0.00578123344469853,0.00545995370080636,0.955327969279191
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.000344836598839478,0.00653709304339569,-0.0124678657662161,0.013157538963895,0.957930933137163
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TP73,Tumor protein p73,24195,-0.00012259233137658,0.00249394893367889,-0.00501073224138721,0.00476554757863405,0.96079545280858
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,L1CAM,Neural cell adhesion molecule L1,29566,9.85142289474881e-05,0.00208059440153426,-0.00397945079805967,0.00417647925595464,0.962235332388593
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TPT1,Translationally-controlled tumor protein,28931,0.000216551550472049,0.00469923005909201,-0.00899393936534829,0.00942704246629239,0.963244934283756
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.000103707457459918,0.00234586014319711,-0.00449417842320642,0.00470159333812626,0.964738403302053
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,MERTK,Tyrosine-protein kinase Mer,29786,-7.08215713019852e-05,0.00182936584379739,-0.00365637862514486,0.00351473548254089,0.969118887995876
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,0.000156149027277246,0.00454224527020783,-0.0087466517023301,0.00905894975688459,0.972576716610259
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEP350,Centrosome-associated protein 350,24016,8.96297321970659e-05,0.00266736965189092,-0.00513841478550914,0.00531767424990328,0.973194574475146
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,7.02494295216598e-05,0.0021738016668001,-0.00419040183740654,0.00433090069644986,0.974219996261752
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.000149685398095659,0.0047738579233104,-0.00950644692778405,0.00920707613159273,0.974986503512135
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,-9.32535582841491e-05,0.00304347857498728,-0.00605847156525921,0.00587196444869092,0.97555653400742
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.000161171458251343,0.00560586371155067,-0.010826321416388,0.0111486643328907,0.977063806608092
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,IKZF2,Zinc finger protein Helios,28797,-0.000172454208403087,0.0065733492648087,-0.0130562187674281,0.012711310350622,0.979069791341115
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.000125875361675937,0.00495704273753048,-0.00984167912723568,0.0095899284038838,0.979741512755367
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,CAPN3,Calpain-3,24793,-5.94060880236336e-05,0.00273375640335097,-0.00541756863859154,0.00529875646254428,0.982663052248957
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,6.04592371025799e-05,0.00404653338552334,-0.00787074619852317,0.00799166467272833,0.988079377631106
NMR metabolomics,X23494.Triglycerides in Very Large VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,1.44254523905127e-05,0.00421250880409804,-0.00824209180364165,0.00827094270842267,0.997267726446097
